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Summary 
 Magnetosomes are magnetic nanoparticles that are formed by magnetotactic bacteria 
(MTB) by a complex, genetically controlled biomineralization process. Magnetosomes from 
the model organism Magnetospirillum gryphiswaldense consist of single-magnetic-domain 
sized nanocrystals of chemically pure magnetite, which are formed intracellularly within 
specialized membranous compartments. The natural coating by the biological membrane and 
the defined physico-chemical properties designate magnetosomes as a biogenic material with 
high bio- and nanotechnological potential. In addition, there is a great interest in the cell 
biology of magnetosome formation in MTB. The development of these true bacterial 
organelles involves the invagination of distinctly sized membrane vesicles and the assembly 
of magnetosome vesicles in chain-like arrangements along novel cytoskeletal structures.  
The first part of this thesis focussed on the development of genetic tools for the 
functionalization and expression of modified magnetosome proteins. The identification of 
proteins that are specifically and efficiently inserted into the magnetosome membrane (MM) 
was facilitated by analysis of green fluorescent protein (GFP) fusions of different 
magnetosome membrane proteins (MMP). After optimization of cultivation conditions for the 
utilization of GFP in MTB, it has been demonstrated that fusions of the proteins MamC, 
MamF and MamG are specifically targeted to the MM. In particular, the MamC-GFP fusion 
protein was stably integrated and highly abundant in the MM. Therefore, MamC represents an 
ideal anchor protein for the immobilization of functional proteins in the MM.  
To address the question, if a specific signal sequence determines the magnetosome 
specific targeting of MamC-GFP, the localization of truncated MamC derivatives was studied. 
These experiments have shown that, except for the last nine C-terminal amino acids, the entire 
sequence is required for the correct targeting and membrane insertion of MamC. Stability of 
MamC-GFP is greatly reduced if larger parts are missing or if the N-terminus is deleted.  
MamC-GFP localized at the expected position of the magnetosome chain irrespective 
of cultivation conditions that impeded magnetite formation. This shows that MMP targeting, 
magnetosome vesicle formation and magnetosome chain assembly are not dependent on the 
prevalence of magnetite inducing conditions or the presence of magnetite crystals. In contrast, 
the localization of MamC-GFP was altered in the magnetic ΔmamK as well as in the non-
magnetic MSR-1B, ΔmamB, ΔmamM, ΔmamJKL mutants in comparison to the wild type. 
This indicates that the interaction with specific proteins in the magnetosome vesicle is 
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required for the correct localization of MamC. The spotted MamC-GFP signals in the ΔmamJ 
mutant, which are congruent with the position of magnetosomes in this strain, indicate that 
MamJ is not required for the magnetosome-specific targeting of MamC-GFP. It has also been 
demonstrated that the native MamC protein and other proteins encoded by the mamGFDC 
operon are not required for the magnetosome-directed targeting of MamC, as the localization 
patterns of MamC-GFP in the ΔmamC and ΔmamGFDC mutants were similar to the 
localization of MamC-GFP in the wild type and congruent with the position of the 
magnetosomes. 
The comparison of different promoters from E. coli and M. gryphiswaldense by 
fluorometry and flow cytometry with a GFP-reporter system revealed that the magnetosomal 
promoter, PmamDC, is highly efficient in M. gryphiswaldense. The applicability of this 
promoter for the functionalization of magnetosomes has been demonstrated by expression of a 
fusion protein of MamC and the antibody binding ‘ZZ’ protein in the MM to generate 
antibody-binding magnetosomes. In addition, the E. coli Ptet promoter has been identified as 
the first inducible promoter for regulated gene expression in MTB. The expression was tightly 
regulated in the absence of an inducer and a ten-fold increase of the proportion of fluorescent 
cells was observed in the presence of the inducer anhydrotetracycline. Therefore, the Ptet 
promoter is an important addition to the M. gryphiswaldense genetic toolbox.  
In the second part of this thesis, magnetosomes were tested for their use in biomedical 
and biotechnological applications. To this end, large scale procedures for the purification of 
intact magnetosomes were developed. In collaboration with the groups of Prof. Dr. C. M. 
Niemeyer (Universität Dortmund) and Dr. R. Wacker (Chimera Biotec), streptavidin-biotin 
chemistry was employed to develop a modular system for the production of DNA- and 
antibody-coated magnetosomes. The modified magnetosomes were used in DNA- and protein 
detection systems, and an automatable magnetosome-based Magneto-Immuno-PCR procedure 
was developed for the sensitive detection of antigens.  
With collaborators from the groups of Dr. T. Hieronymus (RWTH Aachen) and Dr. I. 
Hilger (Universität Jena), it has been shown that magnetosomes can be used as specific 
magnetic resonance imaging (MRI) contrast agents for phagocytotic cells such as 
macrophages and dendritic cells to study cell migration. Fluorescently labelled magnetosomes 
were successfully used as bimodal contrast agents for the visualization of labelled cells by 
MRI and fluorescence imaging.  
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Introduction 
The formation of magnetosomes in magnetotactic bacteria (MTB) is of great 
interdisciplinary interest in fields of microbial cell biology, biotechnology and 
nanotechnology. Magnetosomes, which serve as navigational tools for geomagnetic 
orientation, are formed by a complex synthesis process. This process is of particular cell 
biological interest as it involves the formation of a unique microbial organelle, the 
magnetosome vesicle, which represents a third membranous compartment in addition to the 
cytoplasmic and the periplasmic membrane. It has been shown that a novel cytoskeletal 
element, the magnetosome filament, is essential for the assembly of magnetosome chains. 
However, due to the limited availability of genetic tools, many aspects of magnetosome 
formation are still elusive.  
Magnetosomes may also represent a superior alternative to chemically synthesized 
magnetic nanoparticles for a broad range of disciplines including nanosciences, material 
sciences and biotechnology. Despite of the development of various elaborate chemical 
procedures, the production of magnetite nanoparticles with uniform magnetic properties, sizes 
and shapes as well as a stable, biocompatible surface that prevents particle aggregation, has 
remained a challenge (Gupta et al. 2005; Wu et al. 2008). The strict biological control of the 
biomineralization process of bacterial magnetosomes results in nearly monodisperse, 
membrane-bounded magnetic nanoparticles with unique magnetic properties, which could be 
useful for many applications.  
In this thesis biotechnological applications of magnetosomes were investigated, and 
novel genetic tools for M. gryphiswaldense were developed. These tools have not only been 
useful for the genetic engineering of magnetosomes but also provided new insights into the 
cell biology of magnetosome formation.  
Magnetotactic bacteria and the natural function of magnetosomes  
While analyzing bacterial enrichments from mud samples of a salt marsh close to 
Woods Hole, Massachussets, the american microbiologist Richard Blakemore made the 
serendipitous discovery of a novel group of bacteria, which swam along geomagnetic field 
lines (Blakemore 1975). MTB are a phylogenetically and morphologically heterogeneous 
group of microorganisms, which are found in the oxic-anoxic transition zone of fresh water 
and marine habitats (Bazylinski et al. 2007b; Flies et al. 2005). The outstanding feature of this 
group is the presence of membrane-bounded magnetic organelles called magnetosomes 
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(Balkwill et al. 1980; Gorby et al. 1988). Magnetosomes consist of membrane-bounded 
nanocrystals of a magnetic iron mineral and are assembled in chain-like structures within the 
cell. The presence of magnetosome chains cause the cells to align passively along magnetic 
field lines and to behave like self-propelled compass needles. MTB combine aerotaxis, 
magnetic orientation in the earth magnetic field and possibly chemotaxis, to efficiently find 
optimal growth conditions in chemically stratified habitats (Frankel et al. 2007). 
Magnetotactic orientation was found among various Gram-negative organisms of the α-, β- 
and δ-proteobacteria as well as members of the Nitrospira-Phylum, and many different cell 
morphologies were observed such as cocci, vibrio, rods, spirilla and even multicellular 
aggregates (Amann et al. 2006; DeLong et al. 1993; Flies et al. 2005; Schüler 2008; Spring et 
al. 1993). As MTB are difficult to cultivate, until now only few strains are available as axenic 
cultures. The best characterized MTB are the three α-proteobacteria Magnetospirillum 
magnetotacticum MS-1, Magnetospirillum magneticum AMB-1 and Magnetospirillum 
gryphiswaldense MSR-1 (Bazylinski et al. 2007a).  
Magnetospirillum gryphiswaldense  
M. gryphiswaldense was isolated 1990 from the sediment of a small river near 
Greifswald (Schleifer et al. 1991; Schüler et al. 1992). The helically shaped cells, which are 
motile by a single flagellum at each cell pole, are 2-3 µm long and 0.5-0.8 µm in diameter. 
The microaerophilic organism grows chemorganoheterotrophically with different organic 
acids as energy and carbon source and with oxygen or nitrate as terminal electron acceptors 
(Schleifer et al. 1991). In comparison to other MTB, M. gryphiswaldense is characterized by a 
slightly higher oxygen tolerance (Heyen et al. 2003). The availability of a genetic system and 
the nearly completed draft genome sequence designate M. gryphiswaldense as a model 
organism for molecular biological studies on magnetite biomineralization and for the 
development of biotechnological applications of magnetosomes (Richter et al. 2007; Schüler 
2008; Schultheiss et al. 2003).  
Properties of the magnetic crystal 
The properties of the inorganic magnetosome core are critical not only for their natural 
function in magnetotaxis but also for their application in biotechnology. In contrast to some 
environmental organisms, which form greigite (Fe3S4) magnetosomes (Farina et al. 1990; 
Mann et al. 1990), M. gryphiswaldense and other cultivated MTB exclusively form magnetite 
(Fe3O4) crystals even under reducing conditions, which have been considered to promote 
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greigite formation (Faivre et al. 2008b; Frankel et al. 1979; Schleifer et al. 1991). This 
indicates that MTB exert a high degree of control over the composition of magnetosome 
crystals. Cultivation experiments of M. gryphiswaldense with increased copper, zinc, nickel 
and manganese concentrations also yielded magnetosomes consisting of pure magnetite, free 
of contaminations from other metals (Faivre et al. 2008b). However, the incorporation of 
cobalt might be an exception, since the formation of cobalt-doped magnetosomes with 
modified magnetic properties has been reported recently (Staniland et al. 2008). 
Magnetosome crystals also display a high degree of structural perfection. Recently, the highly 
sensitive XMCD (X-ray magnetic circular dichroism) method has been employed to analyze 
magnetite crystals from M. gryphiswaldense, extracellularly produced magnetite by 
Geobacter sulfurreducens, Shewanella oneidensis, Geothrix fermentans as well as geological 
and chemical magnetite. This study has shown that the structure of magnetosomal magnetite 
crystals is almost identical to the calculated structure of stoichiometric magnetite. In 
comparison to stoichiometric magnetite only a slightly higher ratio of Fe2+ to Fe3+ and a 
slightly lower ratio of tetrahedral to octahedral iron was observed for magnetosomal 
magnetite (Coker et al. 2007; see Manuscript 11). The high chemical purity and structural 
perfection of the magnetite crystals is a result from the biomineralization pathway in MTB, 
which, in contrast to earlier presumptions (Frankel et al. 1983), does not proceed via 
intermediates such as ferrihydrate. Instead, the current model is that Fe2+ and Fe3+ are first 
accumulated and then rapidly precipitate in magnetosome vesicles under chemically defined 
conditions (Faivre et al. 2007). For their natural function, it is important to control the 
chemical composition of magnetosomes, as the slightest changes of the crystal structure could 
have a great influence on the magnetic properties of the magnetosomes (Staniland et al. 2008; 
Thomas-Keprta et al. 2000). From a biotechnological perspective, the chemical purity of 
magnetosomal magnetite crystals is not only a great advantage, because of the defined 
magnetic properties of the material, but also because magnetite particles are considered 
biocompatible (Gupta et al. 2005; Schwertmann et al. 1991). 
The magnetic properties of magnetosomes also largely depend on the crystal 
morphology (Kopp et al. 2006). The crystal morphologies are under species-specific control 
and almost identical among a single species (Arató et al. 2005; Bazylinski 1994; Sparks et al. 
1986). While many different crystal morphologies such as bullet-shaped, pseudo-hexagonal 
prismatic and cubooctahedral magnetosomes have been observed in different bacteria, 
M. gryphiswaldense forms cubo-octahedral magnetosomes (Schüler et al. 1999).  
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Similar to the morphology, the magnetosome size can vary greatly between different 
species. Generally, sizes from 35 nm to around 120 nm in diameter are observed (Arató et al. 
2005; Devouard et al. 1998; Lins et al. 1998; Moskowitz et al. 1988). Mature magnetosomes 
of M. gryphiswaldense usually have a diameter of 37-42 nm in average (Faivre et al. 2008a; 
Scheffel et al. 2008; Schüler et al. 1998). The size of magnetite nanoparticles largely 
determines their magnetic properties. Magnetite particles with sizes from approximately 30 
nm to about 150 nm, like magnetosomes, have the maximum magnetization for magnetite 
(Faivre et al. 2008b; Kopp et al. 2008). These particles are in a single-magnetic-domain state, 
which means that all elementary magnetic dipoles are aligned parallel (Faivre et al. 2008b; 
Kopp et al. 2008). Smaller magnetite particles (< 35 nm) also consist of a single magnetic 
domain, but they possess superparamagnetic characteristics and do not retain a temporally 
stable magnetization at room temperature because of thermal fluctuations. Larger multi-
domain particles (> 150 nm) generally consist of several magnetic domains with magnetic 
moments oriented in different directions. Thus, multidomain particles have a reduced 
remanent magnetization in comparison to single-domain particles (Faivre et al. 2008b).  
In summary, their high chemical purity, homogeneous sizes and morphologies as well 
as their extraordinary magnetic properties designate magnetosomes from MTB as a novel 
biomaterial for bio- and nanotechnological applications.     
Applications of magnetosomes  
Magnetic nanoparticles are of interest for a broad range of disciplines including 
nanosciences, material sciences and biotechnology. Synthetic magnetic nanoparticles are used 
in commercial applications such as data storage devices and in form of magnetic fluids in 
liquid sealings, as magnetic inks, dampers and shock absorbers (Wu et al. 2008; Zahn 2001). 
In nanotechnology, magnetic nanoparticles are considered as components of nanomotors, 
nanogenerators, nanopumps and other similar nanometer-scale devices (Zahn 2001). 
Magnetic iron oxide nanoparticles are also of interest for various bioapplications, such as 
magnetic drug targeting, magnetic resonance imaging (MRI), magnetic fluid hyperthermia, 
magnetofection and procedures for the separation of biological entities such as cells, proteins 
and nucleic acids (Barry 2008; Gupta et al. 2005; Ito et al. 2005; Laurent et al. 2008; Lu et al. 
2007; Osaka et al. 2006; Schwertmann et al. 1991).  
Purified magnetosomes represent a distinct class of biogenic magnetic nanomaterials 
that display uniform sizes and shapes, high magnetic susceptibilities, low toxicity, good 
dispersibility, and a biocompatible surface in form of the MM. Consequently, magnetosomes 
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have been suggested in numerous biotechnological and biomedical applications. For instance, 
magnetosomes have been investigated as carriers in magnetic drug targeting (Guo et al. 2008; 
Sun et al. 2008b). Another potential application is the hyperthermal treatment of tumors, 
which involves magnetic nanoparticles to generate heat in specifically targeted tissues and 
induce cell necrosis (Thiesen et al. 2008). Magnetosomes could be used to increase the 
efficiency of tumor treatment by hyperthermia, because they have extremely high specific loss 
powers (960W/g at 10 kA/m and 410 kHz) and generate more heat than chemically 
synthesized magnetic nanoparticles upon exposure to alternating magnetic fields (Eberbeck et 
al. 2005; Hergt et al. 2005). Iron oxide nanoparticles with extraordinary magnetic properties 
are also needed as contrast agents for the discrimination of tissues by MRI (Sun et al. 2008a). 
For instance, tumor cells can be detected, because they do not possess an effective 
reticuloendothelial system and do not accumulate resonance enhancing particles (Pankhurst et 
al. 2003). The potential of magnetosomes in MRI applications has been demonstrated by the 
detection of microtumors in rats (Baeuerlein et al. 1998; Reszka 2000).  
In addition, a number of biotechnological applications have been reported such as 
procedures for the extraction of DNA and mRNA from different biological samples such as 
bacterial cells, blood and tissues (Sode et al. 1993; Yoza et al. 2003a; Yoza et al. 2003b). A 
number of magnetosome-based immunoassays were developed to detect antigens, 
environmental pollutants, hormones and toxic substances (Tanaka et al. 2000; Tanaka et al. 
2004; Yoshino et al. 2005a; Yoshino et al. 2006). Many of these biotechnological 
applications depend on interactions of surface-modified magnetosomes that interact with 
certain target molecules. Therefore, a detailed knowledge of the composition and function of 
the MM is crucial for the development of functional magnetosomes and magnetosome-based 
biotechnogical applications.  
The magnetosome membrane 
The biomineralization of magnetite crystals takes place in specialized subcellular 
compartments, the magnetosome vesicles. Empty and partially filled magnetosome vesicles 
were observed in iron-starved cells by thin-section transmission electron microscopy (TEM) 
and cryo-electron tomography (CET) (Gorby et al. 1988; Komeili et al. 2004; Scheffel et al. 
2006a). Using CET Komeili et al. have recently observed immature magnetite crystals in 
invaginations of the cytoplasmic membrane (Komeili et al. 2006). These findings demonstrate 
(i) that the MM is formed by invagination of the cytoplasmic membrane, and (ii) that 
magnetosome vesicles do not necessarily detach from the cytoplasmic membrane prior to 
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magnetite precipitation (Komeili et al. 2006; Schüler 2008). The CET results also suggest that 
the periplasm and the magnetosome lumen are connected (Komeili et al. 2006). However, 
since magnetosome mineralization relies on controlled redox and pH conditions as well as on 
supersaturating iron concentrations, the magnetosome vesicles are considered to serve as 
“nanoreactors” that provide controlled conditions for magnetite biomineralization. Therefore, 
it has been suggested that chemical exchange between the periplasm and the magnetosome 
lumen is impeded by a barrier in form of a transport protein (Schüler 2008) 
After maturation of the magnetite crystal, the MM provides a “natural coating”, which 
remains attached to the magnetosome crystal even after cell lysis. Biochemical analysis of 
whole cell lipids and purified magnetosomes from M. gryphiswaldense has shown that the 
most abundant polar lipids in the MM and in whole cell extracts are 
phosphatidylethanolamine and phosphatidylglycerol (Grünberg et al. 2004). Analyses of the 
fatty acid compositions revealed that the MM contains most of the fatty acids that are found in 
the whole cell lipid, except for fatty acids that are typically present in the outer membrane of 
gram-negative bacteria (Grünberg et al. 2004; Schüler 2004). These findings are in agreement 
with the formation of magnetosome vesicles by invagination of the cytoplasmic membrane. 
Using proteomic approaches, a distinct set of more than 20 proteins that are specifically 
associated with the MM was found (Gorby et al. 1988; Grünberg et al. 2004; Grünberg et al. 
2001; Tanaka et al. 2006). Sequence analysis revealed that many proteins identified in the 
MM of M. gryphiswaldense display similarities to proteins identified in the MM of M. 
magneticum and M. magnetotacticum. This suggests that different MTB express a conserved 
set of magnetosome membrane proteins (MMP) (Richter et al. 2007; Schüler 2008). In 
M. gryphiswaldense, most of the MMP are encoded within the mamGFDC, mms and mamAB 
operons (Grünberg et al. 2004; Schübbe 2006). These operons are located on a genomic 
magnetosome island with a size of 130 kb (Ullrich et al. 2005). A similar organization of 
magnetosome genes was later also found in other MTB including M. magneticum (Fukuda et 
al. 2006), M. magnetotacticum, the magnetic coccus MC-1 and the magnetic vibrio MV-1 
(Jogler et al. 2008).  
The sequences of some MMP display similarities to experimentally analyzed proteins 
of other organisms. For instance, MamM and MamB belong to the cation diffusion facilitator 
family (Grünberg et al. 2004; Grünberg et al. 2001) and have been shown to be involved in 
the magnetosome-directed iron transport (Junge 2008). Other MMP contain domains with 
similarities to serine proteases (e.g. MamE, MamO), PDZ domains (MamE), and tetra trico-
peptide (TPR) proteins (MamA) (Grünberg et al. 2004; Grünberg et al. 2001). The serine 
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proteases might be involved in the processing of MMP, and proteins with PDZ- and TPR-
motifs possibly interact with other proteins in the MM (Schüler 2008). Analysis of the MamA 
protein in M. magneticum has indicated that this protein is involved in the activation of 
magnetosome vesicles prior to magnetite precipitation. A putative heme-binding protein 
(MamT), an MreB-like protein (MamK) and a putative ion transporter (MamN) were also 
found in association with the MM (Grünberg et al. 2004; Tanaka et al. 2006; B. Voigt, T. 
Schweder, personal communication). In addition, several proteins that contain highly 
repetitive sequence motifs reminiscent of motifs in proteins involved in other 
biomineralization systems (Mms6, MamG, MamD and MamJ) (Grünberg et al. 2004; Schüler 
2008), and many proteins with no homologies to previously characterized proteins were 
identified.    
Even though a specific set of MMP and their genetic determinants were identified, the 
function of most MMP is still unknown. It is also unclear by which mechanisms the MMP are 
targeted and assembled in the magnetosome compartment. To understand the 
biomineralization process on a molecular level, genetic and biochemical analyses of MMP are 
required. In addition to the aforementioned MamM, MamB and MamA proteins, MamJ, 
MamK, Mms6 and proteins encoded by the mamGFDC operon were analyzed 
experimentally. The results of these studies are summarized in the following sections.  
The mamGFDC operon 
The proteins encoded by the mamGFDC operon contain several putative 
transmembrane domains and are the most abundant proteins in the MM of M. 
gryphiswaldense (Figure 1). The proteins, which are expressed from a single promoter 
upstream of mamG (PmamDC) (Schübbe 2006), constitute 35% of the proteins in the MM 
(Grünberg et al. 2004). There are no known homologues in organisms other than MTB, and 
thus the proteins represent unique, MTB-specific protein families (Grünberg et al. 2004). The 
presence of conspicuous LG-rich repetitive motifs, which are reminiscent of proteins that 
have a tendency for self-aggregation of other biomineralization systems, in MamG and 
MamD indicate a potential role in biomineralization (Figure 1, C) (Schüler 2008). A similar 
LG rich repeat was also found in Mms6, which has been suggested to be involved in 
magnetite nucleation (Amemiya et al. 2007). Deletions of mamC or of the entire mamGFDC 
operon have shown that the proteins are not essential for magnetite biomineralization, even 
though the crystals of both mutants displayed slightly decreased sizes. Complementation 
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experiments indicated that MamG, MamF, MamD and MamC have redundant functions and 
act cumulatively to control the magnetosome crystal size (Scheffel et al. 2008).  
High abundance in the MM and functional redundancy of MamG, MamF, MamD and 
MamC is of high relevance for biotechnological applications. Especially the small MamG, 
MamF and MamC proteins (Figure 1, C) could be useful as anchor proteins for the display of 
polypeptides and functional proteins in the MM, without changing the properties of the 
magnetite crystals.  
 
 
Figure 1: Characteristics of the MMP MamG, MamD, MamF, and MamC. (A) Genetic organization of the 
mamGFDC operon; (B) Separation of MMP by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-
PAGE) (Grünberg et al. 2001). The positions and sizes of MamG, MamD, MamF and MamC are indicated; (C) 
Bioinformatic prediction of transmembrane domains (TopPred:http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html, last 
accessed 20.01.09) and selected characteristics of MamG, MamD, MamF and MamC. (Modified after (Scheffel 
2007; Schüler 2008)    
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The assembly of magnetosome chains 
In independent studies of M. gryphiswaldense and M. magneticum, intriguing 
filamentous structures were observed close to the magnetosome vesicles by CET. The so-
called magnetosome filament consists of many 3-4 nm thick filaments, which extend from 
cell pole to cell pole (Komeili et al. 2006; Scheffel et al. 2006a). Presumably, the 
magnetosome filaments stabilize magnetosome chains in the cell. This is required as strings of 
magnetic dipoles easily collapse (Kirschvink 1982), and calculations show that a magnetic 
moment of a chain of at least eleven magnetosomes is needed to align a bacterial cell in the 
geomagnetic field (Faivre et al. 2008b). In addition, the magnetosome filament might play a 
role for the transmission of the magnetic torque to the cell.  
By analysis of GFP fusions in M. magneticum and M. gryphiswaldense it was 
observed that three proteins, MamA, MamJ and MamK, localize as thin lines reminiscent of 
the magnetosome filament (Komeili et al. 2006; Komeili et al. 2004; Scheffel et al. 2006a; 
Scheffel et al. 2007). As a deletion of MamA in M. magneticum did not affect the localization 
of magnetosomes but resulted in a reduced number of magnetosome crystals per cell, the 
protein is probably not involved in magnetosome chain assembly (Komeili et al. 2004). A 
deletion of the MreB-like MamK protein in M. magneticum resulted in cells with 
magnetosomes dispersed throughout the cell (Komeili et al. 2006). In M. gryphiswaldense, 
cells lacking MamK still contained magnetosome chains, but the chains were shorter and 
often several short chains were observed in the same cell (Katzmann, personal 
communication). In addition, in vitro data and the expression of MamK-Mcherry in E. coli 
demonstrated that MamK polymerizes to filamentous structures (Pradel et al. 2006; Taoka et 
al. 2007). All these studies indicate that MamK is involved in the formation of the 
magnetosome filament.    
A deletion of mamJ, which encodes for an acidic protein with a high content of 
repetitive sequence motifs, does not affect biomineralization but resulted in the formation of 
three dimensional magnetosome clusters instead of magnetosome chains (Scheffel et al. 
2006a). Bacterial two-hybrid studies have shown that MamJ interacts with MamK (Scheffel et 
al. 2007). Therefore, it has been hypothesized that the integral MMP MamJ links 
magnetosome particles to the magnetosome filaments by interaction with MamK (Scheffel et 
al. 2007).  
Based on genetic analyses of magnetosome proteins and on ultrastructural data it has 
been possible to propose a hypothetical model for the molecular mechanisms of magnetite 
biomineralization and magnetosome chain assembly (Figure 2) (Scheffel et al. 2006b). 
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However, the recent genetic advances and the identification of the magnetosome filament of a 
novel cytoskeletal structure have clearly demonstrated that magnetosome biomineralization is 
a highly complex process, which poses many new questions. How is the targeting of 
magnetosome proteins to the vesicles facilitated? Which factors mediate vesicle invagination? 
Why are magnetosome chains most often observed at midcell, even though the magnetosome 
filament bundles extend from cell pole to cell pole? Do magnetosome proteins interact with 
other cytoskeletal protein or with the cell division machinery? Are interactions with the cell 
division machinery involved in magnetosome partitioning during cell division? To answer 
these and other cell biological questions the genetic analysis of additional magnetosome genes 
and the development of novel genetic tools will be required.     
 
 
Figure 2: Schematic illustration of the current model for magnetite biomineralization in MTB based on 
ultrastructural and genetic data. Magnetosome vesicles are formed by invaginations of the cytoplasmic 
membrane. A number of proteins are incorporated into the MM. After activation by the MamA protein iron 
might be transported into the magnetosome vesicles either from the periplasm or from the cytoplasm by the 
MamM and MamB proteins. After iron supersaturation, magnetite nucleation is mediated by the Mms6 protein. 
Crystal growth is supported by the proteins MamG, MamF, MamD and MamC. The magnetosome vesicles are 
arranged in a chain-like manner along the longitudinal axis of the cell by interaction of the MMP MamJ and the 
MamK protein, which is probably part of the magnetosome filament. The possible pathways for iron transport 
are indicated by black arrows. (Adapted from (Scheffel et al. 2006b)). 
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Tools for the genetic analysis of magnetosome formation and for genetic 
engineering of magnetosomes  
General genetic tools for MTB  
Despite considerable efforts by many researchers, the genetic analysis of 
magnetosome biomineralization in MTB is still cumbersome. This is mainly attributed to their 
slow growth and their fastidious growth requirements (Jogler et al. 2006). Another difficulty 
of the genetic analysis of MTB is that genomic rearrangements occur frequently (Schübbe et 
al. 2003; Ullrich et al. 2005). This is probably caused by mobile genetic elements that are 
highly abundant in genomes of MTB (Matsunaga et al. 2005; Richter et al. 2007). Only 
recently a limited number of procedures for the genetic analysis of MTB has been established.    
Transfer of plasmid DNA into MTB is generally achieved by conjugation from E. coli 
(Matsunaga et al. 1992; Schultheiss et al. 2003). Several attempts to develop an 
electroporation procedure were made, but, due to adverse effects of the magnetosome chain in 
strong electric fields, the efficiency is not satisfying (Okamura et al. 2003; Schultheiss et al. 
2003). A number of replicative plasmids with different antibiotic resistance markers are 
available for MTB. These include broad host range vectors of the IncQ, IncP, and pBBR1 
incompatibility groups and an endogenous plasmid from M. magneticum (Matsunaga et al. 
1992; Okamura et al. 2003; Schultheiss et al. 2003). In addition, procedures for transposon- 
and site-specific deletions were developed (Matsunaga et al. 1992; Schultheiss et al. 2004). 
Systems for the generation of non-marked mutants were developed to minimize pleiotropic 
effects of deletions of genes located within an operon (Komeili et al. 2006; Komeili et al. 
2004; Scheffel et al. 2008; Scheffel et al. 2006a). A cre-lox based system has also been used 
recently to generate non-polar, in frame deletions in M. gryphiswaldense (Junge 2008; 
Scheffel et al. 2008). For instance, in M. gryphiswaldense deletions of the cation diffusion 
facilitator proteins MamM and MamB, which are encoded in the mamAB operon and are part 
of the magnetosome subproteome (Grünberg et al. 2004), indicate, that these proteins are 
essential for magnetosome formation (Junge 2008). 
GFP as a reporter for gene expression and protein localization in MTB 
The green fluorescent protein (GFP) and its derivatives are reporters that can be used 
to study gene expression and protein localization in many different bacteria. In Escherichia 
coli, the hierarchically and temporally ordered localization of many different cell division 
proteins was visualized during cell cycle with fluorescent proteins. Other cell biological 
model organisms are Bacillus subtilis and Caulobacter crescentus, in which GFP assisted 
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studies have led to a better understanding of the determinants of cell shape, sporulation, DNA 
segregation, cell division and membrane protein targeting (Southward et al. 2002; Valdivia et 
al. 1996). Until now, in M. gryphiswaldense and other MTB, mostly reporters like 
β-glucuronidase, encoded by gusA, which can be used for blue/white screening (Schultheiss et 
al. 2004) and luciferase (Nakamura et al. 1995b; Matsunaga et al. 2000) have been used for 
the analysis of gene expression. Only recently, GFP and derivatives have been employed as 
tools for protein localization studies in MTB (Komeili et al. 2006; Komeili et al. 2004; 
Scheffel et al. 2006a; Scheffel et al. 2007; Schultheiss et al. 2005). Even though the 
utilization of GFP has provided amazing insights especially into the cell biology of MTB, the 
utilization of GFP in MTB poses some difficulties and pitfalls, which have not been addressed 
systematically yet. One problem in previous studies was that only a low proportion of cells 
displayed fluorescence (Komeili et al. 2006; Komeili et al. 2004). In addition, the use of GFP 
under micro- and anaerobic growth conditions is limited, since oxygen is required for the 
maturation of the fluorophore (Heim et al. 1994; Reid et al. 1997). This is problematic in 
MTB as magnetite formation only occurs under microaerobic and anaerobic conditions.  
Genetic engineering of the magnetosome surface 
Most applications of magnetosomes require the presence of specific functional 
moieties, such as antibodies, oligonucleotides, fluorophores or enzymes, on the particle 
surface. Generally, the functionalization of magnetosomes with various functions may be 
facilitated by a number of chemical or genetic approaches (Figure 3). The genetic engineering 
of MMP holds several advantages compared to chemical procedures for magnetosome 
functionalization: (i) harsh conditions, which can cause protein denaturation and loss of 
activity during chemical modification, can be omitted; (ii) integral parts of the MM can be 
specifically modified in a controlled manner; (iii) it is not necessary to use expensive reagents 
such as crosslinking agents; (iv) modified magnetosomes can be purified directly from the 
cells without further need for modification and loss of material. Several studies have been 
undertaken to generate functionalized magnetosomes by expression of genetically engineered 
proteins in M. magneticum. For instance, the expression of translational fusions of functional 
proteins such as protein A, which binds antibodies, G-protein coupled receptors or luciferase 
with M. magneticum MagA and Mms16 was demonstrated (Matsunaga et al. 2002; 
Matsunaga et al. 1999; Tanaka et al. 2000; Yoshino et al. 2004). However, by comparison 
with Mms13, it has recently been shown that MagA and Mms16 are inefficient MM anchors 
(Yoshino et al. 2006). The efficiency of the Mms13 protein in respect to anchoring functional 
moieties to the magnetosome surface in M. magneticum was also demonstrated by expression 
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of Mms13 fusions with biotin accepting peptides and biotin carboxyl carrier protein to 
generate biotinylated magnetosomes in vivo (Maeda et al. 2008). Altogether, previous 
investigations of procedures for magnetosome functionalization by genetic engineering in M. 
magneticum indicated that the efficiency is largely dependent on a suitable anchor protein. 
Ideally, this anchor protein should be integrated stably into the MM in high amounts. In 
addition, the anchor protein should not interfere with biomineralization or with the function of 
the added moiety. In addition, it has been highlighted that the efficiency of magnetosome 
functionalization in M. magneticum is largely dependent on the promoter that is used for 
expression of heterologous proteins (Yoshino et al. 2005b). Until now, in M. gryphiswaldense 
the E. coli Plac promoter has been used exclusively, and it was not yet assessed whether this 
promoter is as active as native promoters in M. gryphiswaldense. Even though an inducible 
expression system would be very useful for the expression of toxic genes and to control the 
number of functional moieties on the magnetosome surface, such a system is still lacking for 
MTB.  
 
Figure 3: Potential modifications of magnetosome particles by the introduction of different functional 
moieties resulting in hybrid magnetic nanoparticles. (A) expression of enzyme and fluorophore proteins (e. g. 
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GFP); (B) biotinylation of membrane lipids and proteins to facilitate subsequent streptavidin-mediated 
conjugation of antibodies and DNA; (C) conjugates with gold particles or quantum dots via a DNA linker; (D) 
expression of fusion tags such as intein- or strep-tags as anchor groups for subsequent conjugate formation with 
various biomolecules. MM magnetosome membrane, MMP magnetosome protein, SAV streptavidin (Adapted 
from Manuscript 8, Figure 6) 
Aims 
The central objectives of this thesis have been the development of novel tools for the 
genetic engineering of magnetosomes in M. gryphiswaldense and other MTB, as well as the 
production of magnetosomes to investigate the usability of bacterial magnetosomes in 
biomedical, bio- and nanotechnological applications.  
The first part of this thesis has been devoted to the development of novel techniques 
for the expression of genetically engineered proteins in the MM. This approach requires the 
identification of a suitable membrane anchor protein that is specifically and efficiently 
targeted to the magnetosome compartment. Translational fusions of this protein should be 
tightly attached to magnetosomes, withstand mechanical and chemical stresses, and not 
interfere with biomineralization or with the function of the added moiety. As GFP is a very 
robust and versatile reporter, it was of interest to optimize the expression conditions for 
utilization of GFP in MTB. Subsequently, GFP fusions of different MMP should be analyzed 
to identify a MM anchor and to provide new insights into the localization and targeting of 
MMP in living cells. Especially, for future functionalization experiments it was of interest to 
identify a signal sequence or protein domain that facilitates magnetosome-directed protein 
targeting.  
Another prerequisite for the in vivo functionalization of magnetosomes is a highly 
efficient expression system for MTB. At the onset of this investigation in M. gryphiswaldense 
the E. coli Plac promoter was used exclusively. As the performance of this promoter had not 
been assessed systematically, one aim of this thesis was to compare the performance of 
different promoters in M. gryphiswaldense and to develop an efficient expression system for 
M. gryphiswaldense.  
The second part of this thesis has been devoted to the production of purified 
magnetosomes to investigate magnetosome-based applications. It was of particular interest to 
develop magnetosome-based immunoassays and nucleic acid detection systems, and to 
investigate if magnetosomes can be used to label specific cell types for MRI. 
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Results and Discussion 
Part I: Development of tools for in vivo functionalization of magnetosomes 
and protein localization in magnetotactic bacteria 
The expression of heterologous peptides or proteins on the magnetosome surface by 
genetic engineering of MMP offers several advantages compared to chemical 
functionalization approaches. Therefore, the development of suitable genetic tools for 
M. gryphiswaldense is of bio- and nanotechnological significance. Several methods for the 
genetic analysis of M. gryphiswaldense such as the conjugative transfer of plasmids, 
electroporation, site-directed mutagenesis, expression and intracellular localization of 
fluorescently labelled proteins have been established recently (Scheffel et al. 2008; Scheffel et 
al. 2006a; Scheffel et al. 2007; Schultheiss et al. 2005; Schultheiss et al. 2004; Schultheiss et 
al. 2003). However, studies on magnetosome functionalization by genetic engineering of 
MMP have been limited to M. magneticum. For M. gryphiswaldense, specific tools such as 
efficient MM anchor proteins and protein expression systems are still lacking. In advantage to 
M. magneticum, several mutants of M. gryphiswaldense that produce magnetosomes with 
altered sizes and modified magnetic (e.g. superparamagnetic) properties, are available (Hoell 
et al. 2004; Scheffel et al. 2008; Ullrich et al. 2005). Magnetosomes from these strains could 
be used to produce a wide range of magnetic nanoparticles with specifically adapted 
biochemical and physicochemical characteristics for different applications. 
Construction and analysis of GFP-labelled magnetosome membrane 
proteins 
Expression of GFP in microaerophilic bacteria 
A variant of the green fluorescent protein (GFP) was selected as a tool to study gene 
expression and protein localization in microaerophilic bacteria. GFP is a highly stable protein, 
which can be fused to many different proteins without loss of function (Phillips 2001) and 
which has been used in many different organisms including M. gryphiswaldense and M. 
magneticum (Komeili et al. 2006; Komeili et al. 2004; Scheffel et al. 2006a; Scheffel et al. 
2007; Schultheiss et al. 2005). Upon cultivation of a GFP expressing M. gryphiswaldense 
strain under microaerobic growth conditions (1% oxygen; 1:1 ratio of headspace:culture 
volume), which are usually used during cell cultivation for magnetosome purification, it was 
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noticed that the overall fluorescence intensity and the proportion of fluorescent to non-
fluorescent cells were very low. Since the inefficient maturation of the GFP fluorophore due 
to lack of oxygen had been reported in other organisms (Hansen et al. 2001; Heim et al. 1994; 
Reid et al. 1997; Wadhams et al. 2002; Zhang et al. 2005), GFP fluorescence of cells 
cultivated under different aeration regimes was investigated. Measurements of the magnetic 
orientation (Cmag) (Schüler et al. 1995), fluorescence intensity and the proportion of 
fluorescent cells after variation of the oxygen concentration and the headspace-to-liquid ratio 
were conducted. The results showed the highest fluorescence values for aerobically cultivated 
cells, whereas magnetite formation was maximal under microaerobic conditions. Utilization 
of air in the headspace and of a headspace-to-liquid ratio of 1:4 resulted in substantial 
magnetite formation (Cmag: 1.7) and a expedient proportion of fluorescent cells (19.7%) 
(Manuscript 1, Table 4). Under these conditions oxygen decreased gradually during 
cultivation. Therefore, sufficient oxygen was present to facilitate GFP maturation at the onset 
of cultivation, while microaerobic conditions prevailed at later growth stages and facilitated 
magnetite formation.  
Even though the utilization of GFP in microaerophilic bacteria requires the accurate 
control of specific cultivation conditions, there is no equivalent alternative at the moment. 
Other commonly used enzymatic reporter proteins such as β-glucuronidase, β-galactosidase 
and luciferase may be suitable to study gene expression in bulk cultures but are inappropriate 
to study gene expression on a single-cell level. In addition, these reporters are larger and less 
stable than GFP and cannot be easily fused to other proteins to analyze protein localization in 
vivo. Most of the new commercially available coral reef proteins (Clontech, Mountain View, 
CA U.S.A) as well as the popular “mFruits” fluorescent proteins are also expected to require 
oxygen for maturation, as the fluorophores of these proteins are chemically identical to the 
classical Aequorea victoria GFP or to Discosoma dsRed, which requires additional reactions 
during fluorophore formation (Shu et al. 2006; Wall et al. 2000). In future, flavin-derived 
fluorescent proteins that fluoresce under anaerobic conditions (Drepper et al. 2007) could be 
used as reporters for gene expression and protein localization in MTB. However, those 
proteins have not been used as fusion partners for protein localization studies yet and initial 
attempts to express these proteins in M. gryphiswaldense from an E. coli Plac promoter failed 
(data not shown).  
MamC is an efficient anchor for the display of fusion proteins on magnetosome particles 
In M. magneticum MagA, Mms16 and Mms13, which is an ortholog of the 
M. gryphiswaldense MamC, were used as MM anchors for the magnetosome specific display 
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of fusion protein (Matsunaga et al. 2002; Matsunaga et al. 1999; Tanaka et al. 2000; Yoshino 
et al. 2006; Yoshino et al. 2004). However, consecutive studies have shown that MagA and 
Mms16 (renamed as ApdA in M. gryphiswaldense) are not part of the magnetosome 
subproteome of M. gryphiswaldense but represent contaminations that non-specifically 
associated with the magnetosome particles upon cell disruption (Handrick et al. 2004; 
Schultheiss et al. 2005).  
For the identification of a potential MM anchor protein in M. gryphiswaldense GFP 
was used as a reporter. From a range of C- and N-terminal GFP fusion constructs of different 
MMP, i.e. MamE, MamO, MamP, MamT, MamC, MamF and MamG, only C-terminal 
fusions of the highly abundant MMP MamC, MamF and MamG generated fluorescence 
intensities sufficient for detection by fluorescence microscopy in M. gryphiswaldense. 
Fluorescence of the three fusion proteins was typically observed as linear signals along the 
cell axis at midcell, where the magnetosome chain is located in most cells. Thus, all three 
proteins seemed to be targeted specifically and exclusively to the MM (Manuscript 1, Figure 
2). This hypothesis was confirmed by immunoblot analysis of different cell fractions for the 
presence of GFP fusion proteins (Manuscript 1, Figure 3). In addition, quantification of the 
fluorescence of purified magnetosomes from M. gryphiswaldense strains expressing MamC-, 
MamF- and MamG-GFP demonstrated that the fluorescence is retained in vitro (Manuscript 
1, Figure 4, Figure 5). The highest level of magnetosome-bound fluorescence was observed 
with MamC-GFP modified magnetosomes (Manuscript 1, Figure 5). Previous studies have 
shown that all genes of the mamGFDC operon are not essential for magnetosome formation, 
but that deletions of these protein result in magnetosomes with slightly decreased 
magnetosome crystal sizes (Scheffel et al. 2008). Therefore, the expression of modified 
versions of these proteins is not expected to inhibit biomineralization, and the three proteins 
might be well suited as MM anchors.  
MamC-GFP modified magnetosomes retained functionality under a variety of storage 
and incubation conditions in vitro. Detection of degradation products of MamF- and MamG-
GFP by immunoblot analysis of purified magnetosomes indicated that the fusion proteins are 
less stable than MamC-GFP (Manuscript 1, Figure 6). Even though expression of native 
MamC is co-regulated with the other proteins encoded by the mamGFDC operon (Schübbe 
2006), MamC is the most abundant single protein in the MM (Grünberg et al. 2001). This and 
the fact that the protein withstands tryptic digestion (Grünberg et al. 2001) point out that 
MamC is a highly stable protein. Therefore, from the tested proteins, MamC is the most 
appropriate MM anchor for magnetosome functionalization in M. gryphiswaldense.  
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In vivo localization of GFP-labelled magnetosome proteins in M. gryphiswaldense 
GFP fusion proteins are useful reporters for protein localization in cell biology. Until 
now, very little is known about magnetosome protein sorting and the assembly of 
magnetosome vesicles. Therefore, it was of interest to compare the localization patterns of all 
available GFP-magnetosome protein fusions, to identify different targeting mechanisms and 
to gain information about the assembly of magnetosome vesicles and chains.  
MamC-, MamF- and MamG-GFP predominantly localized at midcell in 0.5-2 µm long 
linear signals, which were extended along the longitudinal cell axis. In all cases no significant 
fluorescence was associated with the cytoplasmic membrane (Manuscript 1, Figure 2). The 
brightest and most compelling signals were observed with MamC-GFP, although the signal 
was occasionally observed as a single bright fluorescent spot at midcell (Figure 4A). This 
localization pattern is slightly different from the previously reported localizations of other 
proteins involved in magnetosome formation.  
In collaboration with Katja Junge (AG Schüler), GFP fusions of the presumed 
magnetosome-specific iron transporter MamM were constructed and analyzed by 
deconvolution microscopy. The yet unpublished results have shown that MamM-GFP 
localizes in the cytoplasmic membrane as well as at the position expected for the 
magnetosome chain (Figure 4A). This could mean that either MamM is non-specifically 
inserted both into cytoplasmic and magnetosome membranes, or that MamM is integrated into 
the cytoplasmic membrane prior to magnetosome vesicle invagination and is targeted by a 
“diffusion-and-capture”-like mechanism, similar as described for the targeting of spore-
forming proteins previously (Rudner et al. 2002). It is also conceivable that MamM-GFP is 
far more abundant in the cell than native MamM, due to the artificial in trans expression. In 
this case MamM-GFP might only be inserted into the cytoplasmic membrane after the 
capacity of the magnetosome vesicles is exceeded. In future, the effect of the expression level 
of MamM-GFP on its localization could be adressed by localization studies of MamM-GFP 
expressed from different promoters and by immunoblot quantification of MamM-GFP and 
native MamM.  
In contrast to MamC, MamF and MamG, previously studied GFP fusions of the 
magnetosome proteins MamK (Komeili et al. 2006; Scheffel 2007; Scheffel et al. 2007; 
Schübbe 2005), MamJ (Scheffel et al. 2006a) and MamA (Komeili et al. 2004) are not 
specifically and exclusively targeted to the MM. The results of localization studies of MamK 
are difficult to interpret as until now six different GFP fusions of M. magneticum and M. 
gryphiswaldense MamK have been constructed and different localization patterns have been 
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observed  (Komeili et al. 2006; Scheffel 2007; Scheffel et al. 2007; Schübbe 2005). However, 
several studies on MamK have indicated that it is involved in magnetosome filament 
formation and not exclusively targeted to the MM like MamC-, MamF- and MamG-GFP 
(Komeili et al. 2006; Pradel et al. 2006; Scheffel et al. 2007; Taoka et al. 2007; E. Katzmann, 
personal communication). In exponentially growing M. magneticum cells MamA localizes in 
filamentous structures, which reach from pole to pole. In stationary cells punctuate signals are 
observed at midcell (Komeili et al. 2004). In M. gryphiswaldense a MamJ-GFP fusion 
showed a linear signal extending through most of the cell reminiscent of the MamA-GFP 
localization in M. magneticum (Scheffel et al. 2006a). Since the signals of MamA- and 
MamJ-GFP fusions are much longer than the length of the magnetosome chain, the proteins 
seem to interact with other parts of the cell and cannot be used to visualize the position of the 
magnetosome chain in vivo.  
In summary, the comparison of GFP fusion proteins of different magnetosome 
proteins shows that MamC-, MamF- and MamG-GFP are targeted specifically and 
exclusively to the position of the magnetosome chain, whereas other GFP-labelled 
magnetosome proteins may also localize in different cellular structures such as the 
cytoplasmic membrane or the magnetosome filament. Due to its strong fluorescence and high 
abundance in the MM, MamC-GFP is the most appropriate tool to track the position of the 
magnetosome chain in vivo. For instance, MamC-GFP could be used in future experiments to 
monitor the positioning and partitioning of the magnetosome chain during cell division. In 
addition, the targeting mechanism of MamC is of great interest to identify the determinants of 
magnetosome-specific protein sorting.  
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Figure 4: MamC-GFP is specifically targeted to the magnetosome membrane. (A) In vivo localization of 
MamC-GFP and MamM-GFP in wild type cells of M. gryphiswaldense. As a control the localization of unfused 
GFP is shown. The cell membranes were stained with FM4-64 as described in Manuscript 1. In addition, 
constructs and cultivation conditions for the expression of MamC-GFP and GFP and microscopy procedures are 
described in Manuscript 1. The construct for the expression of MamM-GFP was cloned in cooperation with 
Katja Junge (Junge 2008). For better visualisation and to avoid artefacts, the localization of MamM-GFP was 
studied by deconvolution analysis of image-Z-stacks with the Olympus 3D-Blind algorithm. In addition, the cell 
shape and position was visualized by differential interference contrast (DIC) microscopy. Scale bars are 2 µm. 
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(B) Topology of the MamC protein as predicted by the TopPred topology prediction tool 
(http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html, last accessed 20.01.09).        
Analysis of GFP fusions of truncated MamC variants  
In a further set of unpublished experiments, the MamC protein was investigated more 
closely to gain more information on the highly specific sorting mechanism of this protein. The 
identification of signal sequence for magnetosome specific protein targeting would greatly 
improve the understanding of protein assembly in the MM. In addition, the identification of a 
signal sequence could be useful for the biotechnological functionalization of magnetosomes.  
MamC has two predicted transmembrane domains, and the region between these 
transmembrane domains is probably located inside the magnetosome vesicle. The short N-
terminus (11 amino acids) and the long C-terminal tail (36 amino acids) are exposed to the 
cytoplasm (Figure 4B). To identify potential targeting signals of MamG, MamF, and MamC 
the sequences were analyzed with different software tools (TatP 
(http://www.cbs.dtu.dk/services/TatP/, last accessed 05.03.09); TatFind (http://signalfind.org/tatfind.html, last 
accessed 05.03.09); SignalP http://www.cbs.dtu.dk/services/SignalP/, last accessed 05.03.09)). In the case of 
MamC, a potential Sec-dependent translocation signal (probability: 0.577) was predicted by 
the Hidden Markov Model analysis of the SignalP program but not by any other tool. For 
MamF no signal sequence was predicted by any of the programs. In contrast, for MamG a 
putative signal sequence was predicted by the SignalP (probability: 0.997) and the TatP 
programs. Interestingly, the predicted translocation signals of MamC and MamG overlap with 
the transmembrane helices predicted by TopPred. This indicates that the proteins are inserted 
into the membrane but not cleaved and translocated.  
As the bioinformatic investigation of the MamC sequence only gave a vague hint for a 
Sec-dependent membrane insertion mechanism, and as no potential signal sequences were 
identified by comparison with other MMP, an experimental approach was taken to investigate 
the targeting of MamC. To test if different protein domains contain a signal sequence for 
magnetosome-directed targeting, GFP was fused to truncated versions of MamC. These 
constructs either lacked the N-terminal region (MamCΔ1-9), the N-terminus and the first 
transmembrane domain (MamCΔ1-31), or the region from the N-terminus to the second 
transmembrane domain (MamCΔ1-52). In addition, GFP fusions of different C-terminal 
deletions were constructed including (i) a version that lacks the second transmembrane 
domain and the whole C-terminal tail (MamC1-53), (ii) a version which only lacks the C-
terminal tail (MamC1-99), and (iii) a version that lacks only the last nine C-terminal amino 
acids (MamC1-116). Using fluorescence microscopy, weak signals for all fusion proteins 
Results and Discussion 
 
24 
except MamC1-116-GFP were observed in the cytoplasm (Figure 5). In contrast, the 
fluorescence intensity of MamC1-116-GFP was higher, and the protein localized in a similar 
pattern as full-length MamC-GFP (Figure 5). Analysis of different cell fractions by anti-GFP-
immunoblot showed a strong signal for MamC1-116-GFP in the MM fraction and therefore 
confirmed the results from the fluorescence microscopy (Figure 6). A signal of the expected 
molecular weight (38 kDa) was also detected in the MMP fraction of cells with the 
MamCΔ1-9-GFP fusion. This signal was rather weak, and it is possible that only a small 
fraction of MamCΔ1-9-GFP that could not be detected by fluorescence microscopy was 
inserted into the MM. Even though the MamCΔ1-9-GFP fusion lacks part of the putative Sec-
pathway signal, it is not possible to exclude the Sec pathway as a transort mechanism, as the 
residual part of the signal sequence might have accounted for the protein fraction that was 
inserted into the MM. For all fusion proteins, except for full length MamC-GFP and 
MamC1-116-GFP, a putatively false positive signal with the size of the MamC-GFP fusion 
(39.5 kDa) was observed in the membrane protein fraction. The size of this unspecific signal 
did not shift even if truncated versions of MamC with reduced sizes were analyzed. The 
absence of signals in the cytoplasmic protein fraction, despite of the microscopical detection 
of cytoplasmic fluorescence and the presence of several smaller bandsin the immunoblot, 
indicated that the GFP fusions of truncated MamC variants were not stable, but degraded 
rapidly. Therefore, the cytoplasmic fluorescence observed for GFP fusions of different MamC 
variants can either be explained by inefficient targeting of the fusion proteins or by 
degradation products.  
In conclusion, it was not possible to identify a distinct signal that entails the 
magnetosome-directed targeting of fusion proteins with this approach. The deletion of N-
terminal regions and of larger regions from the C-terminus results in mistargeting and protein 
degradation. Only the last nine C-terminal amino acids are dispensable for the correct 
localization of MamC-GFP. This is in agreement with a comparison of the MamC sequences 
from M. gryphiswaldense, M. magneticum, M. magnetotacticum, the magnetic vibrio MV-1 
and the magnetic coccus MC-1, which has shown that the C-terminus is less conserved than 
the rest of the protein (data not shown). After all, the magnetosome-specific targeting of 
MamC could be mediated not by a single signal peptide but by an interface composed of 
several residues or sequence stretches, which are distributed over the primary protein 
structure. In future experiments, the determinants of MamC-targeting may be identified by 
analysis of MamC-versions with single amino acid substitutions.  
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Figure 5: In vivo localization of translational fusions of truncated versions of MamC and GFP. To 
construct the fusion proteins truncated variants of mamC were PCR amplified (Primer sequences are listed in the 
supplementary in table 1), cloned into pJET1.2/blunt (Fermentas, St. Leon-Rot, Germany) or pGEMT-Easy 
(Promega, Madison, Wisconsin) and sequenced. The truncated mamC genes were subcloned into pCL5 
(Manuscript 1) in front of the egfp gene. The constructed plasmids were transferred to M. gryphiswaldense by 
conjugation and analyzed by fluorescence microscopy as described in Manuscript 1. Since the fluorescence of 
MamC1-99 –GFP was very weak, membrane staining with FM4-64 was omitted to avoid artefacts caused by weak 
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FM4-64 fluorescence in the GFP channel. A DIC micrograph is shown, to illustrate the position and the shape of 
the cells. Scale bars are 2 µm.  
 
Figure 6: Immunoblot analysis of the localization of MamC-truncations fused to GFP. M. gryphiswaldense 
cultures expressing different truncated versions of MamC fused to GFP were cultivated in sealed 2 l flask with a 
culture volume of 1.7 l and air in the headspace for 24 h at 28°C. Magnetosomes were purified and cellular 
proteins were fractionated into soluble (SP) and membrane proteins (MP) (Manuscript 1). The protocol for 
immunoblot detection was modified from Manuscript 1. Briefly, 7.5 µg of MMP (MMP), SP and MP of each 
culture were separated by SDS-PAGE (12% gels) and blotted onto nitrocellulose membranes. For detection 
rabbit Anti-GFP antibody was used in a 1:1000 dilution as a primary antibody and shrimp alkaline phosphatase 
labelled anti-rabbit-IgG was in a 1:2000 dilution as a secondary antibody. The size of MamC-GFP is indicated 
by black arrows.      
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Localization of MamC-GFP in non-magnetic M. gryphiswaldense cells 
It was of interest to investigate the localization of MamC-GFP and MamF-GFP in 
cells that were cultivated without iron and under aerobic conditions, because magnetite 
formation is inhibited under these conditions. These experiments were intended to analyze the 
localization of MMP in non-magnetic cells and to identify a potential role of magnetite in the 
targeting of magnetosome proteins.  
In both non-magnetic cultures, the localization of MamC-GFP and MamF-GFP was 
virtually identical to the localization of both proteins in magnetic cells (Figure 7, Figure 4). 
This indicates that the localization of magnetosome vesicles and proteins is not altered under 
magnetite suppressing conditions. This also means that magnetite synthesis is not required for 
the correct targeting of MamC- or MamF-GFP. Since magnetite crystals are not required for 
the correct localization of the fusion proteins, other MMP must facilitate the magnetosome-
specific targeting of MamC and MamF.  
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Figure 7: Fluorescence microscopy of MamC- and MamF-GFP in non-magnetic M. gryphiswaldense 
MSR-1 wild type cells. M. gryphiswaldense harbouring pCL6 (MamC-GFP) or pCL7 (MamF-GFP) 
(Manuscript 1) were cultivated for three passages under aerobic conditions in 15 ml polypropylene tubes with a 5 
ml culture volume either in flask standard medium (FSM) (Heyen et al. 2003) or for iron depletion experiments 
in low iron medium (LIM) (Faivre et al. 2008a). Both methods resulted in non-magnetic cells with a cellular 
magnetism (Cmag) (Schüler et al. 1995) below 0.01. Staining and imaging was carried out as described in 
Manuscript 1. Scale bars are 2 µm.  
Results and Discussion 
29 
Localization of MamC-GFP in mutants of M. gryphiswaldense 
In the next set of experiments it was studied whether the localization of MamC-GFP is 
dependent on the presence of one or more magnetosome proteins. Initially, the localization of 
MamC-GFP was studied in four different non-magnetic mutants, namely MSR-1B, ΔmamB, 
ΔmamM, ΔmamJKL. Strain MSR-1B is a spontaneous mutant that lacks a 40 kb region of the 
magnetosome island including the mms6-, the mamDC- and the mamAB- operon (Schübbe et 
al. 2003), whereas the ΔmamB, ΔmamM, ΔmamJKL mutants were constructed by site-specific 
mutagenesis (Junge 2008; E. Katzmann, unpublished). In all non-magnetic mutants MamC-
GFP formed one or several fluorescent spots and did not localize in a linear structure at 
midcell, which was observed in the wild type (Figure 4; Figure 8). The fluorescent spots 
presumably represent MamC-GFP inclusion bodies, which may be formed because of 
inefficient MamC-GFP targeting in the non-magnetic mutants. This interpretation is in 
agreement with the preliminary phenotypic characterization of the strain MSR-1B and 
ΔmamJKL mutant, which suggests that magnetosome vesicles are absent from these mutants 
(K. Junge, G. Wanner, D. Schüler; E. Katzmann, unpublished). Hence, MamC-GFP cannot be 
inserted into magnetosome vesicles in these strains. However, empty magnetosome vesicles 
in a chain-like arrangement were detected by thin section TEM in the ΔmamB mutant, and 
similar vesicular structures were observed in the ΔmamM mutant (Junge 2008; E. Katzmann, 
unpublished). Thus the mislocalization of MamC-GFP in these strains may be attributed 
either to a lower number of target organelles in the mutants or to the lack of specific proteins 
in the MM that are required for the correct insertion of MamC.  
A punctuate localization pattern of MamC-GFP, which was similar to the localization 
of MamC-GFP in non-magnetic cells, was observed in the ΔmamK mutant, in which the 
magnetosome chain alignment is disturbed and several short chains are observed instead of 
one long continuous magnetosome chain (E. Katzmann, unpublished). This finding indicates 
that the MamK protein is required for the correct assembly of proteins in the MM and is 
required for the proper localization of MamC. However, since ΔmamK only contains a 
reduced number of magnetosomes compared to the wild type (E. Katzmann, unpublished), it 
is also possible that a fraction of MamC-GFP is inserted in the magnetosome vesicles 
correctly, whereas excessive MamC-GFP is mislocalized.  
In a ΔmamJ mutant magnetosomes are clustered in three dimensional aggregates 
(Scheffel et al. 2006a). The localization of MamC-GFP in patches with a diameter of up to 
1 µm (Figure 8) is consistent with the magnetosome directed targeting of MamC-GFP in the 
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ΔmamJ mutant. Hence, the results indicate that MamC-GFP is targeted specifically to the 
magnetosome compartments even if MamJ is absent and if magnetosome vesicles are not 
arranged in chains.  
In ΔmamC and ΔmamGFDC mutants, which produce magnetosomes with reduced 
sizes, MamC-GFP localized in a linear signal at midcell, which was reminiscent of the 
localization pattern in wild type cells (Figure 8). In conclusion, these experiments 
demonstrated that neither native MamC nor other constituents of the mamGFDC operon are 
required for the magnetosome-specific targeting of MamC. In the future, the localization of 
MamC-GFP in the ΔmamK, ΔmamJ, ΔmamC and ΔmamGFDC mutants should be verified by 
immunoblot analysis.  
At this stage it can be excluded that neither MamJ nor the proteins encoded by the 
mamGFDC operon are required to direct MamC to the magnetosome vesicle. The aberrant 
localization of MamC-GFP in several different mutants suggests that the lack of a single 
protein, i.e. MamK, MamB or MamM, has an effect either on the number of magnetosome 
vesicles or on the assembly of MMP in magnetosome vesicles. A promising approach for 
future experiments is to identify interaction partners of MamC by bacterial two hybrid 
analysis or by co-immunoprecipitation.  
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Figure 8: In vivo localization of MamC-GFP in different mutants of M. gryphiswaldense. MamC-GFP was 
expressed from the pCL6 plasmid (Manuscript 1) in different mutants of M. gryphiswaldense. The available 
mutants included the non-magnetic mutants MSR-1B (Schübbe et al. 2003), ΔmamB, ΔmamM (Junge 2008), 
ΔmamJKL (constructed by E. Katzmann, unpublished), the ΔmamJ (Scheffel et al. 2006a) and ΔmamK 
(constructed by E. Katzmann, unpublished) mutants with altered magnetosome chain arrangement and the 
ΔmamC (Scheffel et al. 2008) and ΔmamGFDC (Scheffel et al. 2008) mutants with smaller magnetosome crystal 
sizes. Membrane-staining with FM4-64, conjugation and microscopy was done as described previously 
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(Manuscript 1). To illustrate the phenotypes of the different mutants TEM pictures of representative mutants are 
shown. The picture of the non-magnetic ΔmamJKL mutant and the ΔmamK mutant was provided by E. 
Katzmann. The ΔmamJ micrograph was taken from Scheffel et al. (2006a). The thin section of the ΔmamGFDC 
mutant was made by G. Wanner (Scheffel et al. 2008). If not indicated otherwise in the figure, the scale bars are 
2 µm.  
 
Analysis of promoters for efficient and inducible gene expression in 
M. gryphiswaldense 
Until now, protein expression in M. gryphiswaldense and other MTB has been limited 
by lack of an appropriate expression system. Incomplete complementation of mutants and 
weak expression of fusion proteins expressed in M. gryphiswaldense have indicated that the 
previously used E. coli Plac and Ptac promoters are not efficient in the α-proteobacteria 
M. gryphiswaldense and M. magneticum (Komeili et al. 2006; Komeili et al. 2004; Pradel et 
al. 2006; Scheffel et al. 2008; Scheffel et al. 2006a; Scheffel et al. 2007; Manuscript 1; K. 
Junge, unpublished). Only a single study in M. magneticum has reported a system for the 
expression of fusion proteins. A luciferase-based assay showed that from six tested putative 
promoters the highest expression was obtained with the promoter of a putative peroxiredoxin 
gene (Pmsp3) (Yoshino et al. 2005b). However, peroxiredoxins are involved in the response to 
oxidative stress (Seaver et al. 2001), and their regulation may prevent the expression of genes 
under microaerobic or anaerobic conditions. To identify efficient promoters for gene 
expression in M. gryphiswaldense, the expression of GFP from several sequences of putative 
and previously identified promoters from M. gryphiswaldense and E. coli were investigated.  
The promoter of the mamGFDC operon (PmamDC) is a strong promoter in 
M. gryphiswaldense 
In total, six sequences of either putative or predicted promoters in M. gryphiswaldense 
were analyzed (PmamDC, PmamAB, PapdA, Pmsp3, PrpsJ, PrplK and Pure). With the BPROM promoter 
prediction tool (http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb, 
last accessed 08.12.08) -35 and -10 regions with high similarities to E. coli promoters were 
identified for all sequences except of the putative ribosomal promoter PrplK (Manuscript 2, 
Figure 1). However, the promoters from M. gryphiswaldense were not functional in E. coli 
(Manuscript 2, Figure 2). The inactivity of α-proteobacterial promoters in E. coli is a common 
phenomenon. For example, promoters from Caulobacter crescentus and Sinorhizobium 
meliloti are also not active in E. coli (MacLellan et al. 2006; Malakooti et al. 1995; Smit et al. 
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1984). Promoter activity in M. gryphiswaldense was analyzed by fluorescence microscopy, 
fluorometry and immunoblot analysis. These studies demonstrated that all 
M. gryphiswaldense promoters except of the putative Pure promoter activate GFP expression 
more efficiently than the E. coli Plac promoter (Manuscript 2, Figure 2). The magnetosomal 
promoter PmamDC, which was previously identified by primer extension analysis in 
M. gryphiswaldense (Schübbe 2006) promotes GFP expression more efficiently than 
homologues of the highly active M. magneticum promoters Pmsp3 and Pmms16 (in M. 
gryphiswaldense called PapdA) (Yoshino et al. 2005b). PmamDC activity is even higher than the 
activity of the putatively strong ribosomal promoters PrpsJ (rpsJ: MGR3815 ribosomal protein 
S10) and PrplK (rplK: MGR3801 ribosomal protein L11).  
The analysis of three truncated versions of PmamDC showed that a 96 bp fragment, 
containing only four bases upstream of the -35 region, is sufficient for the efficient expression 
of GFP (Manuscript 2, Figure 5). This indicates that neither transcription factors nor upstream 
promoter elements like A-tract sequences are required for efficient transcription from PmamDC. 
In future experiments, the short 96 bp fragment could be incorporated in a primer to simplify 
cloning, and it could reduce the frequency of unwanted recombinations between plasmid-
borne and chromosomal PmamDC. 
To investigate the applicability of PmamDC as a tool for the production of genetically 
engineered magnetosomes, the promoter was used for expression of a MamC-ZZ fusion 
protein in M. gryphiswaldense. The MamC-ZZ protein consists of the MM anchor protein 
MamC and an antibody-binding ZZ domain, which is a derivative of the staphylococcal 
protein A (Löwenadler et al. 1987). Immunoblot analysis of different cell fractions showed 
that the antibody binding protein was highly expressed and specifically targeted to the MM 
(Manuscript 2, Figure 6). In addition, it was shown that purified MamC-ZZ magnetosomes 
bind rabbit antibodies in aqueous suspensions (Manuscript 2, Figure 6). Hence, these particles 
can be used for the purification of antibodies as previously described with ZZ-modified 
bacterial polyester granules (Brockelbank et al. 2006). The utilization of the highly efficient 
PmamDC promoter and the availability of M. gryphiswaldense mutants with magnetosomes 
displaying altered magnetic properties could be used for the production of ZZ-modified 
magnetosomes with improved properties for magneto-immunoassays.  
Ptet is an inducible promoter in M. gryphiswaldense 
A putative Pure promoter that might be induced in the presence of urea or under 
nitrogen-limitation (D'Orazio et al. 1993; Friedrich et al. 1977) and the widely used Ptet 
promoter from the E. coli Tn10 TcR gene (Skerra 1994) were analyzed with GFP as a reporter. 
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While no inducing conditions for Pure could be identified, fluorometry and microscopy 
showed that the Ptet promoter can be induced in M. gryphiswaldense by the addition of 5-50 
ng ml-1 anhydrotetracycline (Manuscript 2, Figure 3). Although Ptet is not as active as PmamDC, 
this promoter is a valuable addition to the M. gryphiswaldense genetic toolbox. The tightly 
regulated Ptet promoter could be used for the expression of deleterious proteins or for the 
expression of GFP fusions for cell cycle-dependent protein localization studies.  
The expression of GFP from different promoters is not homogeneous in all cells of a 
population  
The results also show that GFP is a useful transcriptional reporter in 
M. gryphiswaldense. One major advantage of GFP in comparison to other transcriptional 
reporters is its detectability at a single cell level by fluorescence microscopy or flow 
cytometry. Flow cytometry revealed that GFP was heterogeneously expressed in populations 
of M. gryphiswaldense from all promoters. Even with strong promoters like PmamDC the 
proportion of fluorescent cells was not higher than 60 % of all cells. Inhomogeneous gene 
expression in isogenic cell populations is frequently observed in bacteria (Davidson et al. 
2008; Siegele et al. 1997) and might be caused by variations of growth rates and protein 
synthesis, different cell-cycle stages, or the stochasticity of gene expression (Elowitz et al. 
2002; Roostalu et al. 2008; Strovas et al. 2007). For future applications of genetically 
engineered magnetosomes, it is of significance that not all magnetosomes display functional 
moieties in equal amounts. It is important to use sufficiently large amounts of magnetosomes 
so that variations in the degree of functionalization of single magnetosomes do not affect the 
results.  
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Part II: Production of magnetosomes for the development of diagnostic 
applications 
Investigations on the applicability of magnetosomes from M. gryphiswaldense in in 
vitro applications, such as magnetic separation procedures and immunoassays as well as in in 
vivo applications like MRI required the constant supply of large amounts of magnetosomes. In 
order to guarantee that variations of magnetosome characteristics from different charges were 
minimal, a previously developed oxystat fermentation procedure for M. gryphiswaldense 
(Heyen et al. 2003) was adapted to maintain constant pH, oxygen partial pressure and 
temperature during cultivation. In total, a culture volume of 440 l was produced with the 20 l 
oxystat fermenter system for the purification of magnetosomes (∼ 400 mg Fe). Initially, only 
the wild type strain M. gryphiswaldense MSR-1 was cultivated. Later on, the strain MSR-1K, 
which produces superparamagnetic magnetite crystals with reduced sizes (Figure 9) (Hoell et 
al. 2004; Ullrich et al. 2005), was cultivated. Superparamagnetic particles do not maintain a 
permanent magnetic moment and do not interact magnetically as strongly as single-magnetic-
domain particles in the absence of an external magnetic field. Therefore, the MSR-1K 
magnetosomes have been less susceptible to aggregation and have been advantageous for 
chemical modifications of the MM (Bülent Ceyhan, Universität Dortmund, personal 
communication). 
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Figure 9: Transmission electron micrographs of purified magnetosomes from M. gryphiswaldense MSR-1 
(A) and M. gryphiswaldense MSR1-K (B). Scale bars are 50 nm.  
Optimization of the magnetosome purification procedure for biotechnological applications 
In previous studies, magnetosomes were purified mainly for biochemical studies 
(Grünberg et al. 2004). Therefore, the purity of the isolated magnetosomes was the only 
concern. For biotechnological applications, it was also important that the MM remains intact 
during the purification procedure. The MM represents a coating of the magnetite crystal, 
which is essential for the magnetosome dispersibility and for the chemical modification of 
magnetosomes. Hence, it was necessary to optimize the previously developed procedure by 
Grünberg et al. (2004) for biotechnical applications. The magnetosome purification procedure 
involves three main steps, i.e. cell lysis, magnetic separation and density gradient 
centrifugation. While the previously used cell lysis procedure by French Press was found 
most appropriate for the extraction of intact magnetosomes, it was observed that 
magnetosomes are highly susceptible to mechanical forces after cell lysis. During the 
magnetic separation step, magnetosomes are retained in a special magnetic column (C-
MACS, Miltenyi-Biotech, Germany) while non-magnetic cellular components pass through 
the column. It is essential not to apply forces other than gravity and to limit the flow speed to 
a maximum of 10 ml/minute to avoid sheering of the MM and magnetosome aggregation 
(Figure 10). The next step is the density fractionation of magnetosomes by centrifugation 
through a sucrose cushion. The sucrose concentration was increased to 60 % w/w to improve 
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the purity of the magnetosomes. To minimise MM sheering, the sedimented magnetosomes 
were resuspended by incubation for about 16 h at 4°C in extraction buffer.  
Using a specifically adapted magnetic separation stand, the purified magnetosomes 
can be easily separated from aqueous suspensions (Figure 11). The magnetic separation stand 
was also used for the testing of magnetosome stability in different chemical environments 
(Manuscript 1, Figure 6) and for the magnetic separation of molecules that interact with 
genetically engineered magnetosomes (Manuscript 2; Figure 6). 
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Figure 10: Effect of different purification procedures on the aggregation of magnetosomes. Magnetosomes 
from the same batch of cells were purified by different methods and resuspended in buffer (10 mM Hepes, 1 mM 
EDTA, pH 7.4) to an OD550 of 0.5. The decrease of turbidity was plotted against the time, and the aggregation 
rate was calculated from the slope of the curve. UC w/o MS: density gradient centrifugation (60 % sucrose), 
without magnetic separation, NW: normal purification procedure; density gradient centrifugation (60 % sucrose) 
and magnetic separation with the application of mild suction (Flow speed ~30 ml/min), MW: mild purification 
procedure; density gradient centrifugation (60 % sucrose) and magnetic separation with gravity flow during the 
magnetic column separation step and reduction of the flow speed to ~10 ml/min, VW: vigorous washing 
procedure; density gradient centrifugation (60 % sucrose) and magnetic separation with the application of 
extensive suction (Flow speed  > 100 ml/min). MW w/o UC: mild purification without density gradient 
centrifugation.  
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Figure 11: Purified magnetosomes are easily separated from aqueous suspensions in a specifically adapted 
magnetic separation stand. The magnetic separation stand was designed for the magnetic separation of 
magnetosomes from suspensions in 1.5 and 2.0 ml reaction tubes or from 15 ml polypropylene tubes. High 
energy permanent magnets (neodynium-iron-boron and samarium cobalt magnets) facilitated the separation of 
magnetosomes from suspensions within 1-5 min. The tube in the back and the tube in the magnetic separation 
stand contain aliquots of the same magnetosome suspension.  
 
Using the pure and intact magnetosomes from the M. gryphiswaldense strains MSR-1 
and MSR-1K it was possible to develop several novel applications. In the following, two 
studies are discussed, which investigated possibilities for the chemical modification of 
isolated magnetosomes with biomolecules and their application in immunoassays. In addition, 
the main findings of three studies that investigated the potential of purified magnetosomes as 
contrast agents for magnetic resonance imaging (MRI) of specific cell types will be presented.  
Oligonucleotide- and antibody- modified magnetosomes generated by streptavidin-biotin 
chemistry 
In general, it is possible to functionalize magnetosomes either by genetic approaches 
within the cell or by chemical procedures after purification from the cells. As genetic tools 
that are required for the genetic modification of magnetosomes were not available at the onset 
of this thesis, chemical functionalization procedures were investigated in parallel. In previous 
studies the modification of magnetosomes from M. magneticum was achieved by 
glutaraldehyde-induced crosslinking for the immobilization of proteins on the magnetosome 
surface (Matsunaga et al. 1987; Matsunaga et al. 2001). Amine-modified oligonucleotides 
were attached to the MM with the heterobifunctional reagent N-succinimidyl 3-(2-
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pyridyldithio) propionate (Sode et al. 1993). Similar reagents were also used for the 
production of myosin conjugated magnetosomes, which interact with actin filaments and for 
the production of biotinylated magnetosomes (Amemiya et al. 2005; Tanaka et al. 1997). 
Despite the utilization of several different procedures, a systematic comparison of different 
procedures was not carried out.  
Instead of the functionalization of magnetosomes with one specific moiety, a modular 
approach was developed for the functionalization of purified magnetosomes from 
M. gryphiswaldense. In a first step, different procedures for the biotinylation of 
magnetosomes were investigated. In the second step, the biotinylated magnetosomes were 
conjugated to different biotinylated biomolecules, such as antibodies or oligonucleotides, with 
streptavidin as a coupling reagent. Purified magnetosomes from M. gryphiswaldense were 
reacted with two biotinylation reagents: (i) the biotin lipid, biotin-DPPE [(1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(biotinyl) (disodium salt)], which integrates into the MM 
non-specifically and (ii) NHS-biotin [sulfo-N-hydroxy-succinimide esters sodium salt], which 
forms covalent bonds with free amino groups. For a quantitative comparison of the 
efficiencies of both biotinylation procedures, streptavidin was attached to the biotinylated 
magnetosomes. After addition of Cy5- and biotin-labelled oligonucleotides the amount of 
magnetosome-bound streptavidin was quantified by fluorometric measurement of Cy5. The 
experiment has shown that the use of biotin-DPPE results in the immobilization of two- to 
threefold more streptavidin on the magnetosome surface than use of NHS-biotin, which 
interacts specifically with lysine residues. However, the reproducibility of the results was 
lower with use of biotin-DPPE, which indicates that addition of the biotin-lipid also caused 
aggregation of the magnetosomes (Manuscript 3).  
Using streptavidin-biotin chemistry, the biotinylated magnetosomes could be further 
functionalized with biotinylated oligonucleotides and antibodies. Bifunctional magnetosomes 
were generated by addition of two different oligonucleotides in equimolar ratio. The modified 
magnetosomes were used (i) for detection of specific target oligonucleotides immobilized on 
a glass slide, (ii) for DNA directed assembly of three dimensional binary networks of 
oligonucleotide-coated gold nanoparticles and oligonucleotide-modified magnetosomes, and 
(iii) for detection of antigens in a sandwich immunoassay (Manuscript 3). 
Magneto-Immuno-PCR 
The ultra sensitive detection and quantification of specific proteins within complex 
biological matrices is of vital importance in the fields of clinical diagnostics, agriculture, drug 
development and doping control (Borgono et al. 2006; Chassy 2002; Matsakas et al. 2005; 
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Scaros et al. 2005; Zolg et al. 2004). For development of a highly sensitive and automatable 
protein detection method, it was of interest to combine the use of magnetic particles for 
antigen-capture and antigen-enrichment with the ultra sensitive immuno-PCR procedure, 
which combines an enzyme-linked-immunosorbent assay (ELISA) with the amplification 
power of PCR (Niemeyer et al. 2007).  
Streptavidin-modified, superparamagnetic magnetosomes purified from the 
M. gryphiswaldense strain MSR-1K (Manuscript 3) and commercially available streptavidin-
coated, micrometric beads (Roche) were used to develop systems for the detection of hepatitis 
B surface antigen (HBsAg). After incubation with biotinylated HBsAg-antibody, the magnetic 
beads and the modified magnetosomes were used to separate HBsAg from spiked human 
serum. The antigen was detected either by ELISA with a conjugate of alkaline-phosphatase or 
by real-time Immuno-PCR with an anti-HBsAg-ImperacerTM conjugate (Chimera Biotec). 
The experiments have shown that the magnetosome-assisted immuno-PCR (magneto 
immuno-PCR) is 125 fold more sensitive than the analogous magnetosome-ELISA 
(Manuscript 4). Comparison of the performance of modified magnetosomes with 
commercially available streptavidin coated micrometric magnetic beads revealed that the 
sensitivity of the assay is increased 25-fold if magnetosomes are used. In addition, the linear 
dynamic range for quantification is increased from 200 - 8 ng/ml with commercially available 
magnetic beads to 200 ng/ml - 320 pg/ml with magnetosomes. These results clearly 
demonstrate that magnetosomes are advantageous to synthetic magnetic microbeads for the 
development of highly sensitive magneto-immuno-PCR procedures. The greatest advantage 
of the magnetosome-based procedures is that it is automatable and could be adapted for high-
throughput applications (Manuscript 4). 
Utilization of magnetosomes as contrast agents for magnetic resonance imaging 
Magnetic nanoparticles are being vigorously researched as the next generation of MRI 
contrast agents (Corot et al. 2006; Sun et al. 2008a). MRI is a non-invasive, non-harmful 
method to obtain clinical images and to visualize different tissues in vivo. The differentiation 
of tissues with similar chemical composition can be achieved with special contrast agents 
(Sun et al. 2008a). Iron oxide nanoparticles are currently the preferred contrast agents for the 
monitoring of specific cell types and tissues (Bulte et al. 2004). Initial in vitro studies have 
indicated that bacterial magnetosomes might represent an alternative to chemically produced 
iron oxide particles as magnetosomes can be detected at low concentrations (0.6-0.9 nM Fe) 
in an aqueous buffer in a 1.5 Tesla whole body scanner (Herborn et al. 2003). Magnetosomes 
were also successfully employed to detect microtumors in rat livers by MRI (Reszka 2000). In 
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addition, MRI can be used to monitor cell migration of specifically labelled cells during 
pathological processes. It is of particular interest to monitor the trafficking of macrophages, 
because these cells are well-known effectors and regulators of the inflammatory response, 
which migrate to regions of acute inflammation (Bulte et al. 2004).  
Labelling of macrophages with magnetosomes 
The magnetic resonance relaxation properties of magnetosomes embedded in agarose 
were measured in vitro to test if magnetosomes can be used as contrast agents for the labelling 
of macrophages in MRI (Manuscript 5). Interestingly, the R2 relaxivity of magnetosomes was 
2-3 fold higher than of commercially available magnetic nanoparticles (Resovist®, Schering, 
Berlin), which indicates that a lower dosage of magnetosomes is required to observe the same 
signal change compared to Resovist®. Mouse macrophages (J77A.1), which were incubated 
with magnetosomes, took up magnetosomes by phagocytosis and could be detected by MRI. 
After injection of magnetosomes into mice and induction of peritonitis, initial ex vivo 
experiments have indicated that it is possible to visualize the position of acute inflammations 
by MRI (Manuscript 5, Figure 6).      
Fluorescently labelled magnetosomes as biomodal probes for magnetic resonance and near 
infrared fluorescence optical imaging 
One of the fastest growing areas in the field of molecular imaging is the development 
of fluorescence-based methods for the detection of pathologic changes in vivo (Weissleder et 
al. 2008). While these methods provide high sensitivity, spatial and temporal resolution, they 
are limited in tissue penetration (Ballou et al. 2005). Therefore, macroscopic fluorescence-
based imaging methods and MRI are complementary methods and bimodal contrast agents, 
which could be used in both applications, are a desired material.  
For the development of bimodal contrast agents, purified magnetosomes were 
covalently labelled with a Succinimdyl-ester-modified near infrared fluorescent dye (DY-
676), which reacts with accessible amino groups. Flow cytometry was employed to verify that 
fluorescently labelled magnetosomes (FM676) were synthesized. Cultured mouse 
macrophages (J774) that were treated with the bimodal contrast agent (FM676) took up 
FM676 agent by phagocytosis. The modified magnetosomes were visible in endosomes by 
ultrathin section microscopic analysis, and the intracellular colocalization of dense structures 
observed by phase contrast microscopy and near infrared fluorescence signals confirmed that 
FM676 was taken up in the cells and remained stable during uptake. Imaging of FM676 
treated macrophages in a small-animal-near-infrared-fluorescence-imager and by MRI 
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demonstrated that fluorescently labelled magnetosomes (FM676) can be readily detected by 
both methods. Due to the unique magnetic properties of the magnetosome crystal, the FM676 
particles display high transversal relaxivities compared to Resovist® (Schering, Berlin, 
Germany) and increase the sensitivity of MRI. In conclusion, the utilization of fluorescently 
labelled magnetosomes as bimodal contrast agents for optical and magnetic resonance 
imaging of inflammatory processes is yet another highly promising application of purified 
magnetosomes from M. gryphiswaldense.  
Labelling of dendritic cells with magnetosomes 
In addition to macrophages, dendritic cells (DC) represent a further cell type that is 
potentially capable of magnetosome phagocytosis. Like macrophages DC belong to the group 
of antigen presenting cells and are essential for the activation of T cells. In most tissues DC 
are present in an immature state. Upon induction by an immunological stimulus they mature 
to active antigen presenting cells and migrate to the lymphoid organs, where they interact 
with antigen-specific T cells (Banchereau et al. 1998). DC loaded with specific antigens are 
under clinical investigation as cellular vaccines (Figdor et al. 2004). Since the success of 
these procedures largely depends on the accurate administration and migration of DC, 
procedures for the non-invasive monitoring of DC migration need to be developed. It was 
demonstrated by magnetic separation, transmission electron microscopy and quantification of 
the cellular iron content that DC take up magnetosomes purified from M. gryphiswaldense as 
well as synthetic lipid-iron-oxide nanoparticles by phagocytosis. DC containing either 
biogenic or synthetic magnetic nanoparticles were visualized by MRI in vitro. In vivo MRI of 
C57BL/6 mice, which received injections of magnetic nanoparticles containing DC, showed 
hypointense signals in the draining lymph nodes close to the injection site after 24 h. In 
control experiments with non-modified DC no signals were detected. In addition, the presence 
of large amounts of iron in the draining lymphnodes was verified by histological analysis. 
These data show that magnetosomes can be used for the magnetic labelling of DC and to 
monitor the localization of labelled DC in vivo. In future, genetically engineered 
magnetosomes, which display certain antigenic proteins or peptides, could be used to load DC 
with antigens and create cellular vaccines, which can be monitored in vivo by MRI. 
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Outlook 
The genetic tools that were developed in this study will be of great value for many 
future applications. Using MamC as a MM anchor protein and the highly efficient PmamDC 
promoter, it will be possible to express different functional moieties on the MM, as it was 
exemplified with GFP and the antibody binding ZZ-protein. For instance, it might be possible 
to express enzymatic functions on the magnetosome surface for the production of catalysts 
that can be separated after a reaction magnetically.  
As a positional marker for magnetosome vesicles in living cells, MamC-GFP is also of 
great cell biological interest. The protein could be employed in live-cell and time-lapse 
imaging studies to elucidate the dynamics of magnetosome vesicle localization and 
magnetosome chain assembly during cell division. For this purpose, it will be also of interest 
to express fluorescently labelled cell division proteins such as Fts proteins in 
M. gryphiswaldense and study the localization of the magnetosome chain and the cell division 
machinery simultaneously.  
While we have shown that MamC is specifically targeted to the magnetosome 
compartment, it is still unclear how proteins are assembled in the MM. The herein presented 
results indicate that the correct positioning of MamC relies on the presence of other proteins 
in the MM. In future, studies will be required to identify interaction partners of MamC and 
other MMP by methods such as bacterial-two-hybrid assays or co-immunoprecipitation. 
In this study a procedure for the production of highly pure and intact magnetosomes 
was developed. These magnetosomes were used successfully in a number of applications. 
However, it is still a long way to the development of a commercially competitive 
magnetosome-based product. First of all, it would be of advantage to lower the production 
costs for magnetosomes. This could be achieved by scale up and optimization of the 
fermentation procedure, such as the development of a fed batch system as described recently 
(Sun et al. 2008c). Another option is the isolation of strains with increased magnetosome 
production. For in vitro applications, such as procedures for DNA and protein detection, in 
future, genetically engineered magnetosomes could be used instead of chemically 
functionalized particles. In vivo applications, such as MRI, will require studies on the 
immunogenicity of bacterial magnetosomes.  
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Table 1: Primer sequences for truncation experiments 
 
Primer name Sequence 
mamCfwXhoI CTCGAGAGGACAACAGCGATGAGCTTTC 
mamCrevNdeI CATATGGGCCAATTCTTCCCTCAG 
mamCrevNdeI267ct CATATGGGCGGCGACGCCGGCGATTAG 
mamCrevNdeI349ct CATATGGTCGGACGCTGTCGCCTC 
mamCrevNdeI159ct CATATGTTCCTTGCCGGTGTCGATG 
mamCfwXhoI28ct CTCGAGATGGCGAAATCCGTCCCTGGAATC 
mamCfwXhoI94ct CTCGAGATGAATGCCCGCCTTTTGAAGGAC 
mamCfwXhoI157ct CTCGAGATGGAAGCCGCCGGCGCCGGGCTTG 
 
 
Table 2: Plasmids used for MamC truncation experiments 
 
Plasmid Description Source 
pCL5 pBBR1MCS1 + 10 glycine linker + egfp Article 6 
pBBRMamC(Δ1-9)-GFP pCL5 + PCR product from 
mamCrevNde/mamCfwXhoI28ct 
This study 
pBBRMamC(Δ1-31)-GFP pCL5 + PCR product from 
mamCrevNde/mamCfwXhoI94ct 
This study 
pBBRMamC(Δ1-52)-GFP pCL5 + PCR product from 
mamCrevNde/mamCfwXhoI157ct 
This study 
pBBRMamC(1-53)-GFP pCL5 + PCR product from 
mamCfwXhoI/mamCrevNdeI159ct  
This study 
pBBRMamC(1-99)-GFP pCL5 + PCR product from 
mamCfwXhoI/mamCrevNdeI267ct 
This study 
pBBRMamC(1-116)-GFP pCL5 + PCR product from 
mamCfwXhoI/mamCrevNdeI349ct 
This study 
pBBRMamC(29-53)-GFP pCL5 + PCR product from 
mamCfwXhoI28ct/mamCrevNdeI349ct 
This study 
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Abstract 
The magnetosomes of magnetotactic bacteria are prokaryotic organelles consisting of 
a magnetite crystal bounded by a phospholipid bilayer that contains a distinct set of proteins 
with various functions. Because of their unique magnetic and crystalline properties, 
magnetosome particles are potentially useful as magnetic nanoparticles in a number of 
applications, which in many examples requires the coupling of functional moieties to the 
magnetosome membrane. In this work we studied the use of green fluorescent protein (GFP) 
as reporter for magnetosomal localization and expression of fusion proteins in the 
microaerophilic Magnetospirillum gryphiswaldense by flow cytometry, fluorescence 
microscopy, and biochemical analysis. Although optimum conditions for high fluorescence 
and magnetite synthesis were mutually exclusive, we established oxygen-limited growth 
conditions, which supported growth, magnetite biomineralization, and GFP fluorophore 
formation at reasonable rates. Under these optimized conditions we studied the subcellular 
localization and expression of the GFP-tagged magnetosome proteins MamC, MamF, and 
MamG by fluorescence microscopy and immunoblotting. While all fusions specifically 
localized at the magnetosome membrane, MamC-GFP displayed the strongest expression and 
fluorescence. MamC-GFP-tagged magnetosomes purified from cells displayed strong 
fluorescence, which was sensitive towards detergents, but stable under a wide range of 
temperature and salt concentrations. In summary, our data demonstrate the use of GFP as a 
reporter for protein localization under magnetite forming conditions and the utility of MamC 
as an anchor for magnetosome-specific display of heterologous gene fusions. 
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Introduction 
The magnetosomes of magnetotactic bacteria are specialized organelles for magnetic 
orientation that consist of membrane-enveloped crystals of a magnetic iron mineral (1, 34). In 
strains of Magnetospirillum, magnetosomes are synthesized by magnetite (Fe3O4) 
precipitation within specific vesicles formed by the magnetosome membrane (MM), which 
invaginates from the cytoplasmic membrane and contains a number of specific proteins that 
are involved in the synthesis of functional magnetosome particles (7, 9, 16, 44). Increasing 
efforts in interdisciplinary research are aimed at understanding how magnetotactic bacteria 
achieve their outstanding control over the properties of the magnetic mineral crystals, and 
their assembly into highly ordered chain-like structures (2, 15). Recently, magnetotactic 
bacteria have emerged as powerful models for the study of cell biology and organelle 
formation in prokaryotes, as magnetosomes display many common features of eukaryotic 
organelles (15). In addition, the uniform sizes, crystal habits, and magnetic characteristics of 
magnetosomes have attracted interest in their use as magnetic nanoparticles with superior 
properties (20-22), and a number of potential applications such as magnetic separation and 
detection of analytes, the use as contrast agents in magnetic resonance imaging (MRI), or 
their use in magnetic hyperthermia have been suggested for magnetic nanoparticles derived 
from magnetic bacteria (13, 24, 52, 55). Many of these applications require the 
functionalization of isolated magnetosome particles, e.g. by the magnetosome-specific display 
of functional moieties, such as enzymes, antibody binding proteins, protein tags, or 
oligonucleotides (22). This has been mostly achieved by chemical coupling of specific ligands 
to lipids or proteins of the MM (4, 26, 45, 48).  Alternatively, the use integral magnetosome 
membrane proteins (MMPs) as anchor for the magnetosome-specific display of heterologous 
proteins fused to them has been suggested (22, 53, 54). For example, luciferase was used as a 
reporter for magnetosome directed expression of genetic fusions to the Mms13 protein of M. 
magneticum (27). Another protein that is useful as a reporter for expression and intracellular 
localization of magnetosome proteins is the green fluorescent protein (GFP). Use of GFP 
fusions has revolutionized the understanding of subcellular organization and membrane 
targeting in model bacteria such as Escherichia coli, Bacillus subtilis and Caulobacter 
crescentus (25, 41). In addition, GFP was used as molecular marker in various environmental 
microorganisms (23) and has served as a powerful transcriptional reporter to measure real-
time gene expression in single living cells by flow cytometry or microscopy (3). GFP-assisted 
fluorescence microscopy has already been used to study the subcellular localization of several 
magnetosome proteins in the magnetotactic bacteria M. magneticum and M. gryphiswaldense. 
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Investigated proteins include the MamA protein, which is presumably involved in the 
activation of magnetosomes, as well as the acidic MamJ protein and the actin-like MamK 
protein, both of which control the intracellular assembly of magnetosome chains. Although 
these examples already demonstrated its principal usefulness in MTB, the use of GFP 
expression as intracellular marker of magnetosome localization can be problematic. Magnetite 
crystals are formed in these microaerophilic organisms only at low oxygen concentrations 
below 10 mbar (14), while on the other hand the use of GFP at micro- or anaerobiosis is 
limited since the maturation of the protein requires molecular oxygen during the last step of 
fluorophore maturation (12, 30). Accordingly, it has been noticed that fluorescence intensities 
and the proportion of fluorescent cells were rather low and varied considerably under 
microoxic growth conditions, and so far, the application of GFP in relationship to magnetite 
formation in magnetic bacteria has not been addressed systematically. 
This study was intended to investigate the expression of GFP in the microaerophilic 
M. gryphiswaldense at various oxygen levels by flow cytometry and fluorescence 
microscopy.  Cultivation conditions were optimized with respect to growth, biomineralization 
of magnetite crystals as well as the maximum expression of GFP and fluorophore formation. 
We further analyzed by fluorescence microscopy and immunoblotting the subcellular 
localization of the GFP-tagged magnetosome proteins MamC, MamF, and MamG, which 
were previously shown to be involved in the size control of growing magnetite crystals (32). 
The GFP modified fluorescent magnetic nanoparticles were purified from bacterial cells, and 
the stability of expression and fluorescence of MamC-GFP-labelled magnetosomes was 
studied in vitro under various conditions. These studies served (i) to characterize GFP 
modified magnetosomes as a novel biomaterial, which might be useful for biomedical 
applications, and (ii) as a prerequisite for future experiments using magnetosome proteins as 
an anchor for magnetosome-specific display of heterologous gene fusions. 
 
Materials and Methods 
Strains and growth conditions 
Escherichia coli strains DH5α and TOP10 (TOP10 chemically competent cells, 
Invitrogen, Karlsruhe, Germany) were used as hosts for cloning. For conjugation experiments 
the E. coli strain S17-1 was used (40). E. coli strains were grown on Luria-Bertani at 37°C, 
the medium was supplemented with kanamycin or ampicillin (50 µg/ml) if appropriate. 
Throughout this study the M. gryphiswaldense strain R3/S1, which is a spontaneous 
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rifampicin and streptomycin resistant mutant of the M. gryphiswaldense strain MSR-1 was 
used (38). M. gryphiswaldense was routinely grown microaerobically at 28°C under moderate 
shaking (100 rpm) in modified FSM medium using 27 mM pyruvate as a carbon source as 
described previously (14). For cultivation on petri dishes agar was added to 1.5% wt/vol to 
FSM medium.  
Fermentor production of fluorescent magnetosomes  
R3/S1(pCL6) was cultivated in a modified Biostat A Twin dual vessel laboratory 
fermentor (B. Braun Biotech International, Melsungen, Germany) in LSM medium as 
described previously (14). Oxygen electrodes (InPro6000; Mettler Toledo, Gießen, Germany) 
were calibrated with nitrogen and a microoxic gas mixture (1% oxygen in nitrogen) or 
synthetic air (flow rate 3 L min-1) as described by Heyen and Schüler (14). The medium (10 
liters) was inoculated with a 1-liter preculture grown in a 2-liter flask containing air in the 
headspace. The fermentor was inoculated to an initial cell density of approximately 1 x 107 
cells ml-1. During cultivation agitation (150 rpm), temperature (28°C) and pH (7.0) were 
maintained constant. Bacteria were grown microaerobically at 0.125 or 2 mbar oxygen until 
the stationary phase for 24 h. Alternatively, bacteria were cultivated aerobically at 200 mbar 
oxygen for 16 h and subsequently shifted to 0.2 mbar, as indicated in the experiments.  
Molecular genetic techniques 
If not otherwise specified, standard DNA procedures were employed (31).  Cloned 
genes and fusion constructs were sequenced using BigDye terminator v3.1 chemistry on an 
ABI 3700 capillary sequencer (Applied Biosystems, Darmstadt, Germany). Sequence data 
were analyzed with Lasergene 6 (DNAstar Inc. Madison, WI). Primers were purchased from 
Carl Roth GmbH (Karlsruhe, Germany) and MWG Biotech (Ebersberg, Germany). The 
primer sequences are listed in Table 1.  
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Table 1: Primers used in this study. Restriction sites that were incorporated in the primer are indicated in bold 
and the sequence region encoding for the glycine-linker is written in italics.  
 
Primer name Target gene Sequence 
CL1 egfp catatgggaggcggaggcggtggcggaggtggcggagtgagcaagggcgaggag 
CL2 egfp gtggatccttacttgtacagctcgtc 
CL3 mamG ctcgagggagatcagatgatcaagggcatc 
CL4 mamG catatgagcaggctcggcggaggc 
CL5 mamF ctcgagagggcaaagcaatggccgagac 
CL6 mamF catatggatcagggcgactacatggctg 
CL7 mamC ctcgagaggacaacagcgatgagctttc 
CL8 mamC catatgggccaattcttccctcag 
 
 
Construction of GFP-Fusion proteins 
In this study the GFPmut1 variant, which is also termed EGFP (enhanced GFP), was 
used (5, 23). The egfp gene was PCR amplified (Taq-Mastermix, Promega, Heidelberg, 
Germany) from the pEGFPN-1 (BD Biotech) plasmid using the CL1 forward primer, which 
adds a NdeI restriction site and a ten glycine linker to the 5’ end of the egfp gene, and reverse 
primer CL2. The PCR product was cloned into pGEMT-Easy (Promega) to yield pCL1. The 
mamC (CL7, CL8), mamF (CL5, CL6) and mamG (CL3, CL4) genes were amplified with the 
corresponding primer pairs (indicated in parentheses) using genomic DNA of 
M. gryphiswaldense R3/S1 as a template. The PCR products were cloned into pGEMT-Easy 
(Promega) and transformed into CaCl2 competent DH5α to generate pCL2-4. The egfp gene 
was subcloned from pCL1 into the EcoRI site of the pBBRMCS-2 (18) plasmid to yield the 
plasmids pCL5. Colony PCR was performed to screen for plasmids in which egfp was present 
in the same orientation as the Plac promoter. Translational fusions of mamC, mamF and 
mamG with egfp connected via a ten glycine linker were constructed by ligating the respective 
mam genes from pCL2, pCL3 and pCL4 into the NdeI and XhoI sites of the pCL5 vector to 
generate the plasmids pCL6, pCL7 and pCL8, respectively. For a complete list of plasmids 
used in this study refer to Table 2. The plasmids harboring the mam-egfp fusions were 
transferred into M. gryphiswaldense R3/S1 by conjugation from E. coli S17-1 as described 
previously (39). 
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 Table 2: Plasmids used in this study  
Plasmid name description Source 
pEGFPN-1 GFP expression vector, Ap BD Biotech 
pGEMT-Easy Cloning vector, Ap Promega 
pCL1 pGEMT-Easy + 10 glycine linker + egfp This study 
pCL2 pGEMT-Easy + mamC This study 
pCL3 pGEMT-Easy + mamF This study 
pCL4 pGEMT-Easy + mamG This study 
pBBR1-MCS2 mobilizable broad host range vector, Km Kovach et al (11) 
pCL5 pBBR1-MCS2 + 10Gegfp from pCL1 This study 
pCL6 pCL5 + mamC from pCL1 This study 
pCL7 pCL5 + mamF from pCL2 This study 
pCL8 pCL5 + mamG from pCL3 This study 
 
  
Fluorescence microscopy 
M. gryphiswaldense R3/S1 strains bearing the plasmids pCL5-pCL8 were grown in 15 
ml polypropylene tubes with sealed screw caps and a culture volume of 11 ml to stationary 
phase. The cell membranes were stained with the membrane stain FM4-64 (Invitrogen, 
Karlsruhe, Germany) at a final concentration of 1.5 µM. The stained cells were immobilized 
on agarose pads (FSM medium excluding yeast extract and peptone, but supplemented with 
1% agarose). Immobilized cells were imaged with an Olympus BX61 microscope equipped 
with a 100x UPLSAPO100XO objective with a numerical aperture of 1.40 and an Olympus 
F-View II camera. Images were captured and analyzed using Olympus cellM and ImageJ 
1.36b software. For the microscopic visualization of fluorescent magnetosomes 
approximately 15 µl of a magnetosome suspension with a magnetosome concentration 
corresponding to an iron concentration of 10 mM were spotted on a microscopic slide. After 
placement of a bar magnet next to the microscopic slide the fluorescent magnetosomes were 
imaged with a Zeiss LSM510 microscope equipped with a 10x objective and a Photometrics 
Coolsnap HQ camera.   
Analytical procedures 
Cell growth and magnetism were measured turbidimetrically at 565 nm. The average 
magnetic orientation of cell suspensions was assayed as previously described (36). Briefly, an 
external magnetic field was employed to align cells at different angles relative to the light 
beam. The ratio of the resulting maximum and minimum extinction (Cmag) correlates with the 
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average number of magnetic particles per cell and was used as a semi-quantitative assessment 
of magnetite formation (a Cmag = 0 was assumed for non-magnetic cells).  
For the determination of iron concentration of magnetosome suspensions, 
magnetosomes were sedimented by centrifugation, resuspended in 65% HNO3 and incubated 
at 99°C overnight to dissolve the magnetite crystals. The iron content of the solution was 
determined with a modified version (47) of the ferrozine assay (42).  
The protein concentration of the cell lysate (CL), the non-magnetic (NF), soluble (SP), 
membranous (MP) and magnetosome protein fractions were assessed with a bicinchoninic 
protein quantification kit (Sigma, Munich, Germany) according to manufacturer’s 
instructions.  
The magnetosome bound fluorescence was quantified with an Infinite 500 96well 
fluorescence reader using I-Control v1.2.7.0 software (Tecan, Crailsheim, Germany). The 
excitation wavelength was 485 nm (20 nm bandwidth) and emission was recorded at 535 nm 
(25 nm bandwidth). Different dilutions of magnetosomes (0-10 mM iron) were prepared in 
triplicate in 100 µl EP (10 mM Hepes, 1 mM EDTA pH7.4) in a black 96-well Nunclon plate. 
The value for each sample was averaged from 10 reads over an integration period of 20 µs.   
Flow cytometry 
Flow cytometry was performed with a FACScalibur flow cytometer (Becton-
Dickinson) equipped with an argon laser emitting at 488 nm. GFP fluorescence was recorded 
in the FL-1 channel. Cells of M. gryphiswaldense R3/S1 and derivatives bearing the plasmids 
pCL5 to pCL8 were washed in phosphate-buffered saline and resuspended in phosphate-
buffered saline in a 1:100 dilution to maintain a counting speed between 300 and 1000 events 
s-1. Unless otherwise indicated, 50 000 events were counted. Data were analyzed using 
FlowJo software (Treestar). Untransformed R3/S1 was used as a non-fluorescent standard. 
Contaminating cell debris and media constituents were excluded from the analysis based on 
forward (FSC) and side scatter (SSC) data. To estimate the proportion of fluorescent cells a 
threshold for fluorescence was set to the fluorescent intensity below which 99% of 
untransformed R3/S1 were detected.  
Isolation of magnetosomes 
The procedure for magnetosome purification was modified after Grünberg et al. (9). 
M. gryphiswaldense strains were exposed to air in sealed 5L flasks (Schott, Mainz, Germany) 
containing 4L modified FSM medium. The cultures were inoculated with 400 ml overnight 
culture to a cell density of approximately 1x107 cells ml-1. The cultures were incubated at 
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28°C at moderate shaking (120 rpm). Stationary phase cultures were harvested by 
centrifugation, washed with WB (20 mM Hepes, 1 mM EDTA pH 7.4) and finally 
resuspended in RB (50 mM Hepes, 1 mM EDTA, 0.1 mM PMSF pH7.4). Cells were 
disrupted by three passages through a French Press at 1260 bar. Cell debris was removed by 
centrifugation at 800 g for 5 min. The cleared cell lysate was passed through a MACS 
magnetic separation column placed between Sm-Co magnets (Miltenyi, Bergisch Gladbach, 
Germany) to separate magnetosomes from the non-magnetic fraction. The column bound 
magnetosomes were washed with ten column volumes (50 ml) of EP, HP (10 mM Hepes, 200 
mM NaCl, 1 mM EDTA pH7.4) and water before the magnetic field was removed and the 
magnetosomes were eluted in EP. Subsequently the magnetosomes were centrifuged through 
an 8-ml sucrose cushion (60% [wt/wt] in EP) at 200 000 x g for 90 min. Due to their high 
specific density, magnetosomes sediment at the bottom of the tube, whereas other cellular 
constituents are retained by the sucrose cushion. Finally, the magnetosomes were resuspended 
in 2 ml EP.  
The NF, which was not retained by the magnetic column, was subjected to 
centrifugation at 4000 g for 60 min to remove residual cell debris. The supernatant was 
subjected to 2h of centrifugation at 100 000 g to separate the cellular membranes from the 
soluble protein fraction. The sedimented membrane fraction was resuspended in EP and 
centrifuged a second time at 100 000 g for 2h. The membrane proteins were resuspended in 
EP supplemented with 1% sodium dodecyl sulfate (SDS). 
SDS-PAGE and Western blot analysis 
Polyacrylamide gels were prepared according to the procedure of Laemmli (19). Protein 
samples from different cellular fractions were resuspended in electrophoresis sample buffer 
(62.5 mM Tris-HCl pH 6.8, 0.1M DTT, 1.6% SDS, 5% glycerol, 0.002% bromophenol blue) 
and denatured at 100°C for 5 min. Fifteen micrograms of protein was loaded onto the gels. 
For SDS-PAGE analysis of the relative abundances of fusion proteins present in the MM, 
MMP were separated on 15% (wt/vol) gels and proteins were visualized by coomassie 
brilliant blue staining. For Western blot analysis 10% (wt/vol) gels were used, and following 
electrophoresis proteins were transferred onto nitrocellulose membranes (Protran, Whatman, 
Germany) by electroblotting. The membranes were blocked for 2h at room temperature. An 
anti-GFP antibody (Santa Cruz, Biotechnology, Inc.) or an anti-MamC antibody (8) was 
added to the blocking solution in 1:1000 or 1:500 dilution, respectively, and incubated for 1h 
at room temperature. The membrane was washed several times with Tween-Tris-buffered 
saline and Tris-buffered saline (TBS) before alkaline phosphatase-labeled goat anti-rabbit IgG 
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antibody (Santa Cruz, Biotechnology, Inc.) was added in 1:1000 dilution in TBS (Tris 
buffered saline). After incubation at room temperature for 45 min the membrane was washed 
with TBS and the BCIP (5-bromo-4-chloro-3-indolyl-phosphate)/ nitroblue tetrazolium) 
detection reagent (Roche Diagnostics, Mannheim, Germany) was used for detection.  
Stability assays of magnetosome fluorescence 
A stock solution with a defined magnetosome concentration (2 mM iron) was prepared 
in EP and dispensed in 100 µl portions into 1.5 ml reaction tubes. Magnetosomes were 
magnetically separated for two minutes by attaching a neodymium magnet to the side of the 
tube. The supernatant was aspirated, and the magnetosomes were resuspended in 100 µl of a 
buffer containing the desired constitution. For pH testing, buffer S (40 mM boric acid, 40 mM 
phosphoric acid) was adjusted with sodium hydroxide to pH values of pH 3 to pH 11 (51). 
Stability to detergents was tested by resuspending magnetosomes in buffer S (pH 8) 
containing different SDS or triton X-100 concentrations from 0 to 1% (w/v). To investigate 
the effect of guanidinium chloride, the magnetosomes were resuspended in buffer S (pH 8) 
containing between 0 and 1 M guanidinium chloride. The influence of sodium chloride was 
tested with buffer S (pH 8) supplemented with 0, 0.1, 0.5, 1, 2 and 4 M sodium chloride. After 
the magnetosome suspensions were incubated for 1 h at 4°C, the magnetosomes were 
separated magnetically as described above, resuspended in buffer S (pH 8) and the 
fluorescence was quantified with a fluorescence reader. The influence of the storage 
temperature was tested by incubating magnetosome suspensions in buffer S (pH 8) at 
temperatures between -20 and 70°C for 12 h followed by a magnetic separation, resuspension 
in the same buffer, and fluorescence quantification as described above.       
Results 
Optimization of growth conditions for maximum GFP fluorophore formation and 
magnetite synthesis 
Synthesis of magnetite crystals in M. gryphiswaldense occurs only below an oxygen 
partial pressure of 10 mbar (14, 35, 50). In initial experiments, we noticed that under these 
microoxic conditions only a small and highly variable proportion of cells expressing GFP 
were fluorescent, and the emitted signal was rather weak and varied between different growth 
experiments (C. Lang and D. Schüler, unpublished observation). As we reasoned that poor 
GFP fluorescence expression was due to limited availability of oxygen for fluorophore 
biosynthesis, we performed a number of experiments in order to establish growth conditions 
Manuscript 1 
69 
that would provide both strong GFP expression and magnetite biomineralization. First, cells 
expressing GFP from the lac promoter on pCL5 were grown in sealed batch flask cultures 
with various headspace-to-volume ratios and under different headspace oxygen 
concentrations. As shown in Table 3 the proportion of fluorescent cells and magnetic 
orientation (as monitored by Cmag) displayed an inverse dependence on the aeration. For 
example, under standard cultivation conditions (1% oxygen in the culture headspace), which 
are used for maximal magnetite production, only 8.5 % of the cells displayed significant 
fluorescence. The highest proportion of fluorescent cells (~ 22 %) was found at the highest 
aeration of 21 % oxygen in the headspace. However, cells were completely devoid of 
magnetite crystals (Cmag = 0) under these conditions. The proportion of fluorescent cells and 
the average intensity increased with the oxygen availability, and both magnetite formation 
and fluorescence intensity were reasonably high if the headspace-to-liquid ratio was 
approximately 1:4, and air was used in the headspace (Table 3). Next, we investigated the 
fluorescence of GFP fused to the MMPs MamG, MamC, and MamF, respectively, under these 
optimized conditions. The expression and intracellular localization of these three proteins was 
of primary interest as they represent the most abundant proteins in the MM, are tightly bound 
to the magnetosome by several transmembrane domains, and thus are promising candidates 
for anchors to display fusion proteins on the surface of magnetosome particles (9, 32). Like 
with unfused GFP, cultures expressing GFP fused to the MamC, MamF, and MamG, from the 
plasmids pCL6, pCL7 and pCL8, respectively, displayed reasonable magnetite formation and 
high fluorescence, and large proportions of fluorescent cells were obtained in flask cultures 
grown under the optimized conditions described before. However, the fusions displayed 
different fluorescence intensities, and the highest fluorescence was observed with MamC-
GFP followed by MamF-GFP and MamG-GFP (Figure 1, Table 3).  
In summary, the best compromise with respect to magnetite formation and GFP 
fluorescence was obtained in flask cultures with growth-limiting oxygen supply, in which 
oxygen concentrations declined from high initial levels in the medium with increasing cell 
numbers, eventually reaching low dissolved oxygen concentrations permitting magnetite 
synthesis (14, 35). As this is accompanied by a change of conditions during growth, further 
experiments were performed in an oxystat fermentor, which allowed the precise maintenance 
of a constant oxygen partial pressure over the entire incubation period (14). Cells expressing 
MamC-GFP from pCL6 were highly magnetic at 0.12 mbar oxygen, however, only 10.8 % of 
the R3/S1(pCL6) cells exhibited fluorescence levels above that of the untransformed control. 
On the contrary, fluorescence intensities and the proportions of fluorescent cells (26.1%) were 
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highest at an oxygen partial pressure of 200 mbar, which however entirely repressed 
magnetite synthesis. At an intermediate oxygen partial pressure of 2 mbar the culture 
produced magnetite, but only 15.8% of the cells was fluorescent, and the average fluorescence 
was low with an intensity only 22% higher than that of the culture grown at 0.12 mbar oxygen 
(Table 3).  
As we concluded from these experiments that strong fluorescence and maximum 
magnetite synthesis are mutually exclusive at any constant oxygen level, shift experiments 
were performed, in which the cells were initially grown for 16 hours under fully oxic 
conditions (200 mbar) to an OD565 of 0.310, and then shifted to microoxic conditions (0.2 
mbar) for eight hours. This treatment resulted in a magnetic culture with 20.3 % fluorescent 
cells and a fluorescence intensity that had increased by 50% compared to the microoxically 
grown culture (Table 3). In addition, we attempted first to incubate the bacteria under 
microoxic conditions and subsequently induce GFP maturation by exposure to air. However 
these experiments were unsuccessful as the fluorescence did not increase over an incubation 
period of 6 h, and cells ceased growth after the shift (data not shown).  
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Figure  1: Flow cytometrical analysis of M. gryphiswaldense R3/S1 expressing either GFP (pCL5) (A), 
MamC-GFP (pCL6) (B), MamG-GFP (pCL8) (C) or MamF-GFP (pCL7) (D). The analysis of the 
untransformed M. gryphiswaldense strain is shown in panel (E). The fluorescence intensity (FL1-H) of each 
event was plotted against the side scatter (SSC). 
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Table 3: Flow cytometric analysis of different GFP and GFP-fusion expressing 
derivatives of M. gryphiswaldense cultivated under different conditions.  
Strains Culture conditions Growth 
stage 
(OD) 
Magnetism 
(Cmag) 
Average 
Fluorescence 
Cell 
proportion 
above 
threshold (%) 
M. gryphiswaldense 
(pCL5) 
1% oxygen 
100 ml culture in  
1 L flask 
0.095 1.7 18.1 8.5 
M. gryphiswaldense 
(pCL5) 
10% oxygen 
100 ml culture in  
1 L flask 
0.183 1.5 41.9 20.0 
M. gryphiswaldense 
(pCL5) 
21%  
100 ml culture in  
1 L flask 
0.138 0.0 52.3 20.4 
M. gryphiswaldense 
(pCL5) 
21% oxygen, 
100 ml culture in 
500 ml flask 
0.224 0.0 50.1 22 
M. gryphiswaldense 
(pCL5) 
21% oxygen, 
400 ml culture in 
500 ml flask 
0.220 1.7 42.6 19.7 
M. gryphiswaldense 
(pCL5) 
21% oxygen, 
4L culture in 5L 
flask 
0.408 2.0 30.8 22.3 
M. gryphiswaldense  
(pCL6) 
21% oxygen, 
4L culture in 5L 
flask 
0.532 1.9 42 22 
M. gryphiswaldense 
(pCL7) 
21% oxygen, 
4L culture in 5L 
flask 
0.408 1.7 15.6 5.3 
M. gryphiswaldense 
(pCL8) 
21% oxygen, 
4L culture in 5L 
flask 
0.416 1.5 24.9 17 
M. gryphiswaldense 
(pCL6) 
0.12 mbar oxygen, 
10 L fermenter 
0.624 1.3 22.8 10.8 
M. gryphiswaldense 
(pCL6) 
2 mbar oxygen, 
10 L fermenter 
0.540 1.6 27.8 15.8 
M. gryphiswaldense 
(pCL6) 
200 mbar oxygen, 
10 L fermenter 
0.480 0.2 46.2 26.1 
M. gryphiswaldense 
(pCL6) 
200 mbar oxygen 
for 16 h +  
0.2 mbar for 8 h,  
10 L fermenter 
0.624 1.3 42.4 20.3 
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The GFP fusions to MamC, MamF and MamG are specifically expressed in the 
MM  
In vivo localization of GFP fusions of MamC, MamF and MamG 
Next, we studied the expression and subcellular localization of GFP fusions of the 
GFP-tagged MamC, MamF, and MamG proteins by fluorescence microscopy under 
conditions of magnetite formation. In cells expressing MamC-GFP, MamF-GFP, and MamG-
GFP the fluorescence was typically observed as linear signals along the cell axis at midcell, 
where the magnetosome chain is usually located (Figure 2). With all three fusions the signals 
either appeared predominantly as 0.5 to 2 µm straight, or less frequently, as punctuated lines. 
The linear signals were either observed at the concave side of the cells or at the shortest 
connection from one turn to the next, which is consistent with a localization along the axis of 
the twist of the helical cells. In MamC-GFP-expressing cells the signal was occasionally 
observed as a single bright fluorescent spot at midcell. No significant fluorescence was 
associated with the cytoplasmic membrane for any of the fusions. However, some 
fluorescence was detectable in the cytoplasm of cell expressing MamF-GFP and MamG-GFP 
(approximately 100% and 50% above background fluorescence of the medium), whereas the 
MamC-GFP fusions display almost no cytoplasmic fluorescence (<10% above background). 
Control cells expressing unfused GFP displayed fluorescence evenly distributed over the 
cytoplasm (Figure 2).  
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Figure  2: Fluorescence micrographs of M. gryphiswaldense R3/S1 strains expressing MamC-GFP (pCL6), 
MamF-GFP (pCL7), MamG-GFP (pCL8) or GFP (pCL5). In the first column the GFP fluorescence signals 
are shown. In the second column the signals of the membrane stain FM4-64 are shown for the same cells 
displayed in the first column and in the third column the overlays of the GFP (green) and FM4-64 (red) signals 
are displayed. The fourth column shows an enlargement of an overlay of a single representative cell. Scale bars 
are 3 µm. 
 
Immunoblot analysis MamC-, MamF- and MamG-GFP localization  
The localization and expression of GFP fusions were further studied by SDS-PAGE 
and immunodetection in cell fractions prepared from fluorescent and magnetic cells. An 
additional protein band of the expected size of the MamC-GFP fusion protein (40 kDa) was 
detected by Coomassie stain in magnetosomes from cells expressing MamC-GFP (Figure 3A, 
top). Bands corresponding to MamF-GFP (40.1 kDa) and MamG-GFP (35.5 kDa) were below 
detection by Coomassie but were recognized with an anti-GFP antibody (Figure 3A, bottom). 
In addition, a band of roughly 20 kDa was immunodetected in the magnetosome fractions 
from all of the GFP fusions, and further bands representing products of proteolytic cleavage 
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were visible in MM preparations from MamF-GFP and MamG-GFP, indicating that these 
fusions were partially degraded in the cells (Figure 3A, bottom). 
Immunodetection of the MamC-GFP fusion by an anti-MamC antibody revealed the 
strongest signal in the MMP fraction, whereas a weak band of this size was also recognized in 
the NF, the MP, and the CL, but not the SP (Figure 3B). Native, unfused MamC recognized 
by anti-MamC as a band of 12.5 kDa displayed an identical subcellular distribution to that of 
MamC-GFP. The presence of low levels of MamC and MamC-GFP in the NF and the MP is 
probably caused by magnetosome membranes, which evaded the magnetic separation 
procedure such as empty magnetosome vesicles, vesicles containing immature magnetite 
crystals and MMs which were detached during the purification procedure. The intensity of the 
MamC-GFP band was approximately 80% of that of the MamC band, indicating that both the 
fusion and the native protein are expressed in comparable quantities (Figure 3B). MamF-GFP 
and MamG-GFP were exclusively detected as weak bands only in the MMP fraction, but were 
below detection in other subcellular fractions including the entire CL (data not shown), which 
indicates that MamF-GFP and MamG-GFP are present only in small amounts, due to either 
strong degradation or poor expression. For comparison, unfused GFP was recognized by an 
anti-GFP antibody at the expected size of approximately 27 kDa in the CL, the NF and in the 
SP, but not in the MP or the MMP (Figure 3C). 
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Figure  3: Detection of GFP fusion proteins in isolated magnetosomes and other cell fractions. M – marker, 
CL – cell lysate, NF – non-magnetic fraction, SP – soluble protein, MP – membrane protein, MMP – 
magnetosome membrane protein 
A: Detection of GFP fusion proteins on isolated magnetosomes. Upper panel: SDS-PAGE of purified MMPs 
from the M. gryphiswaldense R3/S1 strain, and derivatives harbouring the plasmids pCL5 (GFP), pCL6 (MamC-
GFP), pCL7 (MamF-GFP) and pCL8 (MamG-GFP). The MamC-GFP signal is indicated by an arrow (◄). 
Lower panel: Immunoblot of an identical gel as shown in the upper panel probed with an anti-GFP antibody. 
Besides the MamC-GFP signal (◄), signals for MamF-GFP (■) and MamG-GFP (□) are observed. In addition a 
putatively non-specific signal (*) is detected at a size of 20 kDa in the magnetosome fraction of MamC-GFP, 
MamF-GFP and MamG-GFP expressing cells.  
B: Immundetection of MamC (•) and MamC-GFP (◄) in different cell fractions of R3/S1(pCL6) (MamC-GFP) 
and in the magnetosome membrane fractions of R3/S1(pCL5) (GFP) and R3/S1 with an anti-MamC antibody.  
C: Immunodetection of GFP (○) in different cell fractions of R3/S1(pCL5) (GFP) with an anti-GFP antibody. 
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Isolated magnetosomes expressing GFP fusions to MamC, MamF and MamG 
display stable fluorescence in vitro 
The next question was whether GFP fusions expressed on magnetosomes retain 
functionality in vitro, as in vitro stability would a prerequisite for any future application of 
proteins genetically fused to magnetosome proteins. Freshly isolated magnetosomes 
expressing MamC-GFP, MamF-GFP or MamG-GFP, displayed strong fluorescence, which 
was visible under the fluorescence microscope in form of bundles of chains that formed in the 
presence of an ambient magnetic field (Figure 4, also see supplemental materials).  MamC-
GFP magnetosomes displayed the highest fluorescence, while the fluorescence of MamF-GFP 
and MamG-GFP magnetosomes of cells from identical cultures was approximately threefold 
(MamF-GFP) and fivefold (MamG-GFP) lower (Figure 5). The stability of fluorescent 
magnetosomes was tested by measuring the fluorescence after incubation in various 
conditions including different pH, temperatures, salt and detergent concentrations (Figure 6). 
The highest fluorescence intensity was retained between pH 8 and pH 9, which is close to the 
reported optimum pH of GFP (29), and at pH 11 the intensity was still 20% of the value at pH 
9, whereas fluorescence was abolished at acidic pH below pH 6. At pH 7 only 60 % of the 
intensity was retained. The fluorescence intensity was equally high if magnetosomes were 
stored at temperatures below 24°C or frozen at -20°C. Temperature increase to 30°C or 50°C 
led to a decrease (∼20%) of fluorescence, and after storage at 70°C only approximately 15% 
of the fluorescence of magnetosomes stored at 4°C was retained. In addition, the particles 
incubated at this high temperature rapidly agglomerated, indicating that the membrane 
enclosing the particles became disturbed, probably due to denaturation. Sodium chloride had a 
quenching effect on the magnetosome fluorescence only at a high concentration of 4 M, and 
guanidinium chloride reduced the fluorescence intensity to roughly 50% at a concentration of 
1 M. However, the detergents SDS and triton X-100 lead to a loss of approximately 80 % of 
the magnetosome bound fluorescence at a concentration of 0.05 %, probably due to 
solubilization and loss of MamC-GFP. Remarkably, a fluorescence of approximately 20% 
was retained even at higher detergent concentrations, which might be due to nonspecific 
adsorption of MamC-GFP to the surfaces of magnetite crystals after membrane solubilization. 
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Figure  4: Fluorescence micrographs of magnetosome particles isolated from R3/S1 (pCL6). The 
magnetosome particles aggregated into bundles of chains in the presence of an ambient magnetic field. The scale 
bar is 100 µm. 
 
 
Figure  5: Fluorescene measurements of magnetosomes isolated from the R3/S1 strain or R3/S1 
derivatives harbouring the plasmids pCL5 (GFP), pCL6 (MamC-GFP), pCL7 (MamF-GFP) and pCL8 (MamG-
GFP). Fluorescence was quantified on 100 µl aliquots of magnetosome suspensions containing a magnetosome 
amount equivalent to 5 mM iron.  
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Figure  6: In vitro stability of fluorescent magnetosomes purified from R3/S1(pCL6) (A) Effect of the pH of 
the buffer on magnetosome fluorescence. (B) Thermal stability of the magnetosome-bound fluorescence (C-F) 
Fluorescence of magnetosomes incubated with different amounts of sodium chloride (C), guanidinium chloride 
(D), sodium dodecyl sulphate (E) or triton X-100 (F). Following an incubation period of one hour, the 
magnetosomes were magnetically separated and resuspended in buffer S pH 8 to remove unbound fluorophores. 
Subsequently, the stability of the magnetosomes was assessed by fluorescence quantification. The error bars 
represent the standard deviations, which were calculated from four independent experiments.  
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Discussion 
Although GFP has been used previously as a tag to follow the subcellular localization 
of magnetosome proteins in microaerophilic magnetotactic bacteria (16, 17, 33, 37), its 
expression and activity under the microoxic conditions required for magnetite synthesis have 
not yet been assessed systematically. However, they are crucial for correlating protein 
localization with the position of magnetite crystals and chains. Here, we have demonstrated 
that the optimum requirements for fluorophore formation and magnetite synthesis are 
mutually exclusive, and no permanent growth condition was found to permit high 
fluorescence and magnetite synthesis simultaneously. Magnetite synthesis occurs only below 
10 mbar (14), whereas GFP requires molecular oxygen during fluorophore maturation, which 
limits its use in oxygen-limited systems (30). This problem has been partially overcome in a 
variety of anaerobic and microaerophilic bacteria by shifting anaerobically grown cells to oxic 
conditions after growth to stimulate fluorophore formation. For example, in Enterobacter 
aerogenes a 60 min shift from anaerobic to aerobic conditions was sufficient to double 
fluorescence (56). Hansen et al. found that the GFP variant GFPmut3* displayed fluorescence 
in Streptococcus gordonii with 0.1 ppm dissolved oxygen. In the same study, it was also 
observed that fluorescence was activated in an anaerobically grown, non-fluorescent S. 
gordonii biofilm by a 20 min shift to aerobic conditions (11). In anaerobically grown 
Rhodobacter sphaeroides GFP was visualized after 4h of aeration by vigorous shaking (49) . 
An abrupt shift from anoxic or microoxic conditions to oxic conditions did not induce 
fluorophore formation in M. gryphiswaldense in our experiments, but inhibited further 
growth. The highest percentage of both fluorescent and magnetic cells were obtained, when 
fluorophore formation and magnetite synthesis became sequentially induced, if culture 
conditions were chosen that provided gradually decreasing oxygen levels during the 
incubation due to the increasing oxygen consumption of cells. Although the proportion of 
fluorescent cells never reached 100%, nearly all cells under these conditions contained 
magnetosome chains (data not shown). Our data also show that even under high oxygen 
tensions only 22-26% of the cells displayed significant fluorescence intensities. This may be 
attributed to a low expression level of GFP from the lac promoter. In addition a dependence 
of protein expression on the cell cycle within a heterogeneous population, and stochasticity of 
gene expression might be involved, as described for other bacteria (6, 43).    
Of all tested fusions, the MamC-GFP fusion displayed the highest fluorescence both in 
vivo and on isolated magnetosomes, which was consistent with the highest abundance of both 
the fusion and the unfused MamC protein, which displayed similar expression levels. In 
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contrast, MamF-GFP and MamG-GFP fusions were below detection by Coomassie in MM 
preparations. The immunodetection of several proteolytic degradation products of MamF- and 
MamG-GFP fusions indicated that these proteins are less stable. GFP fusions to MamF and 
MamG were substantially more weakly expressed than their unfused counterparts. This could 
be explained either by a bias in targeting to the MM, or by a relatively low expression from 
the lac promoter present on the vector backbone, which makes future expression studies of 
native or inducible promoters highly desirable.  
The GFP fusions of MamC, MamF and MamG displayed nearly identical localization 
patterns, and the extension of the linear fluorescence signal correlated well with the typical 
length and position of the magnetosome chain. Results of localization studies are in 
agreement with previous biochemical studies (9), and with the immunogold-labeling studies 
of Mam12, which is orthologous to MamC in M. magnetotacticum. However, due to the weak 
immunogold signals, the immunogold-labeling experiments were not fully conclusive 
regarding the intracellular Mam12 localization (46). In contrast, the observed localization of 
MamC-GFP as a bright dot at midcell might indicate that the intracellular localization of the 
MamC protein along the chain is variable and may change over the cell cycle. The absence of 
strong fluorescence and immuno-signals from different compartments of cells expressing 
GFP fusions to either MamC, MamF or MamG indicated that these hydrophobic proteins are 
targeted exclusively to the MM. This is in contrast to other, more hydrophilic magnetosome 
proteins, which showed a variable and slightly different subcellular localization. For instance, 
in M. magneticum, GFP fusions of the protein MamA, which is postulated to be involved in 
the ”activation” of magnetite precipitation and regulation of magnetosome chain length, 
showed a growth stage dependent localization pattern. During exponential phase, a 
filamentous structure was seen, which reached from pole to pole and stationary cells 
displayed more punctuated signals at midcell (17). GFP fused to MamK, which is an actin-
like protein presumably forming the cytoskeletal magnetosome filament, localized as straight 
lines that extended through most of the cell (16). Similar to MamK and MamA, GFP fused to 
the MamJ protein of M. gryphiswaldense, which is predicted to attach magnetosome vesicles 
to the magnetosome filament, localized as long filaments extending from pole to pole (33). 
While the localization of these hydrophilic proteins clearly extended the length of the 
magnetosome chains, the linear fluorescent signals corresponding to the MamGFC-GFP 
fusions seem to be confined to the position of the chain of magnetite crystals. Remarkably, 
none of the MamGFC-GFP proteins were found to be associated with the cytoplasmic 
membrane (CM), although MamGFC represent hydrophobic proteins with a predicted 
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localization in the CM. Hence, our data indicate that MamC, MamF and MamG are targeted 
to the MM by a highly specific mechanism, which seems different from that of other MMPs, 
such as MamA, MamJ and MamK. It is possible that certain magnetosome membrane 
proteins such as MamA, MamJ and MamK display a different localization pattern to MamC, 
MamF and MamG as they interact with the magnetosome filament, whereas MamC, MamF 
and MamG, which are part of the magnetosome membrane, are predominantly associated with 
mature magnetsomes.  
The utilization of magnetic nanoparticles for many applications generally requires a 
specifically functionalized particle surface (reviewed in reference 22). For example, it is very 
attractive to specifically display foreign polypeptides, such as enzymes, fluorophores, or 
coupling groups on the surface of particles, and the genetic modification of magnetosome 
associated proteins may provide an elegant way to construct multifunctionalized magnetic 
nanoparticles. In our study, the MamC-GFP fusion protein retained functionality in vitro and 
remained attached with the magnetosomes after their isolation from disrupted cell, as 
indicated by robust magnetosome-specific fluorescence under a variety of storage and 
incubation conditions. Such GFP-coupled magnetosomes might be useful as fluorescence-
labeled magnetic nanoparticles in several applications, such as bimodal contrast agents for the 
fluorescent and magnetic resonance imaging of macrophages (24). In addition to GFP, other 
functional moieties, such as enzymes, antibody binding proteins, receptors, peptide hormones, 
growth factors, autobiotinylation signals, and protein tags for “click chemistry” could be 
expressed on the magnetosome particle by use of magnetosome specific anchor proteins. 
Previous studies in M. magneticum attempted to use either the MagA or Mms16 proteins as 
membrane anchors for magnetosome-specific display of fusions proteins (28, 53). However, it 
has been challenged that MagA and Mms16 (renamed as ApdA in M. gryphiswaldense) are 
native constituents of the MM, but in fact may rather represent contaminations from other 
subcellular compartments that become non-specifically associated with the magnetosomes 
particles upon cell disruption (10, 34, 37). Magnetosomes modified with a luciferase fusion of 
the magnetosome protein Mms13, which is an ortholog of MamC, had more than 400-fold-
higher luminescence intensity than Mms16-luciferase-modified magnetosomes in M. 
magneticum AMB-1 (53). This is in agreement with our results that demonstrate that GFP 
fused to MamC displayed strong and stable fluorescence in vitro. MamC seems to represent a 
useful, perhaps universal anchor for magnetosome display of other proteins for several 
reasons. First, MamC is tightly attached to the magnetite crystal surface, and its association 
has been shown to be resistant to proteolysis, and chemical stress (9). Second, as the most 
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abundant magnetosome protein, it is highly expressed. By densitometric quantification we 
roughly estimated the number of MamC-GFP copies per magnetosome particle to be 50 to 
100 (data not shown). In addition, as an anchor, MamC is not likely to interfere with the 
function of the added moiety because of its relatively small size, and its hydrophilic C-
terminus is accessible for the expression of fusion proteins. Conversely, MamC fusions with 
heterologous proteins are not expected to interfere with magnetosome formation, as it has 
been demonstrated that the deletion of MamC had only a minor effect on magnetite synthesis 
(32).  
In conclusion, we established cultivation conditions for the expression of GFP in M. 
gryphiswaldense. Under these growth conditions, it is possible to use GFP as fluorescent tag 
for subcellular protein localization or as reporter gene to study gene expression in correlation 
to magnetite synthesis within the same cell. Furthermore, the use of MamC as an anchor for 
future functionalization of magnetosomes for biotechnological applications has been 
demonstrated.  
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Abstract 
Magnetospirillum gryphiswaldense is a widely used model organism to study the 
biomineralization of magnetosomes, which are unique prokaryotic organelles. Analysis of the 
formation of magnetosomes as well as their functionalization for bionanotechnological 
application has been hampered by the relative shortage of tools for genetic manipulation of M. 
gryphiswaldense and other magnetotactic bacteria. To develop an expression system for M. 
gryphiswaldense we estimated gene expression from known and predicted genuine M. 
gryphiswaldense promoters as well as several widely used E. coli promoters using GFP as a 
reporter. Highest level of GFP expression was observed with the magnetosomal PmamDC 
promoter. In addition, the E. coli Ptet promoter was efficiently induced by anhydrotetracycline 
in M. gryphiswaldense, even though absolute expression levels from Ptet were lower than from 
PmamDC. The usefulness of PmamDC as a gene expression tool was further demonstrated by 
magnetosome-specific display of a translational fusion of the magnetosome protein MamC 
and the antibody binding “ZZ” domain. This resulted in the generation of antibody-binding 
magnetic nanoparticles that could be used for magnetic separation of antibodies and for 
immunoassays.  
 
Introduction 
The ability of magnetotactic bacteria (MTB) to orient in geomagnetic fields is based 
on the formation of magnetosomes, which are intracellular organelles consisting of 
nanocrystals of the magnetic iron oxide magnetite (Fe3O4) that are formed within a distinct 
subcellular compartment provided by the magnetosome membrane (MM) (39). The two 
strains Magnetospirillum magneticum and M. gryphiswaldense have recently emerged as 
model systems to study the biomineralization and cell biology of magnetosome formation as 
well as potential applications of these bacterial magnetic nanoparticles. A magnetosome-
specific subset of proteins was identified that are presumably involved in vesicle formation, 
magnetosome-directed iron transport, magnetite crystallization, and magnetosome chain 
assembly (12, 18, 19, 32, 35-37, 48). Although the genetic analysis of MTB is still 
complicated by a relative shortage of genetic tools, recently methods became available for 
transformation and mutagenesis of M. magneticum and M. gryphiswaldense.  In addition, 
GFP was successfully used as a reporter to study the localization of proteins involved in 
magnetosome formation and chain assembly in vivo (18, 19, 36, 37). Flow cytometry was 
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used to study the use of GFP in microaerophilic MTB, and optimized growth conditions for 
both GFP fluorophore formation and magnetite biomineralization were established (23).  
Because of their unique magnetic characteristics, magnetosomes have attracted bio- 
and nanotechnological attention in applications such as magnetic separation, magnetic 
resonance imaging, or magnetic hyperthermia (5, 14, 27, 31, 52), which require the 
immobilization of functional moieties on the magnetosome surface. This can be achieved 
either by chemical modification of purified magnetosomes or by genetic modification of MM 
proteins (22, 24, 31).   
Despite the demand for efficient and inducible expression systems, only one study 
reported a system for the expression of fusion proteins in the MM of M. magneticum. Using 
luciferase as a reporter several putative promoters driving the expression of highly abundant 
membrane and magnetosome proteins were studied. The highest expression of luciferase was 
observed with the promoter of a putative peroxiredoxin gene (Pmsp3) (53). In M. 
gryphiswaldense an E. coli Plac promoter was recently used for the expression of GFP fusion 
proteins that were specifically targeted to the magnetosome compartment (23).  In another 
study of M. gryphiswaldense, three promoters (PmamAB, PmamDC and Pmms) that drive the 
expression of magnetosomal operons were identified by primer extension analysis. By 
quantitative real-time RT-PCR and microarray analysis it was shown that the three promoters 
are highly transcribed under magnetite-inducing conditions, i.e. at microaerobiosis and in the 
presence of micromolar amounts of iron (38). 
In order to identify genuine promoters for gene expression in M. gryphiswaldense we 
investigated the expression of GFP from putative and previously identified promoters of M. 
gryphiswaldense, several homologues of promoters previously identified in M. magneticum, 
as well as the Plac and Ptet promoters of E. coli, which have been widely used in many 
different bacteria. Using fluorescence microscopy, fluorometry, immunoblot analysis and 
flow cytometry we show that PmamDC is a highly efficient promoter in M. gryphiswaldense. 
Although GFP expression was not uniform within the cell population, we demonstrate that 
PmamDC can be used for magnetosome-specific expression of a fusion protein comprising the 
“ZZ” domain of protein A and the MM protein MamC, resulting in magnetic nanoparticles 
which specifically interact with rabbit IgG antibodies.  
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Materials and Methods  
Bacterial strains, media, and growth conditions 
Escherichia coli strain DH5α was used as a host for cloning and the E. coli strain 
BW29427 (thrB1004 pro thi rpsL hsdS lacZΔM15 RP4-1360 Δ(araBAD)567 
ΔdapA1341::[erm pir (wt)]) (Datsenko, K. and Wanner B.L. unpublished) was used for 
conjugation experiments. E. coli strains were grown on Luria-Bertani (LB) at 37°C. If 
appropriate the medium was supplemented with kanamycin (25 µg ml-1) or ampicillin (50 µg 
ml-1). For cultivation of strain BW29427 LB was supplemented with DL-α,ε-diaminopimelic 
acid to 1 mM. Throughout this study the M. gryphiswaldense strain R3/S1 was used (41). M. 
gryphiswaldense was routinely grown microaerobically at 30°C at moderate shaking (100 
rpm) in modified FSM medium using 27 mM lactate as a carbon source as described 
previously (15). For cultivation on petri dishes agar was added to 1.5% w/v to FSM medium.  
 
Construction of vectors 
If not specified otherwise DNA methods were conducted according to standard 
procedures (34). Primers were purchased from Sigma-Aldrich (Munich, Germany). The 
primer sequences are listed in Table 1. Cloned genes and fusion constructs were sequenced 
using BigDye terminator v3.1 chemistry on an ABI 3730 48 capillary sequencer (Applied 
Biosystems). Sequence data was analyzed with Vector NTI 10.3 (Invitrogen).  
In this study the GFPmut1 variant, which is also termed EGFP, was used (6, 25). The 
egfp gene was PCR amplified (Taq-Mastermix, Promega) from the pEGFPN-1 (BD Biotech) 
plasmid using the egfpfw forward primer, which adds a NdeI restriction site to the 5’ end of 
the egfp gene, and reverse primer CL2, which introduces a BamHI site. The PCR product was 
cloned into pGEMT-Easy (Promega) to yield pGEMegfp. The plasmid pBBRegfp was 
generated by subcloning the egfp gene from pGEMegfp into the EcoRI site of the 
pBBR1MCS-2 (20) plasmid downstream of the Plac promoter. The Plac promoter was excised 
by restriction enzyme digestion with NsiI and ApaI, and the vector was religated after Mung 
Bean nuclease (New England Biolabs) treatment to yield the promoterless GFP reporter 
plasmid pBBRpl.  
Putative promoter regions of PmamDC, PmamAB, Pmsp3, PapdA, Pure, PrplK and PrpsJ were PCR 
amplified with Taq polymerase (Fermentas) from genomic DNA of M. gryphiswaldense 
R3/S1 as a template with primers that generate a XhoI or HindIII (PrplK) site at the 5’ end, and 
a NdeI or VspI (Pmsp3) site at the 3’ end of the fragments. The PCR fragments were 200 to 400 
bp long and included the intergenic region upstream from the start codon to the next open 
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reading frame. To facilitate cloning into the NdeI restriction site a CAT triplet was inserted in 
front of the start codon. The PCR products were cloned into pGEMT-Easy and sequenced. 
The promoter fragments were subcloned into the XhoI or HindIII and NdeI restriction sites of 
pBBRpl resulting in the plasmids pBBRPmamDC, pBBRPmamAB, pBBRPmsp3, 
pBBRPapdA, pBBRPure, pBBRPrplK and pBBRPrpsJ. 
The Ptet promoter was amplified together with the tetR repressor gene in two steps 
employing splicing by overlap extension PCR from the plasmid pASK-IBA5 to eliminate an 
internal NdeI restriction site. In the first round two PCR fragments were produced by 
amplification with the primer pairs ptetfw/ptetintrev and ptetintfw/ptetrev (16). In the second 
PCR round these products were used as template for the primers ptetfw/ptetrev. The PCR 
fragment was cloned into pCR2.1 TOPO (Invitrogen) to yield plasmid pCRPtet. The 
promoter/repressor fragment was then subcloned into the NdeI and XhoI restriction sites of 
pBBRpl. 
Shortened PmamDC promoter fragments were PCR amplified with the forward primers 
PmamDC96, PmamDC262, PmamDC163 and the reverse primer PmamDCrev and cloned 
into pGEMT-Easy. Using the NdeI and XhoI restriction sites the PmamDC fragments were 
subcloned into pBBRpl to generate pBBRPdc96, pBBRPdc163 and pBBRPdc262.  
For the construction of a MamC-ZZ fusion protein the ezz gene, which codes for the 
antibody binding ZZ-protein domain, was PCR amplified with primers zzfw/zzrev from 
pEZZ18 (GE Healthcare) and cloned into pGEM-T Easy. The ZZ-fragment was then cloned 
into the XbaI and NdeI restriction sites of the pCL6 vector (23) to replace the egfp gene with 
the ezz gene and create the mamC-ezz fusion construct pBBRCZZ. The PmamDC promoter was 
amplified with PmamDCfw/PmamDCx1rev and cloned into pJET1.2/blunt (Fermentas). The 
PmamDC fragment was released from the resulting pJET1.2 derivative pJETPdcx1 and cloned 
into the XhoI site of pBBRCZZ upstream of the mamC-ezz fusion to yield pBBRPdcCZZ. 
For a complete list of plasmids used in this study refer to Table 2. The plasmids were 
transferred into M. gryphiswaldense R3/S1 by conjugation from E. coli BW29427 as 
described previously (42). 
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Table 1: Primers used in this study. Restriction sites that were incorporated in the primer 
are indicated in bold. 
Primer name Sequence  
egfpfw CATATGGTGAGCAAGGGCGAGGAG 
CL2 GTGGATCCTTACTTGTACAGCTCGTC 
papdAfw CTCGAGGAGCCTCTCCATTAAACAATG 
papdArev CATATGCTTGAATTCCTCCAACCGGGGGTATG 
prplKfw AAGCTTGGCATCAAGGTTTCGGAAG 
prplKrev CATATGTTTACCCTACCTCTGGTCG 
prpsJfw CTCGAGGTCCTTCG GGATCGCTTG AC 
prpsJrev CATATGATTCACGTCATCCGTTAAATC 
purerev CATATGGTGGTTATGCGCTGCTCAAAATC 
purefw CTCGAGCTTTTCTCGATCCGGGAAAAATAC 
PmamDCrev CATATGCTGATCTCCGGCAAGTGTATG 
PmamDCfw CTCGAGCAATGACCACCACCACCTTA AAC 
PmamABfw CTCGAGATGGCGCAAAGATGTGACGT C 
PmamABrev CATATGTCCCGTCACAATTCACCTCC 
pmsp3fw CTCGAGGAACTCCAAAAGCAAGGCTATTTAC 
pmsp3rev ATTAATCCGAAAGCTCCTTGAATCAAAAG 
ptetfw CTCGAGCTTCCGGCTGGCTGGTTTATTG 
ptetrev CATATGTTTTTGCCCTCGTTATCTAG 
ptetintrev CCGCAGATGATCAATTCAAGGCCGAATAAG 
ptetintfw CTTGAATTGATCATCTGCGGATTAGAAAAAC 
PmamDC96 CTCGAGCTTTTTCGCTTTACTAGCTC 
PmamDC262 CTCGAGGCACCCTGTTTGGCAGGC 
PmamDC163 CTCGAGATAACTCTATTTTTGCACACCC 
PmamDCxlrev CTCGAGGATCTCCGGCAAGTGTATGCAC 
zzfw GCTGCACATATGGCGCAACACGATGAAGCC 
zzrev CCATCTAGAAATATTACCGCCAGCCATTG 
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Table 2: Plasmids used in this study list 
Plasmid name Description Source 
pEGFPN1 GFP expression vector; Ap BD Biotech 
pGEMT-Easy Cloning vector; Ap Promega 
pBBR1MCS-2 Mobilizable broad-host-range vector; Km Kovach et al. (18) 
pASK-IBA5 Tetracycline inducible expression vector IBA-Go 
pCR2.1 – TOPO Cloning vector; Ap Invitrogen 
pGEMegfp pGEMT-Easy + egfp This study 
pBBRegfp pBBR1MCS-2 + egfp from pGEMegfp This study 
pBBRpl Promoterless GFP-reporter vector based on pBBRegfp This study 
pGEMPmamDC pGEMT-Easy + PmamDC This study 
pGEMPmamAB pGEMT-Easy + PmamAB This study 
pGEMPure pGEMT-Easy + Pure This study 
pGEMPapdA pGEMT-Easy + Pmms16 This study 
pGEMPmsp3 pGEMT-Easy + Pmsp3 This study 
pGEMPrplK pGEMT-Easy + PrplK This study 
pGEMPrpsJ pGEMT-Easy + PrpsJ This study 
pBBRPmamDC pBBRpl + PmamDC from pGEMPmamDC This study 
pBBRPmamAB pBBRpl + PmamAB from pGEMPmamAB This study 
pBBRPure pBBRpl + Pure from pGEMPure This study 
pBBRPapdA pBBRpl + Pmms16 from pGEMPapdA This study 
pBBRPmsp3 pBBRpl + Pmsp3 from pGEMPmsp3 This study 
pBBRPrpLK pBBRpl + PrplK from pGEMPrplK This study 
pBBRPrpsJ pBBRpl + PrpsJ from pGEMPrpsJ This study 
pCRPtet pCR2.1 + Ptet This study 
pBBRPtet pBBRpl + Ptet This study 
pGEMPdc96 pGEMT-Easy + 96 bp fragment of PmamDC This study 
pGEMPdc163 pGEMT-Easy + 163 bp fragment of PmamDC This study 
pGEMPdc262 pGEMT-Easy + 262 bp fragment of PmamDC This study 
pBBRPdc96 pBBRol + 96 bp fragment of PmamDC from pGEMPdc96 This study 
pBBRPdc163 pBBRol + 163 bp fragment of PmamDC from pGEMPdc163 This study 
pBBRPdc262 pBBRol + 262 bp fragment of PmamDC from pGEMPdc262 This study 
pEZZ18 Protein A gene fusion vector; Ap GE Healthcare 
pGEMZZ pGEMT-Easy + “ZZ“ protein domain This study 
pCL6 pBBR1MCS-2 + MamC-GFP (23) 
pBBRCZZ exchange of GFP with ZZ function in pCL6 This study 
pJETPdcx1 pJET1.2 + PmamDC This study 
pBBRPdcCZZ pBBRCZZ + PmamDC from pGEMPdcx1 This study 
 
Promoter activity assays  
For promoter activity assays E. coli cells were grown in LB to an OD600 of 0.5. M. 
gryphiswaldense strains were cultivated in triplicates microaerobically in 3 ml culture 
volumes in 6-well culture plates under a microoxic atmosphere (1% oxygen, 99% nitrogen). 
The cultures were grown to early stationary phase for 20-22 h in FSM medium (15). 
Induction of the Ptet promoter was achieved by the addition of different concentrations of 
anhydrotetracycline after 16 hours of microaerobic cultivation. The fluorescence was 
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quantified after an additional 4 hour period of cultivation. To study the induction of the Ptet 
promoter over time M. gryphiswaldense harbouring pBBRPtet was grown aerobically in 
triplicates in 100 ml volume for 16 hours. After this incubation period 10 ng ml-1 
anhydrotetracycline were added to each culture, and the fluorescence was quantified at 
different time points during a 7 h period of continued incubation.   
 
Fluorescence microscopy 
For microscopic investigation E. coli cells and M. gryphiswaldense cells were 
immobilized on agarose pads (FSM medium excluding yeast extract and peptone, but 
supplemented with 1% agarose). The immobilized cells were imaged with an Olympus IX81 
microscope equipped with a 100x UPLSAPO100XO objective with a numerical aperture of 
1.40 and a Hamamatsu Orca ER camera. Images were captured and analyzed using Olympus 
cellM software.  
 
Detection of GFP fluorescence with a fluorescence reader 
M. gryphiswaldense and E. coli strains expressing GFP from different promoters were 
washed and resuspended in phosphate buffered saline to an OD565 of 0.5. The expression of 
GFP was quantified from 100 µl aliquots of the cell suspension with an Infinite 500 96-well 
fluorescence reader using I-Control v1.2.7.0 software (Tecan). The excitation wavelength was 
485 nm (20-nm bandwidth), and emission was recorded at 535 nm (25-nm bandwidth). The 
value for each sample was averaged from 10 reads over an integration period of 20 µs. 
 
Immunoblot analysis 
Either 10 µg of whole cell protein for analysis of GFP expression from different 
promoters or 7.5 µg of protein from different cell fractions for detection of MamC-ZZ were 
separated by SDS-polyacrylamide (12%) gel electrophoresis (PAGE) according to the 
procedure of Laemmli (21). After electrophoresis, proteins were transferred onto 
nitrocellulose membranes (Protran; Whatman) by electroblotting. The membranes were 
blocked for 2 h at room temperature. An anti-GFP antibody (Santa Cruz Biotechnology) was 
added to the blocking solution at a 1:1,000 dilution and the mixture was incubated for 1 h at 
room temperature. The membrane was washed several times with Tris-buffered saline (TBS) 
(20mM Tris, 0.5M NaCl, pH7.5) and TTBS (TBS, 0.05% v/v Tween 20, pH 7.5) before 
alkaline phosphatase-labelled goat anti-rabbit immunoglobulin G antibody (Santa Cruz, 
Biotechnology) was added at a 1:1,000 dilution in TBS. After incubation at room temperature 
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for 45 min, the membrane was washed with TBS, and the nitroblue tetrazolium/BCIP (5-
bromo-4-chloro-3-indolylphosphate) detection reagent (Roche Diagnostics) was used for 
detection. 
 
Flow cytometry 
Flow cytometry was conducted with a FACScalibur flow cytometer (Becton-
Dickinson). The GFP fluorescence was excited with a 488 nm argon laser. Cells of M. 
gryphiswaldense R3/S1 and derivatives that express GFP from different promoters were 
washed and resuspended in phosphate-buffered saline at a 1:100 dilution to maintain a 
counting speed between 300 and 2,000 events s-1. For each sample 50,000 events were 
counted. Cytometry data were analyzed with FlowJo (Treestar) software. Contaminating cell 
debris and medium constituents were excluded from the analysis based on forward and side 
scatter data. To estimate the proportion of fluorescent cells, a threshold for fluorescence was 
set to the fluorescence intensity below which 99% of untransformed M. gryphiswaldense 
cells, which served as a non-fluorescent standard, were detected.  
 
Isolation of magnetosomes and cell fractionation 
Magnetosome isolation and cell fractionation was done as described previously (23) 
with the only exception that the cells were lysed with a benchtop constant cell disruptor 
(Constant Systems) at a pressure of 1.35 kbar instead of a French press.   
 
Antibody-binding assay 
 Triplicates of magnetosomes from M. gryphiswaldense R3/S1, and derivatives with 
pBBRPdcX1CZZ and pCL6 were diluted to a concentration of 1 mM Fe in 500 µl blocking 
solution (TBS + milk powder). The samples were incubated for 30 min at room temperature 
before rabbit GFP-Antibody was added at a 1:2,000 dilution. After incubation for 45 min 
magnetosomes were collected magnetically and resuspended in TBS. After an additional 
magnetic separation step a conjugate of shrimp alkaline phosphatase (SAP) and goat-anti-
rabbit antibody was added in a 1:2000 dilution in TBS. After an incubation period of 45 min, 
the magnetosomes were magnetically separated and washed with TBS three times. After the 
third magnetic collection of the magnetosomes the particles were resuspended in 200 µl TBS 
of which 100 µl were incubated with 100 µl Attophos SAP detection reagent (Roche) for 5 
min. Fluorescence was detected with an Infinite 500 96-well fluorescence reader using I-
Control v1.2.7.0 software (Tecan). The excitation wavelength was 430 nm (20 nm bandwidth) 
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and emission was recorded at 535 nm (25 nm bandwidth). The value for each sample was 
averaged from 10 reads over an integration period of 20 µs. 
Results 
Sequence analysis of putative promoters in M. gryphiswaldense 
We investigated several genomic fragments from M. gryphiswaldense harbouring 
potential promoter sequences, including putative PmamDC, PmamAB, PapdA, Pmsp3, PrpsJ, PrplK and 
Pure sequences. The PmamDC and PmamAB promoters were mapped previously in M. 
gryphiswaldense (38). Genomic regions homologous to the Pmms16 (PapdA) and the Pmsp3 
promoters which were described previously in M. magneticum (53) were analyzed. As the 
homologue of M. magneticum Mms16 is a PHB-granule-bound phasin in M. 
gryphiswaldense, designated ApdA, the promoter is named PapdA in this organism (40). In 
addition, genomic regions upstream of large ribosomal gene clusters, which potentially 
encode the strong rpsJ (rpsJ: MGR3815 ribosomal protein S10) and rplK (rplK: MGR3801 
ribosomal protein L11) promoters, were analyzed. PrpsJ was previously used as a strong and 
constitutive promoter for heterologous gene expression in Streptomyces avermitilis (17). In E. 
coli PrplK is the major promoter for ribosomal genes rplKAJL and rpoBC (RNA polymerase 
subunits β, β’) (2, 9). We also analyzed the region upstream of a putative urease operon 
(MGR3989-MGR3978), which may encode a putative urea or nitrogen-limitation inducible 
promoter Pure (7, 11) and the Ptet promoter from the E. coli Tn10 TcR gene, which can be 
induced by addition of anhydrotetracyline in a wide range of bacteria (4, 44, 50).  
Analysis of the putative promoter regions with the bacterial promoter prediction tool 
BPROM (Softberry) showed that sequences with similarity to the canonical sequence motif of 
E. coli promoters are present in all regions except for the region upstream of the rplK gene 
(Figure 1). The predicted transcription start points for the PmamAB and PmamDC promoter are 
identical to those identified experimentally (38). Highest similarity to an E. coli promoter 
sequence was found by BPROM analysis in the region upstream of the msp3 gene. All 
putative -35 and -10 promoter sequences are divergent to each other and to the canonical 
sequences of E. coli (-35: TTGACA, -10: TATAAT) (13, 26) and the α-proteobacterium 
Sinorhizobium meliloti (-35: CTTGAC, -10: CTATAT) (29). By sequence alignment the 
highest similarity to the canonical sequences from E. coli and S. meliloti was found for 
PmamAB, with a match of 5 (of 6) nucleotides at the -35 position and a match of 5 (of 6) 
nucleotides at the -10 position to both canonical sequences. The predicted -35 and -10 
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sequences show only a weak conservation with the previously described M. gryphiswaldense 
Pmms promoter (-35: CCGTCT, -10: ATTCCA) (38) (Figure 1). 
 
 
Figure 1: Prediction of promoter regions using the BPROM (Softberry, Inc) promoter prediction tool. 
Predicted -35 and -10 regions (bold), transcriptional start sites (bold, enlarged), putative ribosomal binding sites 
(bold, italics) and start codons (bold, capitals) are highlighted in the figure. In addition the score values of the 
promoter prediction are indicated above the corresponding -35 and -10 regions. The Linear discriminant function 
(LDF), which combines characteristics describing functional motifs and oligonucleotide composition of E. coli 
σ70 promoter sites (for comparison E. coli Plac LDF: 4.38 and Pbad LDF: 4.24) is displayed for the different 
promoters.  
 
Experimental identification of genuine promoters in M. gryphiswaldense 
Putative promoters were cloned upstream of a promoterless GFP reporter gene. E. coli 
cells transformed with transcriptional fusions of M. gryphiswaldense promoters to the GFP 
reporter showed almost no fluorescence upon microscopic inspection (Figure 2A). 
Fluorescence levels for every promoter from M. gryphiswaldense were even below 20% of 
the uninduced E. coli-Plac promoter (Figure 2B), indicating that promoters from M. 
gryphiswaldense are poorly expressed in this organism. In contrast M. gryphiswaldense 
strains harbouring GFP fusions of PmamDC, PmamAB, Pmsp3, PapdA displayed strong fluorescence, 
whereas weaker fluorescence was observed with PrpsJ, PrplK and E. coli-Plac, and virtually no 
fluorescence was seen in strains harbouring the Pure, E. coli-Ptet, and the promoterless control 
(Figure 2C, Figure 2D).  
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Analysis of cell lysates from the different M. gryphiswaldense reporter strains by an 
anti-GFP-immunoblot showed the highest amounts of GFP was produced from PmamDC, 
followed by Pmsp3, PapdA, PmamAB, PrplK and Plac (PmamDC>>Pmsp3, PapdA>PmamAB>>PrplK> E. coli-
Plac). No GFP production was detected in the strain with the promoterless GFP construct (Fig 
2E). These results confirmed that the level of fluorescence in fact is correlated to the amount 
of GFP. 
 
Figure 2: Expression of GFP from different promoters in E. coli and M. gryhiswaldense. (a) Fluorescence 
microscopy of E. coli cells expressing GFP from Plac or PmamDC promoter (exposure time: 1 s). (b) Fluorescence 
quantification of GFP production from E. coli strains expressing GFP from different promoters. (c-e) Analysis of 
GFP expression from different promoters in M. gryphiswaldense by (c) fluorescence microscopy (exposure time: 
0.5 s), (d) fluorometry and (e) immunoblot. The error bars reflect the standard deviation calculated from three 
independent experiments. DIC – differential interference contrast, pl – promoterless control, M – molecular 
weight marker 
 
Ptet is an inducible promoter in M. gryphiswaldense 
To test if Pure can be induced in M. gryphiswaldense under nitrogen limitation and in 
the presence of urea, we tried combinations of different media constituents (1-4 mM sodium 
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nitrate, 0.075-0.3% w/v soy peptone, 0 or 50 mM urea), but were unable to detect GFP 
expression under any condition (data not shown). In contrast, GFP expression from the Ptet 
promoter was observed four hours after the addition of 2.5 ng ml-1 anhydrotetracycline 
(Figure 3A). Maximum GFP fluorescence was detected between 5-50 ng ml-1 
anhydrotetracycline, whereas a concentration of 100 ng ml-1 resulted in a reduced GFP 
expression (Figure 3A). GFP production could be detected already 20 min after induction and 
increased for 4 hours after induction to remain then constant (Figure 3B). Flow cytometric 
analysis of the Ptet – GFP construct showed that the uninduced Ptet promoter produced nearly 
as little fluorescence as the promoterless GFP construct, which is indicative for a tight 
regulation. In the induced culture the expression level from Ptet was about as high as from 
PrplK, but tenfold lower than from PmamDC. The proportion of fluorescent cells increased after 
induction from 2.4 % about tenfold to 26.3 % of the population (Figure 4). 
 
Figure 3: Induction of GFP expression from the Ptet promoter in M. gryphiswaldense. (a) Quantification of 
fluorescence four hours after addition of different concentrations of the inducer anhydrotetracycline. (b) 
Quantification of culture average fluorescence at different time points after addition of 10 ng ml-1 
anhydrotetracycline. Standard deviations calculated from three independent experiments are indicated. 
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GFP is heterogeneously expressed from different promoters in M. gryphiswaldense 
Comparison of the average fluorescence intensities by flow cytometry showed that 
cells containing the PmamDC – GFP construct fluoresced on average twice as much as cells, 
expressing GFP from Pmsp3 or PapdA (Figure 4). However, these experiments also revealed that 
not all cells within a given population uniformly expressed GFP, but that a variable fraction 
of the cells was non-fluorescent (Figure 4). Low proportions of fluorescent cells were 
observed with weak promoters such as Pure (1.96 %) and Ptet (uninduced) (2.67 %). For the 
intermediate-strength promoters Plac, PrplK, Ptet ( induced), PrpsJ and PmamAB the proportions of 
fluorescent cells (from 8.52 % to 56.5 %) correlated well with the increased average 
fluorescence intensities, whereas higher average fluorescence produced by the stronger 
promoters Pmsp3, PmamDC and PapdA was not correlated with a higher proportion of fluorescent 
cells (56.3-50.3%).  
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Figure 4: Flow cytometry of M. gryphiswaldense (a) and strains expressing GFP from different plasmids. 
(b) pBBRPtet uninduced; (c) pBBRPtet induced; (d) pBBRPmamDC; (e) pBBRPmamH; (f) pBBRPmsp3; (g) 
pBBRPapdA ; (h) pBBRPrpsJ; (i) pBBRPrplK; (j) pBBRPure; (k) pBBRpl (promoterless); (l) pBBRegfp (Plac). 
The proportion of fluorescent cells is shown in bold, and the average fluorescence intensity is displayed in the 
upper right corner. 
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A 96 bp PmamDC promoter fragment is sufficient for efficient expression of GFP 
In order to identify potential regulatory sequences and the minimal part required for 
efficient expression, three different truncations of the PmamDC promoter region were 
constructed. In addition to the 325 bp DNA fragment which was described above, a 262 bp 
version (PmamDC262), a 163 bp (PmamDC163 ) version, and a 96 bp (PmamDC96) version were cloned 
upstream of the egfp reporter gene. No differences were detected between the different PmamDC 
truncations after growth under standard conditions (Figure 5) as well as after growth under 
oxic and iron limiting conditions (data not shown).  
 
Figure 5: Fluorescence quantification of GFP expression from the PmamDC and truncated versions 
PmamDC262, PmamDC163 and PmamDC96. Standard deviations calculated from three independent experiments are 
indicated. 
 
PmamDC allows strong expression of recombinant fusions proteins for display in the 
magnetosome membrane 
In order to demonstrate the potential of PmamDC a fusion of MamC, which has 
previously been identified as an efficient magnetosome membrane anchor protein (23) with 
the antibody-binding ZZ domain was expressed from PmamDC. The ZZ domain is a derivative 
of protein A (28) and has been previously demonstrated to be functional in M. magneticum 
(54). By immunoblot analysis of different cell fractions with a rabbit anti-GFP antibody as a 
primary antibody, whose constant region tightly interacts with the ZZ protein domain, we 
detected weak expression of the MamC-ZZ fusion protein in the cell lysate in the membrane 
protein fraction. A strong signal was obtained in the magnetosome membrane fraction (Figure 
6A), which demonstrates that MamC-ZZ is efficiently targeted to this compartment. Next, we 
tested if native MamC-ZZ modified magnetosomes bind antibodies to generate antibody-
displaying magnetic nanoparticles. After incubation of MamC-ZZ modified, unmodified and 
GFP-displaying magnetosomes with rabbit anti-GFP antibody we detected the highest 
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abundance of the rabbit anti-GFP antibody with a shrimp-alkaline-phosphatase labelled goat 
anti-rabbit-antibody on the surface of MamC-ZZ modified magnetosomes (Figure 6B). The 
signal was substantially stronger than the signal observed for MamC-GFP modified 
magnetosomes, which were produced by expression of the MamC-GFP fusion from the Plac 
promoter (23) (Figure 6B). These results demonstrate that MamC-ZZ modified 
magnetosomes efficiently bind rabbit antibodies. In addition, MamC-ZZ magnetosomes, 
which were not incubated with the rabbit anti-GFP antibody, yielded a weak signal, which 
indicates that MamC-ZZ modified antibodies also interact weakly with goat antibody, if also 
much weaker than with rabbit antibodies (Figure 6B). 
 
Figure 6: Expression of a MamC-ZZ fusion protein in M. gryphiswaldense for the production of antibody-
binding magnetosomes. (a) Detection of the MamC-ZZ protein in different cell fractions of M. gryphiswaldense 
pBBRPdcCZZ using a rabbit Anti-GFP-antibody. As a positive control MamC-GFP modified magnetosome and 
as a negative control MamC-Strep modified magnetosomes were utilised. M – molecular weight marker, CL –
cell lysate, NF – non-magnetic fraction, MP – membrane protein fraction, SP – soluble protein fraction, MMP – 
magnetosome membrane protein fraction (b) Antibody-binding assay of MamC-ZZ modified magnetosomes. 
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The strongest signal was observed with magnetosomes purified from M. gryphiswaldense pBBRPdcCZZ (ZZ), 
which were treated with a primary rabbit Anti-GFP antibody (RG) and a shrimp alkaline phosphate conjugate of 
a goat Anti-Rabbit antibody (AR). ZZ-Magnetosomes which were only treated with one antibody, MamC-GFP 
modified magnetosomes (GFP) and non-modified magnetosomes (wt) were included as controls. Standard 
deviations calculated from three replicates are indicated. 
 
Discussion 
In this study we compared previously predicted magnetosomal promoter sequences 
PmamDC and PmamAB (38) with the heterologous regions of Pmms16 (in M. gryphiswaldense PapdA) 
and Pmsp3, and with putative promoter sequences of ribosomal proteins (PrpsJ and PrplK) and a 
putative promoter of an urease operon (Pure) in M. gryphiswaldense. Sequence analysis 
showed that all tested sequences, with the exception of the upstream region of rplK, contained 
a region with high similarity to an E. coli promoter sequence. Nevertheless, promoter 
sequences from M. gryphiswaldense did not activate GFP expression in E. coli. Their 
observed inactivity in E. coli is in agreement with results of previous studies on promoters 
from α-proteobacteria and was described, for example, for promoters from S. meliloti (29), 
and Caulobacter crescentus (30, 45). In M. gryphiswaldense six of seven tested native 
promoters were considerably more active than the E. coli Plac promoter that has been used in 
previous studies in this organism. The strongest promoter in M. gryphiswaldense was PmamDC 
followed by Pmsp3, PapdA, PmamAB, PrpsJ and PrplK.  
As the predicted and previously identified promoter sequences (38) show only weak 
conservation, it is currently not possible to deduce a consensus sequence for promoters in M. 
gryphiswaldense. In addition, a correlation of the promoter sequences with the expression 
level might be obscured, as the expression level might be affected by additional promoter 
regions such as A-tract sequences upstream of the -35 element, transcriptional regulators, and 
different ribosomal binding sites.  
The use of GFP as reporter enabled us to estimate its expression in individual cells by 
flow cytometry. This revealed that GFP was heterogeneously expressed within a given 
population of cells, and that even strong promoters such as PmamDC did not further increase the 
proportion of fluorescent cells above 60%. At this point it is unclear why such a large 
proportion of cells was inactive with respect to GFP expression. However, inhomogeneous 
gene expression in an isogenic population of cells was frequently observed in bacteria (8, 43) 
and might be caused by cell-cycle dependent effects, stochasticity of gene expression or 
variations of growth rates and protein synthesis between individual cells (33, 47, 10). As a 
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similar pattern was observed with several different promoters, it is unlikely that promoter-
specific gene regulatory mechanisms are involved. However, further studies are required to 
understand the reason for the heterogeneity of protein expression and to raise the proportion 
of cells that express a heterologous protein.  
The range of potentially inducible promoters in MTB is rather limited. The widely 
used arabinose and xylose inducible promoters are presumably non-functional in M. 
gryphiswaldense, because M. gryphiswaldense is incapable of sugar utilization. Likewise, the 
vanillate-inducible promoter from Caulobacter crescentus (49) was not functional in M. 
gryphiswaldense (data not shown) and the activity of the putative M. gryphiswaldense 
promoter Pure was unaffected by nitrogen limitation or the presence of urea. In contrast, our 
results demonstrate that the Ptet promoter can be induced in M. gryphiswaldense by the 
addition of 5-50 ng ml-1 anhydrotetracycline. Expression from Ptet was tightly regulated, and 
although the fully induced Ptet promoter is not as strong as the PmamDC promoter in M. 
gryphiswaldense, the availability of an inducible promoter is an important addition to the M. 
gryphiswaldense genetic toolbox. For instance Ptet can be useful in future experiments for the 
regulated expression of deleterious proteins, or in studies of cell cycle-dependent protein 
localization using GFP-fusions.  
Although the use of GFP in microaerophilic bacteria requires caution because of the 
oxygen-dependence of GFP fluorescence (23), our results also demonstrate that GFP is an 
effective transcriptional reporter in magnetotactic bacteria. In comparison to other 
transcriptional reporters such as β-galactosidase (lacZ), luciferase (luc) and β-glucuronidase 
(gusA), the major advantages of GFP is that it is readily detected at a single cell level by 
fluorescence microscopy or flow cytometry. The combination of fluorescent proteins as 
transcriptional reporter with flow cytometry or fluorescence microscopy can be used to 
investigate the heterogeneity of populations and study the bacterial physiological state of 
individual cells (46). In addition, the pBBRpl plasmid could be used in future studies to 
monitor the activity of other clonable promoters, and in combination with flow cytometry it 
might be possible to identify differentially expressed promoters from M. gryphiswaldense and 
related MTB as previously described in other organisms (3, 51).   
Our data show that PmamDC is the strongest promoter so far identified in M. 
gryphiswaldense and was even stronger than the homologues of the previously identified 
promoters Pmsp3 and Pmms16 of M. magneticum (53). Truncation experiments of the PmamDC 
promoter showed that a 96 bp region upstream of the GFP start codon is sufficient for 
efficient gene expression. This region contains only four bases upstream of the -35 region, 
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which indicates that neither an A-tract promoter sequence or transcription factors are required 
for efficient PmamDC transcription. For future applications the short 96 bp fragment will 
facilitate its cloning and also reduce the chance of unwanted recombination between plasmid-
borne and chromosomal PmamDC.  
Another important application for an expression system in magnetotactic bacteria is 
the display of chimeric proteins on magnetosomes to generate functional biogenic 
nanoparticles (22, 24, 31). Besides selection of an appropriate polypeptide anchor, which is 
firmly attached to the magnetite particle, this approach requires robust and abundant 
expression of the chimeric protein in a large proportion of cells. We demonstrated that a 
translational fusion of the magnetosome membrane protein MamC with the antibody-binding 
ZZ domain (MamC-ZZ) was highly expressed from PmamDC and inserted into the 
magnetosome membrane.  The purified ZZ-modified magnetosomes, which selectively bind 
rabbit antibodies, can be used for magneto-immunoassays (54), or for purification of 
antibodies, as described with ZZ-modified bacterial polyester granules (1). One particular 
advantage of M. gryphiswaldense as a host for production of such genetically functionalized 
magnetosomes is that several mutant strains with average magnetosome size between 24 and 
37 nm are available (35), which makes it possible to produce a wide range of magnetic 
nanoparticles with engineered biochemical and physicochemical characteristics. In 
conclusion, our results indicate that our expression system is a powerful tool for the display of 
engineered proteins on the surface of magnetosomes to generate functionalized magnetic 
nanoparticles for bio- and nano-technological applications. 
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Currently there is great interest in the preparation of functional magnetic nanoparticles 
(MNPs) with respect to their application in various fields of biomedical diagnostics and 
nanosciences.[1–3] For example, biofunctionalized MNPs have been used for the in vitro 
detection of proteins[4–6] and nucleic acids,[7, 8] the in vivo detection of cell surface[9] and 
cytosolic[10, 11] proteins, and the signal enhancement of biomolecular detection assays,[12–16] as 
probes for magnetic resonance imaging (MRI),[9, 10, 17–21] and as reagents for hyperthermia 
magnetotherapy.[22–24] Until now, synthetic MNPs have been used almost exclusively for these 
applications although they often do not fully match the high requirements with respect to 
uniform size and morphology, biocompatibility, and high magnetization capabilities. By 
contrast, biogenic MNPs, such as the bacterial magnetosome particles (MPs) derived from 
various magnetotactic bacteria, reveal a number of advantages.[25, 26] In particular, the almost 
monodisperse MPs possess an unusually high magnetization, display unique shapes and sizes, 
which depend on the producing bacterial species, and are typically in the range of 35– 120 nm 
in diameter.[27] Their resulting superparamagnetic or ferrimagnetic properties potentially make 
them highly useful in many (biomedical) applications. MPs are organelles consisting of 
membrane-enclosed magnetite crystals that are thought to direct bacterial swimming towards 
growth-favoring microoxic zones at the bottom of natural waters.[28] The magnetosome 
membrane is comprised of phospholipids and a specific set of proteins[29, 30] and it therefore 
offers a large biocompatible surface, which is accessible for synthetic chemical manipulations 
for the attachment of artifical functional moieties.[31, 32]  
We report here the modification of biogenic magnetosome particles, 1, by a modular 
synthetic chemical approach (Figure 1). Initially, biotin groups were coupled to the 
magnetosome membrane of MPs produced by the magnetotactic bacterium Magnetospirillum 
gryphiswaldense; these MPs are 38 nm in size (mature crystals), have cuboctahedral shapes, 
and have a monocrystalline core consisting of magnetite.[29, 33] Two different strategies were 
used, namely, the incorporation of the biotinylated lipid biotin-DPPE, 2, or the covalent 
modification of the proteins within the magnetosome membrane by using NHS-biotin, 3.[34] 
After this, the membrane-bound biotin groups of the resulting MPs 4a and 4b were used for 
attachment of the protein streptavidin (STV, 5), thereby leading to STV-functionalized MPs 
6a and 6b, respectively. The resulting biotin-binding capacity of particles 6 was then used for 
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the attachment of functional biomolecular entities, such as biotinylated DNA oligonucleotides 
(7 and 8 for DNA sequences; see Table 1) and/or biotinylated antibodies (9). The resulting 
MPs, 10–14, were evaluated for their suitability to serve as probes for the detection of 
complementary targets, nucleic acids, and proteins that are specifically recognized by the MP-
bound DNA oligomers or antibodies, respectively.  
Table 1. Oligonucleotide sequences used in this study.  
Compound Sequence  
7  5’-biotin-TCC TGT GTG AAA TTG TTA TCC GCT-3’  
8  5’-GCA CTT GAG AGC (dT12)-biotin-3’  
linker 17  5’-GCT CTC AAG TGC GAT CTC TTC ACC-3’  
15  5’-SH-(dT12) GGT GAA GAG ATC-3’  
 
In the course of the chemical modification of the MPs, summarized in Figure 1, we 
investigated the biotinylation rate of MPs 4, the number of DNA moieties attached to MPs 10, 
and the hybridization capacities of 10, by using fluorescence-based assays,[34] similarly to 
previously described procedures.[35, 36] For example, for the determination of the DNA 
moieties attached to MPs 10a and 10b, doubly labeled 5’-biotin, 3’-Cy5 oligonucleotides 7 
were coupled to either MPs 6a and 6b. After removal of unbound DNA oligomers and 
repeated magnetic separation/redispersion, the fluorescence of the Cy5-labeled MPs 10a and 
10b was measured with a fluorimeter, and the fluorescence signals of Cy5 (measured at 670 
nm) were converted into molar concentrations of the Cy5-modified oligonucleotide by using a 
standard linear calibration curve.[34] The results, summarized in Table S1 in the Supporting 
Information, indicated that the functionalization of the MPs by means of the biotin-DPPE 
route led to about two-to threefold higher surface coverages with STV and oligonucleotides 
than those obtained by the NHS-based biotinylation route. On average, about 120 and 40 STV 
molecules were bound to 6a and 6b, respectively. Notably, the reproducibility was lower in 
the case of 6a, a fact suggesting that the lipid modification was accompanied by aggregation 
mediated by the magnetosome membrane of the MPs, as discussed below. Independently of 
the biotinylation method, the number of oligonucleotides bound per MP was about 1.5–2-fold 
higher than the number of STV molecules, which suggests that each STV molecule was 
bound preferentially to just a single biotin moiety present on the magnetosomes. The DNA-
hybridization capacities of particles 10 were found to be about 45% for both biotinylation 
routes (Table S1 in the Supporting Information). It should be noted that this hybridization 
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capacity is in good agreement with that observed for DNA-modified gold nanoparticles 
(DNA–AuNPs) of about 5–45 % depending on the oligonucleotide length and surface 
coverage.[35]  
 
Figure 1. a) Schematic drawing of the preparation of oligofunctional DNA-and/or protein-modified 
magnetosome particles. Biotin groups were attached to the magnetosome membrane of MPs 1 either by 
incorparation of [1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt)] (biotin-DPPE, 
2) or by the covalent modification of the proteins within the magnetosome membrane by using sulfo-N-
hydroxysuccinimide ester sodium salt (NHS-biotin, 3). Magnetosomes modified with 2 are labeled a, while 
magnetosomes modified with 3 are labeled b. The surface-bound biotin groups of the resulting MPs 4a and 4b 
were used to bind streptavidin (STV, 5), and the resulting STV-functionalized MPs 6a and 6b were 
functionalized with biotinylated DNA oligomers 7 and 8 and/or antibody 9. b) Chemical structures of the 
biotinylated modifiers 2 and 3. 
 
To evaluate the functionality of the DNA–MP conjugates, particles 11a and 11b were 
allowed to hybridize with gold nanoparticle conjugates (DNA–AuNP 16), prepared from 
thiolated oligonucleotide 15 (for oligonucleotide sequence, see Table 1) and citrate-stabilized 
gold nanoparticles,[34, 36] together with the complementary DNA linker 17 (for oligomer 
sequence, see Table 1) to facilitate aggregation of heterodimeric aggregates comprised of the 
AuNPs and the MPs. Spectroscopic analysis of the hybridization showed the characteristic red 
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shift and damping of the AuNPs plasmon absorption band, thus confirming that the oligomer 
moities of 11 a and 11 b were indeed capable of binding complementary targets (see Figure 
S2 in the Supporting Information). Precipitated MP–AuNP hybrid materials, formed from 38-
nm MP 11b and 11-nm DNA–AuNP 16, were also investigated by transmission electron 
microscopy (TEM). To this end, the binary particle aggregates were purified by magnetic 
separation to remove unbound AuNPs from the solution, before the aggregates were 
resuspended and immobilized on the TEM grids. Typical TEM images of the binary particle 
aggregates are shown in Figure 2. The presence of extended three-dimensional aggregates of 
two different-sized particles can be clearly observed (Figure 2a).  
Due to the specificity of DNA hybridization, we expected a periodic heterodimeric 
structure of the nanoparticle networks, as was observed previously in the aggregation of 
different-sized DNA–AuNPs by Mirkin and co-workers.[37] Although satellite-like structures 
were observed in some areas of the TEM images (Figure 2c), the hybrid structures, in general, 
revealed only a low degree of order. Nonetheless, in comparison to the control experiment 
lacking linker 17 (Figure 2 d), the increased amount of small AuNPs bound to the larger MPs 
clearly indicated successful formation of binary nanoparticle networks. We reasoned that this 
result might be caused by some irreversible aggregation, possibly associated with a cohesion 
of the magnetosome membrane of the MPs occurring during the conjugate synthesis and 
magnetic purification steps. Indeed, dynamic light-scattering measurements revealed a slight 
increase in the hydrodynamic diameter of the MPs subsequent to their conversion into DNA–
MP conjugates, regardless of the synthesis route (Figure S3 in the Supporting Information). 
These results supported our assumption that the MPs were partially aggregated and the 
formation of small aggregates of MPs might interfere with the formation of ordered binary 
network structures upon hybridization with DNA– AuNPs.  
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Figure 2. TEM images of binary network aggregates obtained from DNA-linked MP11b (38 nm in 
diameter) and DNA–AuNP16 (11 nm in diameter) connected by a complementary DNA linker 
oligonucleotide. A control sample lacking the linker is shown in d). Scale bars: a) 500 nm; b) and d) 200 nm; c) 
50 nm. 
 
To further elucidate functionality, STV-modified MPs 6a were converted into 
difunctional DNA conjugates 12a by coupling an equimolar ratio of two biotinylated 
oligonucleotides, 7 and 8, similarly to the procedure described previously for the preparation 
of di-and oligofunctional DNA– AuNPs.[36] Here, the resulting DNA–MPs 12 were used in a 
solid-phase DNA-directed immobilization assay (Figure 3a), such that particle-bound 
oligomer 7 was used to facilitate binding to complementary capture oligomers bound to a 
microtiter plate, while the second particle-bound oligomer 8 was used for generating a layer 
of AuNPs through hybridization with AuNP conjugate 16 by means of the complementary 
DNA linker 17. We had previously used a similar assay for the study of difunctional DNA–
AuNPs.[38] Subsequent to the formation of the AuNP layer, a silver development step was 
carried out for signal detection. As shown in Figure 3b, photometric measurements of the 
precipitated silver revealed that layer formation led to an increase in absorbance at 490 nm. 
Control experiments lacking the DNA linker oligomer 17 showed no such increase in 
absorbance. Therefore, these results confirm the specificity of DNA hybridization of the 
bifunctional DNA–MP conjugates.  
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To take advantage of the modular concept of our synthesis (Figure 1 a), we also 
investigated whether proteins can be bound to the STV-tagged MPs 6. To this end, 6a was 
incubated with a mixture containing equimolar ratios of biotinylated DNA 7 and biotinylated 
antibody anti-mouse immunoglobulin G (IgG, 9). This led to the formation of the difunctional 
MP conjugate 14a, which was then employed for the detection of mouse IgG, used as a model 
antigen in a sandwich immunoassay (Figure 4a). To this end, known amounts of the antigen 
were first immobilized on microplates by using physisorbed capture antibodies (polyclonal 
anti-mouse IgG) and, subsequently, 14 a was allowed to bind to the immobilized antigens. 
The DNA oligomers of the difunctional MP conjugate 14a were then utilized to capture 
DNA–STV–alkaline phosphatase conjugate 19 by means of specific DNA hybridization. 
Signal detection was carried out by the addition of the fluorogenic alkaline phosphatase 
substrate Attophos and fluorescence measurements (Figure 4a). While high signal intensities 
indicated the successful binding of the antigen in the case of 14 a, no such result was 
observed in the control experiments carried out with monofunctional MP conjugates, 
containing either only biotinylated anti-mouse IgG (MP 13a) or only biotinylated DNA 
oligomer 7 (MP 10a). These results again confirmed the successful functionalization of the 
magnetosomes by our chemical-modificiation approach.  
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Figure 3. DNA-directed generation of a surface-bound double layer by using difunctional DNA–MPs and 
monofunctional DNA–gold nanoparticle conjugates on a microplate. a) Schematic drawing of the assay. A 
surface-bound magnetosome layer was generated by hybridization of the particle-bound sequence 7 of 
difunctional MP 12a to biotinylated complementary capture oligomers immobilized on STV-coated microplates. 
The magnetosome-bound sequence 8 of the immobilized MP 12a was then used for binding of DNA–AuNPs 16 
through linker oligomer 17. The immobilization of DNA–AuNPs to the first layer was detected by absorbance 
measurements at 490 nm subsequent to silver enhancement. The drawing is not to scale. b) Signal intensities 
after the silver enhancement. The darkgray bar on the left side corresponds to the signal obtained by 
hybridization of MP 12, linker 17, and DNA–Au conjugate 16. The three light gray bars show the signal 
intensities of various negative controls, namely, the hybridization procedure in the absence of linker 17, capture 
oligomers, or MP 12, respectively. The blackbar demonstrates the signal intensity of a positive control reaction, 
in which 16 was directly immobilized in the absence of MP 12 through linker 17 by using biotinylated capture 
oligomer 8 attached to the STV microplate. The hatched blackbar represents the signal intensity of the 
immobilization of 16 without linker oligomer 17. The white bar represents the background signal of the silver 
solution.  
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Figure 4. Utilization of antibody/DNA-functionalized biogenic MPs as reagents in a sandwich immunoassay. a) 
Schematic drawing. The antigen (mouse IgG, represented by gray spheres) was bound by surface-attached 
capture antibodies through specific immunosorption on a microplate. Subsequently, immobilized antigen was 
labeled with anti-mouse-IgG-functionalized MP 14a. The magnetosomebound DNA oligomer 7 of MP 14a was 
then used for binding of a complementary DNA–STV–alkaline phosphatase conjugate 19, which comprises 
DNA–STV conjugate 18 and biotinylated alkaline phosphatase. Subsequent to the binding of MP 14a to the 
immobilized antigens, Attophos was added as the alkaline phosphatase substrate for fluorescence signal 
detection. MP 14a and 19 were mixed before they were added to the immobilized antigens on the microplate. 
The drawing is not to scale. b) Fluorescence signal intensities obtained in the immunoassay. Signal intensities 
were only observed in the presence of difunctional MP 14a, whereas no signals were generated in the presence 
of monofunctional magnetosomes 11 or 13.  
In conclusion, we have reported here the modular functionalization of biogenic 
magnetosome nanoparticles isolated from the magnetotactic bacterium M. gryphiswaldense. 
Based on either covalent or noncovalent modification of the magnetosome membrane with 
biotin moieties and employment of streptavidin as a connector, DNA oligonucleotides were 
bound the magnetosomes, thus leading to semisynthetic hybrid particles with specific binding 
capabilities for complementary DNA. The DNA–magnetosome conjugates were successfully 
used as reagents in a protein detection assay, and we anticipate further developments of such 
particles for the analysis of protein microarrays, which are increasingly important in 
immunological diagnostics and proteome research.[39] Moreover, because magnetosome 
biomineralization in magnetotactic bacteria is under genetic control, magnetosome particles 
of different sizes and shapes[40] or functionalized magnetosomes displaying heterologous 
fusion proteins can be generated by genetic engineering.[28,41] One may also envision the 
development of new classes of biogenic nanoparticle probes with applications in bioanalytics, 
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imaging, and other fields of nanobiotechnology. 
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Abstract:  
We describe an innovative modification of the Immuno-PCR technology for 
automatable high sensitive antigen detection. The Magneto-Immuno-PCR (M-IPCR) is based 
on antibody-functionalized biogenic magnetosome nanoparticles revealing major advantages 
over synthetic magnetic particles. The general principle of the M-IPCR is similar to that of a 
two-sided (sandwich) immunoassay. However, antibody-functionalized magnetosome 
conjugates were employed for the immobilization and magnetic enrichment of the signal 
generating detection complex enabling the establishment of a surface independent 
immunoassay. To this end, the M-IPCR was carried out by simultaneously tagging the antigen 
with the reagent for read-out, i.e., a conjugate comprising the specific antibody and DNA 
fragments, in the presence of the antibody-functionalized magnetosomes. To demonstrate the 
general functionality of the M-IPCR, the detection of recombinant Hepatitis B surface 
Antigen (HBsAg) in human serum was established. We observed a detection limit of 
320pg/ml of HBsAg using the M-IPCR, which was about 100-fold more sensitive than 
the analogous Magneto-ELISA, established in parallel for comparison purposes.  
 
Keywords: Immuno PCR . Real-time Immuno-PCR . Biomarker . Magnetosome . Hepatitis B 
. Automatization . Protein Analytics 
 
Introduction:  
In the field of clinical diagnostics a biomarker is defined as any biochemical 
compound, for instance a protein, which can be used to accurately and sensitively monitor 
health status or diagnose the progress of disease and the effects of treatment of individuals.[1, 
2] Furthermore in various fields of interest, such as agriculture,[3] drug development[4] or 
doping control,[5] the detection of biological markers are of fast growing importance. 
Currently researchers spend more and more time to identify proteins in human body, animals 
or plants as markers for specific physiological conditions of organisms. This increasing effort 
in research is reflecting the need for new biomarkers facing the requirements of today’s fast 
growing biotechnological and pharmaceutical industry.[4, 6] To support these requirements, 
novel technologies are needed allowing for the precise detection and quantification of this 
new challenging generation of biomarkers, which may occur in very low concentrations 
within complex biological matrices.[7-10] 
Immuno-PCR (IPCR), first described by Sano et al.,[11] has nowadays evolved to an 
established methodology for the ultra sensitive analysis of biomarkers.[12] IPCR combines the 
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standard ELISA technology with the signal amplification power and fast read-out of the real-
time PCR. As the consequence, IPCR not only does lead to a 100- to 10,000-fold gain in 
sensitivity compared to conventional ELISA,[13-15] but it also reveals a very broad linear 
dynamic range of up to five orders of magnitude.[14, 16] Additional advantages of IPCR include 
minimized sample volume requirements, high tolerances against drug and matrix effects and 
its adaptability for the detection of basically any antigen.[17]  
To further increase the performance of IPCR as a standard laboratory routine, 
reduction and automation of the various assay steps is an important goal, and the use of 
magnetic nanoparticles (MPs) may provide a solution for the establishment of automated one-
step immunoassays.[18-20] Key requirements for the efficient use of such MPs comprise their 
uniform size and morphology, biocompatibility and high magnetization capabilities. To 
address these issues, we have recently developed biogenic bacterial magnetosome particles, 
derived from the magnetotactic bacterium Magnetospirillum gryphiswaldense, which were 
modified with oligonucleotides and antibodies by synthetic chemical means.[21] These 
magnetosome conjugates have a number of advantages over conventional synthetic MP. 
Magnetosomes are membrane-enveloped magnetite crystals which are formed intracellulary 
via a genetically controlled biomineralization process. This ensures uniform particle shape 
and a narrow size distribution. The ferrimagnetic single magnetic domain particles possess a 
high magnetic susceptibility, in addition mutants producing smaller, superparamagnetic 
particles are available.[22][23, 24]  
We here report on the development on the development of an IPCR variant, called 
Magneto Immuno-PCR (M-IPCR), which is based on the chemically modified magnetosome 
nanoparticles, bearing streptavidin molecules at the magnetosome membrane.[21] To 
elucidate the performance of M-IPCR we chose the detection of recombinant 
Hepatitis B surface Antigen (HBsAg) in human serum as model system. The general 
scheme of this assay is based on a two-sided (sandwich) immunoassay (Figure 1). 
However, while in standard immunoassays the capture antibodies are typically bound to the 
solid-phase, we here used antibody-functionalized biogenic magnetosome particles as the 
capture phase. The particles were mixed with the commercially available DNA-anti HBsAg 
antibody conjugate directly within the biological matrix (i.e., blood serum), and subsequent to 
the formation of the detection complex, the magnetosomes were collected using an external 
magnetic field. 
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Figure 1: Schematic drawing of the Magneto Immuno-PCR (M-IPCR). A: HBsAg specific magnetosome-
antibody conjugate and DNA-antibody conjugate are incubated simultaneously with the serum sample 
containing HBsAg resulting in a signal-generating immunocomplex. B: The immunocomplex is concentrated 
using an external magnetic field. Subsequent washing steps permit the removal of unbound materials. C: After 
resuspension, a defined volume of the magnetosome solution is transferred to a microplate containing the PCR 
mastermix to enable real-time PCR detection of the immobilized antigen. 
 
In a first step, we established a Magneto-ELISA (M-ELISA) protocol as the model 
system for evaluation of the magnetosome properties. Therein the DNA-antibody conjugate 
was exchanged against an antibody-alkaline-phosphatase conjugate, thus allowing for the 
direct comparison of the two assays. Moreover, to evaluate the M-IPCR in a wider context, 
we compared our magnetosome-based capture phase with commercial magnetic microbeads  
which were functionalized with the respective antibody. Both M-IPCR were compared to 
each other as well as to the analogous M-ELISA with respect to sensitivity, linearity, standard 
deviation and recovery rates.  
 
Results and Discussion:  
To facilitate the M-IPCR, streptavidin (STV)-functionalized magnetosomes were used 
to prepare the capture phase using the convenient coupling with biotinylated antibodies. 
Synthesis and purification of the STV-functionalized magnetosomes was carried out as 
previously described.[21] In brief, the magnetosome membrane was initially biotinylated using 
NHS-biotin, and the membrane-bound biotin groups were then used to bind the STV. The 
STV-functionalized magnetosomes were coupled with biotinylated anti-HBsAg antibody and 
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the resulting particles were washed using magnetic separation (see Experimental section). The 
M-IPCR assay was carried out in microplates to which, subsequent to incubation, a magnetic 
rack was attached to facilitate the magnetic collection of the particles. 
A first set of experiments was carried out to establish a general protocol for 
the assay schematically depicted in Figure 1. Serial dilutions of samples containing 
the antigen, recombinant HBsAg, spiked in standardized human serum, were divided 
into two aliquots. One aliquot was mixed with the commercial anti-HBsAg Imperacer™ 
conjugate for real-time Immuno-PCR (hereafter termed as M-IPCR) and the other with 
alkaline-phosphatase (AP)-antibody conjugate for fluorescence detection (hereafter termed as 
M-ELISA). Subsequent to incubation of the mixtures for 30 min, antibody-functionalized 
magnetosomes were added to the aliquot, incubated for 60 min and concentrated at the bottom 
of the microplate wells using the magnetic rack. The particles were briefly washed and 
resuspended in 50 µl ddH2O, and aliquots of 1 µl, 5 µl or 10 µl were transferred to another 
microplate containing the PCR mastermix to carry out real-time PCR. For M-ELISA, the 
fluorescence substrate AttoPhos (Roche) was added to some of the transferred aliquots in the 
second microplate, and a fluorescence was determined at λ = 560 nm using a microplate 
reader.  
As shown in Figure 2, quantification of the signals revealed a limit of detection for 
M-IPCR (Figure 2A) of 320 pg/ml for 1 µl and 5 µl of transferred volumes and 1.6 ng/ml for 
10 µl. The main reason for these findings is the standard deviation (SD). The average SD of 
2.3% (1 µl) and 1.0% (5 µl) in the assays carried out with the lower volumes transferred 
enabled a higher sensitivity than with larger volumes transferred (10 µl) which showed an SD 
of 10.9%. In comparison, the M-ELISA (Figure 2B) revealed an optimal detection limit of 40 
ng/ml for all three volumes transferred and average SDs of 8.3% (1 µl), 14.2% (5 µl), and 
13.3% (10 µl), respectively. Therefore, an about 125-fold increase in sensitivity was observed 
for the M-IPCR as compared to M-ELISA. These results demonstrate that the increase in 
sensitivity, typically obtained by using Immuno-PCR instead of the analogous ELISA,[12] 
could also be achieved with this IPCR variant. 
The reason for the increased error rates in the M-IPCR at larger transfer volumes is 
likely a consequence of inhibitory effects of the magnetosomes on the PCR amplification. 
This hypothesis arose from a control experiment in which the PCR mastermix was directly 
added to the washed and dried detection complex. No quantifiable signals along with very 
high standard deviations were observed in this case for M-IPCR. In contrast, no significant 
influence was observed for M-ELISA (data not shown). Therefore, transfer volumes of 5 µl 
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appeared to be the optimal compromise between the increase in PCR template concentration 
and the minimization of the inhibitory effects of the magnetosomes.  
We also investigated whether the use of biogenic magnetosomes is advantageous over 
the use of synthetic magnetic beads in our M-IPCR assay. Using the same protocol for M-
IPCR (5 µl transfer volume) we, thus, exchanged the antibody-functionalized magnetosomes 
with antibody-functionalized commercial STV-coated magnetic beads (Roche).  
 
Figure 2: Magneto Immuno-PCR (M-IPCR, A) and Magneto ELISA (M-ELISA, B) for the detection of 
Hepatitis B surface Antigen (HBsAg) in human serum samples. While both technologies are functional the M-
IPCR shows a maximum sensitivity of 320 pg/ml compared to 40 ng/ml in M-ELISA. Different volumes of 1 µl, 
5 µl or 10 µl of the resuspended magentosomes (see Figure 1) were used for real-time PCR (M-IPCR) or 
fluorescence detection (M-ELISA).  
 
As shown in Figure 3, the use of biogenic magnetosomes revealed a 25-fold increased 
sensitivity of 320 ng/ml, compared to the limit of detection (LOD) of 8 ng/ml HBsAg in 
standardized human serum using the commercial beads. The LOD is typically defined as the 
value of NC to which three times the value of the average standard deviation (SD) is added. 
Here, the average percentage SD for the M-IPCR using biogenic magnetosomes was only 
0.9%. Thus, the cut off value for the LOD calculates to DCt =13.20. The magnetic 
microbeads, in contrast, showed an average SD of 2.2% and a cut-oﬀ DCt = 15.71. This 
result was mainly due to the reduced signal to noise ratio and a slight increase in average SD 
in the case of the magnetic beads. However, both techniques showed linear regressions with 
R2 = 0.99 (biogenic magnetosomes) and R2 = 0.98 (magnetic particles). The use of 
magnetosomes resulted in a linear dynamic range of quantification for 200 ng/ml-320 pg/ml). 
In contrast, the magnetic microbeads only revealed a linear dynamic range of quantification of 
200-8 ng/ml. Comparable results were obtained in M-ELISA (Data not shown). Furthermore, 
the recovery rates were calculated using the linear regression of the spiked serum samples. 
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The individual recovery rates determined by this method are listed in Table 1. Biogenic 
magnetosomes revealed average recovery rates of 103% ± 22% while this value was 105% ± 
33% for the magnetic microbeads. These results, again, confirmed the good performance of 
the M-IPCR protocol using biogenic magnetosomes. 
The initial results reported here clearly demonstrate that the biogenic magnetosomes 
posses a higher performance than long established synthetic magnetic microbeads. Most 
likely, this enhanced performance results from their smaller size, monodispersity, and higher 
magnetization [21,23]. However, the use of the biogenic magnetosomes also showed some 
disadvantages during the handling steps of the assay. In particular, a limited tolerance against 
detergents, high salt concentrations and repeated centrifugation steps was observed, which 
most likely stems from the limited stability of the magnetosome’s biological membrane [21]. 
Nonetheless, the protocol reported here overcomes these limitations and further optimization 
of the production and modification processes of the magnetosomes should further increase the 
scope of applications of these biological nanoparticles [21]. 
 
 
Figure 3: Comparison of Magneto Immuno-PCR (M-IPCR) using the biogenic magnetosomes (black squares) 
or commercial magnetic beads (gray triangles). Both techniques showed linear regressions. The use of 
magnetosomes resulted in improved limit of detection (LOD) with 320 pg/ml and decreased standard deviations. 
This led to a 25-fold higher sensitivity, compared to the magnetic beads. The microbeads showed and LOD if 8 
ng/ml. 
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Table 1: Average recovery rates (%) for HBsAg were re-calculated by using the linear regression and the spiked 
serum samples of the calibration curve. 
 
Individual and average values are shown for Magneto Immuno-PCR (M-IPCR). 
 
Conclusions: 
 We here reported on the development of a homogeneous Immuno-PCR assay based on 
antibody-functionalized biogenic magnetosome nanoparticles. Using a clinical relevant 
sample system, i.e., the detection of Hepatitis B surface Antigen (HBsAg) in human serum, an 
initial protocol for M-IPCR was established and some major advantages of the magnetosomes 
in combination with Immuno-PCR were demonstrated in a comparative study. 
Compared to the analogous Magneto-ELISA a more than 100-fold improvement of the 
sensitivity was observed, correlating very well with the typical sensitivity improvement 
accessible by converting a given ELISA into an Immuno-PCR assay.[12] The direct 
comparison of the magnetosomes with commercial magnetic beads as magnetic carriers 
showed that the use of magnetosomes led to better signal to noise ratios, reduced standard 
deviations and an about 25-fold increase in sensitivity, thus demonstrating the advantages of 
using these novel compounds for high sensitivity IPCR protocols. Furthermore the 
magnetosome-based M-IPCR revealed a good dynamic range in quantification and excellent 
recovery rates. Another major advantage of the M-IPCR results from its independency of 
special solid phase materials, i.e. particular microplates with high protein binding capacity, 
high thermostability and size compatibility with customary real-time PCR cyclers, which are 
needed for standard Immuno-PCR protocols.  
In summary we demonstrated a powerful new automatable immunoassay platform 
combining the established Immuno-PCR technology with the advantages of functionalized 
biogenic magnetosome nanoparticles. The promising results obtained here face the challenges 
of new technology developments with respect to high-sensitivity, high-throughput diagnostics 
of biomarkers.  
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Experimental Section:  
 
Magnetic Capture Conjugate Preparation: 
Synthesis and purification of the antibody-functionalized biogenic magnetosome 
particles (MP) was carried out by a modular synthetic chemical approach, as previously 
described.[21] In brief, biotin groups were initially coupled to the magnetosome membrane of 
predominantly superparamagnetic magnetosomes, isolated from the mutant strain M. 
gryphiswaldense MSR-1K, using sulfo-N-hydroxy-succinimide ester sodium salt (NHS-
biotin). Following, the membrane-bound biotin groups were used to attach the protein 
Streptavidin (STV), thereby leading to STV-functionalized magnetosomes.  
Magnetic capture particles of STV-functionalized magnetosomes and biotinylated 
antibodies were prepared by mixing 10 nM stock-solutions of STV-functionalized 
magnetosomes (in TED buffer containing 20 mM Tris-HCl, 5mM EDTA, pH 7.5) and 20-fold 
excess (2.9 µM stock-solution) of biotinylated monoclonal anti-HBsAg IgG (clone NE3, IBT 
Reutlingen, biotinylated with NHS-Biotin (Pierce) according to manufacturers instructions) in 
a 96well PCR microplate (Applied Biosystems). After incubation for 30 min at room 
temperature, the mixtures were immobilized using a magnetic microplate (Dynal) and washed 
with 100 µl TE (10 mM Tris buffer, 5 mM EDTA pH 7.5). After an additional incubation for 
20 min in MSTE-B (10 mM Tris buffer, pH 7.5, 5 mM EDTA) containing 0.1 mg/ml reagent 
grade DNA (Roche), 0.5% milk powder (Oxoid) and 800 µM D-biotin (Sigma) the MPs were 
washed again and diluted to a final concentration of 3.3 nM in TE. 
For comparison, commercial STV-functionalized magnetic beads (Roche) were used. 
The functionalization with anti-HBsAg IgG was done according to manufacturers 
instructions. After an additional incubation for 20 min in MSTE-B the antibody-
functionalized magnetic beads (MB) were immobilized using a magnetic microplate, washed 
with 100 µl TETBS (20 mM Tris-Cl buffer, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.01% 
(w/v) Tween-20) and diluted to a final concentration of 167 µg/ml in TE. 
 
Detection Conjugate Preparation: 
The alkaline-phosphatase (AP)-antibody conjugate for M-ELISA was prepared by 
incubating 1 µl STV-AP (Roche) and 10 pmol (4.8 µM stock-solution) of the biotinylated 
monoclonal anti-HBsAg IgG (clone NF5, IBT Reutlingen, biotinylated with NHS-Biotin 
(Pierce) according to manufacturers instructions) to a total volume of 10 µl TE. After 10 min 
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incubation the conjugate was diluted to a final concentration of 20 nM in MSTE-B. The 
DNA-antibody conjugate (HBsAg Imperacer™ Kit, Chimera Biotec) was diluted 1:10 in 
MSTE-B. 
 
Magneto Immuno-PCR and ELISA: 
To reduce nonspecific binding of the reagents, the PCR microplate was pretreated for 
12 hours with blocking solution (Chimera Biotec). The microplate was washed twice with 
WashBuffer A (Chimera Biotec) and serial dilutions of the antigens were applied. The antigen 
used was Hepatitis B surface Antigen (HBsAg, recombinant, IBT) ranging from 1 µg/ml to 
0.5 pg/ml in standardized human serum (BISEKO, Biotest).  
For M-IPCR the DNA-antibody conjugates were added directly to 30 µl of the antigen 
samples to a final dilution of 1:60. For M-ELISA the AP-antibody conjugate was added 
directly to 30 µl of the antigen samples to a final concentration of 2 nM. The mixture was 
incubated for 30 minutes under orbital shaking.  
Following antibody-functionalized magnetosomes (to a final concentration of 0.8 nM) 
or antibody-functionalized magnetic beads (to a final concentration of 5 µg/well) were added. 
The mixture was incubated for 60 minutes under orbital shaking. Subsequent to complex 
immobilization using a magnetic microplate and washing twice by adding and removing 50 µl 
TE the complex is resuspend in 50 µl ddH2O. 
A microplate (TopYield® modules, Nunc) was prepared by adding 30 µl per well 
PCR Mastermix (HBsAg Imperacer™ Kit, Chimera Biotec) for M-IPCR or 50 µl per well 
AttoPhos (Roche) for M-ELISA. Different amounts of 1, 5 or 10 µl resuspended detection 
complex were transferred to the TopYield® modules and for M-IPCR real-time PCR was 
done according to the HBsAg Imperacer™ Kit protocol (Chimera Biotec) using an ABIPrism 
7000 real-time PCR cycler (Applied Biosystems). For M-ELISA fluorescence read-out was 
carried out after 20 min incubation under orbital shaking using a Victor2 multilabel reader 
(Perkin Elmer). 
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Abstract 
This work investigated macrophages labeled with magnetosomes for the possible detection of 
inflammations by MR molecular imaging. Pure magnetosomes and macrophages containing 
magnetosomes were analyzed using a clinical 1.5 T MR-scanner. Relaxivities of 
magnetosomes and relaxation rates of cells containing magnetosomes were determined. 
Peritonitis was induced in two mice. T1, T2 and T2* weighted images were acquired following 
injection of the probes. Pure magnetosomes and labeled cells showed slight effects on T1, but 
strong effects on T2 and T2* images. Labeled macrophages were located with magnetic 
resonance imaging (MRI) in the colon area, thus demonstrating the feasibility of the proposed 
approach. 
 
Keywords: Magnetosome; Macrophage; Magnetic resonance imaging; Molecular imaging; 
Iron particle; Inflammation 
 
Cell migration is frequently involved in pathological processes, such as the formation 
of metastatic lesions in cancer, or the infiltration of blood-borne or lymphoid inflammatory 
cells in a variety of diseases, such as angiogenesis, multiple sclerosis, rheumatoid arthritis and 
tissue or organ rejection. Since macrophages are well-known effectors and regulators of the 
inflammatory response, visualization of the infiltration of these cells into the host tissue or 
assessment of their reaction with respect to therapeutic interventions would be of high 
diagnostic value. In addition, their biological purpose to internalize any foreign particles 
makes macrophages an interesting target for molecular imaging [1].  
Molecular imaging can be defined as the non-invasive, quantitative and reproducible 
imaging and monitoring of targeted macromolecules and/or biological processes in living 
organisms [2]. To visualize cells and tissues in vivo special probes, however, are needed, 
which bind to the target with high affinity and which are detectable with a high sensitivity by 
the imaging modality. In recent years molecular imaging has been performed with different 
imaging modalities, including positron emission tomography (PET), single photon emission 
computer tomography (SPECT) or near infrared fluorescence spectroscopy (NIRF). Although 
these techniques show high sensitivity for the used probes, they commonly lack anatomic 
resolution which is needed for reliable diagnosis. On the other hand, magnetic resonance 
imaging (MRI) shows high soft tissue contrast with excellent spatial resolution without using 
any ionizing radiation, but with significantly lower label sensitivity compared to optical 
methods, for instance. The present study investigates the applicability of iron oxide particles 
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of bacterial origin (magnetosomes) to label macrophages for MR molecular imaging. 
Therefore, in vitro experiments as well as first animal experiments were performed to 
characterize the relaxation properties of these biogenic nanoparticles and their ability to 
visualize the inflammatory response with MRI.  
The magnetosomes were obtained from the Max Planck Institute for Marine 
Microbiology (Bremen, Germany) and used as MR contrast agent [3]. These biogenic iron 
oxide nanoparticles are produced by the magnetotactic bacteria Magnetospirillum 
gryphiswaldense. They consist of an iron oxide core (Fe3O4) with a diameter of 42 nm that is 
surrounded by a bio membrane (5 nm) resulting in an overall diameter of approximately 
50 nm. 
To investigate the magnetic relaxation properties of the nanoparticles the optically 
labeled magnetosomes were diluted in two identical series of different concentrations with 
iron contents ranging from 3 to 129 µmol/l Fe. Agarose (0.4 g) (Sigma-Aldrich, Steinheim, 
Germany) and 19.6 ml phosphate buffered saline (PBS) were heated to 70°C for 
solubilization of the agarose and the magnetosome ferrofluid was diluted with the agarose gel. 
The samples were placed into 500 µl reaction tubes which were kept on ice until the samples 
solidified. Iron content of the samples was calculated from the ferrofluid iron content and the 
known dilution of the samples (Figure 1(a)).  
To prove the internalization of the magnetosomes by the macrophages three samples 
of J774A.1 mouse macrophages (Cell Lines Service, Heidelberg, Germany) were cultivated 
until confluence in culture bottles with DMEM (Dulbecco’s modified Eagle medium) and 
10% (v/v) heat-inactivated fetal calf serum (37°C, 5 CO2, 95% humidity). Afterwards, the 
medium was removed and replaced by 10 ml DMEM with 10 % (v/v) fetal calf serum and 
770 µl magnetosomes (equivalent 100 µg Fe/ml solution). The macrophages were incubated 
with the magnetosomes for 3 h (37°C, 5 % CO2, 95 % humidity). To remove non-internalized 
magnetosomes the cells were washed six times, each time with 15 ml PBS buffer (100 mM, 
pH 7.4). To avoid cell aggregation which would compromise a homogeneous dispersion of 
cells in the samples and, thus, influence the cell counts necessary for the MRI experiments, 
10 ml PBS with 2 mM ethyl diamine tetra acetic acid (EDTA) were added. Cells were 
carefully removed from the culture bottles and counted in an Abbe-Zeiss counting cell 
chamber. The cells were fixated in 5 % (w/v) paraformaldehyd (Fischar, Heidelberg, 
Germany) for another 15 min at room temperature. Afterwards the macrophages were washed 
with PBS/EDTA. Each of the three macrophage suspensions was diluted twice to identical 
series of cell samples with cell counts ranging from 0 – 2000 cells/µl. The samples were 
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placed in 500 µl reaction tubes and sedimented at 300×g for 5 min. The cell pellets were re-
suspended in PBS 2 % (w/v) agarose (Sigma Aldrich, Steinheim, Germany) and kept on ice 
until the samples solidified (Figure 1(b)). 
 
 
Figure 1. Schematics of the in vitro experiments. (a) For the investigation of the relaxation properties the 
magnetosome ferrofluid was diluted into two identical series of samples with iron contents ranging from 3 to 
129 µmol/l. To gain a homogenous dispersion of nanoparticles inside the sample, 2 % agarose gel was used to 
fixate the magnetosomes. (b) The properties of magnetosomes internalized by macrophages were investigated by 
incubating three solutions of mouse macrophages (J77A.1) with magnetosomes. Two identical series of cell 
samples up to 2000 cells/µl were prepared from each solution. 
 
MR imaging was performed on a clinical 1.5 T scanner (Magnetom Sonata, Siemens 
Medical Solutions, Erlangen, Germany) to determine the relaxation properties of the 
magnetosomes and to prove the internalization of the marker by macrophages in vitro. Four 
samples were placed at a time in a small surface coil with a diameter of 30 mm. T1 relaxation 
times were determined by using an IR Turbo-FLASH sequence (TR = 4000 ms, 
TE = 2.73 ms, TI = 175 – 3000 ms, FOV = 50 mm, slice thickness = 5 mm, flip angle = 8°, 
matrix = 64×64, NEX = 4). For the T2 measurements a single-echo spin-echo sequence was 
used with varying echo times (TR = 3000 ms, TE = 11, 30, 60 and 120 ms, FOV = 60 mm, 
matrix = 192×256, slice thickness = 5 mm, flip angle = 90°). Finally, T2* relaxation times 
were measured with a multi-echo gradient echo sequence (TR = 100 ms, 12 echoes, 
TE = 4.52 – 80 ms, FOV = 60 mm, matrix = 128×92, slice thickness = 5 mm, flip angle = 21°, 
NEX = 10). Relaxation times were determined by applying a ROI-based analysis of the MR 
images and fitting the ROI signals to the appropriate exponential functions. With the known 
iron content of the pure magnetosome samples, the corresponding relaxivities R1, R2 and R2* 
were calculated. The relaxivity is a characteristic measure of any MR contrast agent and 
denotes the ability of magnetic compounds to increase the relaxation rates of the surrounding 
water proton spins.  
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All animal studies were performed in accordance with the guidelines for animal 
research of the regional animal committee. To evaluate the labeling of the macrophages with 
the magnetosomes in an animal model, peritonitis was induced in two mice by an 
intraperitoneal injection of 3 mg Zymosan A (Sigma Aldrich, Steinheim, Germany) in 500 µl 
physiological saline solution. Both animals received an intravenous injection of 
magnetosomes (100 mg/kg) after 90 min. Administration of Zymosan A is known to produce 
a time-dependent cell accumulation in the peritoneal cavity according to the typical profile of 
an acute inflammatory response. Resident peritoneal macrophages initially disappear from the 
peritoneal cavity due to generalized activation and adhesion to the internal mucosa layers. The 
macrophage population then reappears due to a genuine monocyte recruitment and the 
number of macrophages steadily increases between 6 and 24 h after injection. The amount of 
macrophages diminishes after 48 h [4].  
MR imaging of the first mouse was performed 6 h after inducing the peritonitis. A T2* 
weighted, 3D dual-echo gradient echo sequence was performed (TR = 60 ms, TE = 19 and 
50 ms, 64 slices, slice thickness = 1 mm, FOV = 100 mm, matrix = 192×120, NEX = 10). 
Before the MR imaging the mouse was sacrificed with ether and placed in the small loop coil. 
The second mouse was subjected to a second injection of magnetosomes after 18 h. MR 
imaging was performed 24h after inducing the peritonitis, when the inflammatory response 
and thus the amount of macrophages in the peritoneal cavity reached its maximum [4]. This 
mouse was also sacrificed with ether before imaging and placed in the small loop coil. 
Additionally, a 1 ml reaction tube filled with water was placed in the coil. 3D, T2-weighted 
turbo-spin-echo images (TR = 400 ms, TE = 57 ms, 40 slices, slice thickness = 0.6 mm, 
FOV = 80 mm, matrix = 192, flip angle = 180°, NEX = 1) were acquired in this case. Besides 
the T2* properties of iron oxide nanoparticles, resulting in a strong decrease in signal 
intensity, there is also R1 relaxivity associated with these particles, which results in a in a 
signal increase using T1 weighted sequences. At low iron concentrations a T1 enhancing effect 
can be observed, whereas at higher doses the susceptibility phenomenon balances the T1 effect 
[5]. Several studies [6-8] reported significant T1 effects due to the presence of 
superparamagnetic iron oxide particles, especially in inflammatory tissue. Therefore, 3D, T1 
weighted dual-echo gradient-echo images (TR = 20 ms, TE = 2.49 and 4.76 ms, 40 slices, 
slice thickness = 0.6 mm, FOV = 80 mm, matrix = 128, flip angle = 90°, NEX = 4) were 
acquired. 
Iron oxide nanoparticles are known to produce a significant T2* effect [5, 9, 10]. The 
iron oxide core of the magnetosomes, as for every SPIO-based contrast agent, produces 
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magnetic field inhomogeneities around the particle. If protons pass through the area around 
the nanoparticle, basically two effects occur. First the fluctuating, local magnetic fields 
associated with the particles enable the protons to release their energy to the surrounding 
environment faster than without the contrast agent. This process accelerates T1 relaxation. On 
the other hand, the field inhomogeneities produced by the iron oxide core speed up the 
dephasing of the transverse magnetization and therefore the MR signal decay (Figure 2). The 
MR scan also shows that suspending the magnetosomes in 2 % agarose gel does not ensure a 
homogenous dispersion of the nanoparticles inside the sample. The resulting inhomogeneities 
lead to higher standard deviations in the ROI. Nevertheless, distinct signal decay with 
increasing iron content can be seen in the MR image as well.  
 
 
Figure 2. Spin-echo image in coronal orientation of four samples of magnetosomes in 2 % agarose gel 
(TR/TE = 3000/11 ms). ROIs (as indicated in red) were used for analysis. Although the magnetosomes were 
suspended and fixated in the gel, the image shows that the nanoparticles were not dispersed homogenously 
inside the sample. Nevertheless, the signal decay with increasing iron concentration is clearly seen. 
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For the magnetosomes in agarose gel a relatively low R1 relaxivity of 
3.2 ± 0.4 (mM×s)-1 was determined. This is in rough agreement with the findings for typical 
iron containing contrast agents, such as, for example, Resovist® (Schering, Berlin) with an R1 
of 9.5 (mM×s)-1 [11]. Usually, T1 enhancement is observed during the vascular phase of the 
nanoparticles and by using minimal echo times in order to prevent the T2* effect of iron oxide 
from overriding the signal enhancement from T1 shortening. As soon as they are removed 
from the blood pool by the reticuloendothelial system (RES), T1 enhancement is 
predominantly seen in edemas which are characteristic for inflammatory processes. It has also 
been reported that restricted water diffusion and/or particle diffusion, e.g., by 
compartmentalization, limits the T1 effect of iron oxide nanoparticles in cells. This 
observation is in agreement with previous reports of marked T1 effects of USPIO in blood 
(non-compartmentalized) as opposed to the T1 effect of USPIO in liver, spleen or bone 
marrow (compartmentalized). Due to its similar properties to human tissue the fixation of the 
magnetosomes in 2 % agarose gel produces an environment comparable with 
compartmentalized USPIO and therefore restricts the T1 effect [12-14]. 
As expected the magnetosomes revealed a large R2 relaxivity of 526 ± 56  mM s-1 and an even 
higher R2* relaxivity of 1198 ± 342  mM s-1. The internalization of iron oxide nanoparticles 
leads to high concentrations of iron in the phagolysosomes of macrophages that cause very 
effective signal decays [9]. Compared to Resovist® (R2 = 230 mM s-1) [11] the R2 relaxivity of 
magnetosomes is thus considerably higher. Consequently, the iron dose which would have to 
be administrated to observe a similar signal change on T2-weighted images is distinctly lower 
for magnetosomes compared to Resovist®.  
The relaxation properties of the three measured solutions of macrophages incubated 
with magnetosomes were found to be similar to that of the pure magnetosomes. As can be 
seen from Figure 3 the effect of different numbers of cells on 1/T1 remains quite small. All 
three series of cell samples showed good agreement with a mean value of approximately 1/T1 
≈ 0.45 s-1 and small standard deviations. For series 3 a slight increase of the relaxation time 
rate was observed for the samples with cell counts larger than 600 cells/µl. For 1/T2 (Figure 4) 
a more pronounced effect was observed. Again, series 3 showed a stronger dependency of 
1/T2 on the cell count compared to series 1 and 2. The strongest effects, however, were 
observed for 1/T2* (Figure 5). The high relaxation rate of the sample with 100 cells/µl should 
be considered as an outlier. Overall, the standard deviations in Figure 5 are larger compared 
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to that in Figure 4, because local magnetic inhomogeneities are not compensated by the multi-
echo gradient echo sequence and lead to additional signal cancellation.  
 
 
Figure 3. T1 relaxation rates plotted vs. cell counts for the three series of cell samples. The mean relaxation 
rate 1/T1 remains relatively constant for all series up to roughly 600 cells/µl. Series 3 shows an increase in 1/T1 
for the highest cell count which was not observed with the other two series. 
 
 
Figure 4. T2 relaxation rate vs. cell counts of the three series of cell samples. Again, the increase of 1/T2 in 
series 3 is stronger than for series 1 and 2, indicating most likely a larger amount of internalized magnetosomes. 
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Figure 5. T2* relaxation rate vs. cell counts of the three series of cell samples. Increases of 1/T2* are 
observed beyond 2000 cells/µl for series 1, beyond 1000 cells/µl for series 2 and beyond 200 cells/µl for series 
3. 
 
For all relaxation rates 1/T1, 1/ T2 and 1/T2* sample series 1 and 2 revealed similar 
behavior, whereas the values obtained for series 3 showed stronger deviations. Since the 
phagocytic capacity of macrophages fluctuates [15] the cells in this series most likely 
internalized more magnetosomes compared to the cells in series 1 and 2. This would also 
explain the observation that for series 3 changes in 1/T2 and 1/T2* occur consistently at lower 
cell numbers.  
MRI was able to demonstrate the uptake of the magnetosomes by macrophages in vitro. MR 
imaging of the first mouse with induced peritonitis, revealed a signal decrease on the sagittal 
T2* weighted images (Figure 6(a), red arrows) in the area of the peritoneum between colon 
and abdominal wall. A similar effect was observed in the second animal after 24 h. The 
coronal T2 weighted images show a signal decrease around an intestinal loop on the right side 
as well (Figure 6(b), red arrows). In the T1 weighted image the same structure occurs bright 
due to the T1 effect of USPIO (Figure 6(c), red arrows). Both the signal decay on the T2* and 
T2 weighted images and the T1 enhancement in inflammatory tissue are typical for 
superparamagnetic iron oxide nanoparticles. The injected magnetosomes were obviously 
removed from the blood pool by monocytes, which migrated to the focus of inflammation in 
the peritoneal cavity. In all MR images the liver occurred dark (Figure 6(a-c); yellow arrows). 
This observation confirms that for high iron concentrations and restricted water diffusion the 
T2* effect of iron oxide nanoparticles overrides the T1 enhancement.  
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Figure 6. Ex vivo MR animal imaging. (a) T2* weighted images 6 h after inducing the peritonitis. The 
hypointense signal in the liver (yellow arrows) shows that the injected macrophages were effectively removed 
from the blood pool by the RES. Areas of signal loss are also seen near the abdominal wall due to an 
accumulation of magnetosome containing macrophages in the peritoneum surrounding the colon (red arrows). 
MRI of the second mouse (b and c) was performed after 24 h. In the coronal T2 weighted images a hypointense 
area is seen in the left colon (red arrows). The same structure is reproduced hyperintensely in the T1 weighted 
images of the same animal (c). The liver shows again strong signal loss in both the T2 and the T1 weighted 
images (yellow arrows). 
 
In summary, as demonstrated by MRI, macrophages were successfully labeled with 
magnetosomes and characterized with respect to their MR relaxation properties. These 
T2*w 
T2w 
T1w 
a) 
b) 
c) 
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organelles consist of membrane-enclosed magnetite crystals that are thought to help to direct 
bacterial swimming towards growth-favoring microoxic zones at the bottom of natural waters 
[3]. Consequently, they form an interesting class of iron containing contrast agent for MRI 
applications.  
In a pilot ex vivo animal study we were able to identify the inflammation caused by the 
induced peritonitis on the MR images by applying magnetosomes. One limitation, however, is 
related to the inferior sensitivity and resolution of the used clinical MR scanner, which makes 
it difficult to interpret the images properly. Nevertheless, we were still able to prove the 
feasibility of this approach even with a human whole-body scanner. Further studies are 
certainly necessary to investigate this animal model in vivo with a larger number of animals. 
Higher field strengths and dedicated coils would help to increase the available signal-to-noise 
ratio. 
One interesting and very elegant approach would be to combine the used iron oxide 
particles with optical markers as a bimodal probe to improve the sensitivity. The use of such a 
bimodal agent would be highly advantageous as it allows a direct corroboration of the in vivo 
MRI images by, for instance, fluorescent histology or in vivo optical imaging. Fluorescence 
can greatly aid with in vitro as well as in vivo studies as it can serve as a surrogate marker of 
contrast agent uptake without recourse to immunohistochemical staining whereas MRI makes 
it possible to visualize detailed anatomy repeatedly and non-invasively in vivo [16]. 
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Abstract 
Objectives: The purpose of this study was to assess whether fluorochrome-coupled bacterial 
magnetic nanoparticles can be used as bimodal contrast agent for both magnetic resonance 
imaging (MRI) and near-infrared fluorescence optical (NIRF) imaging of cultured 
macrophages. 
Materials and Methods: Bacterial magnetic nanoparticles (magnetosomes, particle diameter: 
42 nm) were harvested from Magnetospirillum gryphiswaldense and characterized by using 
MRI. After covalent coupling to the fluorescent dye DY-676 ( λabs./λem..= 676 nm/701 nm, 
Dyomics, Jena, Germany), the fluorescent magnetosomes were analyzed by fluorescence-
activated cell sorting. Subsequently, murine macrophages J774 were incubated with the 
bimodal contrast agent (3 hours) and examined by a whole-body near infrared small animal 
imaging system as well as by using a 1.5 T clinical MR system. Moreover, labeled cells were 
characterized using confocal laser scanning microscopy (CLSM) and ultrathin section 
transmission electron microscopy. 
Results: Characterization of the nanoparticles by MRI revealed R1 and R2 relaxivities of 3.2 
mM-1s-1 and 526 mM-1 s-1, respectively. Fluorochrome-coupled magnetosomes exhibited 
increased fluorescence intensities at wavelengths >670 nm. Macrophages that were incubated 
with the contrast agent showed a significant fluorescence emission in the near infrared range 
as imaged with a whole body NIR imaging system, FACS analysis and CLSM. Moreover, 
CLSM data showed the greatest fluorescence intensities within intracellular compartments 
and colocalized with the magnetosomes. With MRI, both T1 and T2 relaxation times were 
substantially shortened at concentrations greater than 600 cells/μL. 
Discussion and Conclusion: Macrophages could be labeled with fluorescent magnetosomes, 
and they were successfully imaged using both a 1.5 T MR scanner as well as with NIRF 
optical methods. The use of this bimodal contrast agent for diagnostic purposes may benefit 
from the excellent spatial resolution of the MRI and the high sensitivity of the fluorescence 
imaging. 
Key Words: molecular imaging, bimodal contrast agents,bacterial nanoparticles, magnetic 
resonance imaging, optical imaging 
(Invest Radiol 2007;42: 235–241) 
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Introduction 
In the recent years, significant progress has been achieved in regard to the imaging of 
cells and molecular markers detection of early pathologic changes in vivo. This new field in 
diagnostic imaging called molecular imaging deals with both the development of 
sophisticated imaging techniques and contrast agents for cell labeling and their clinical 
application.1 For example, superparamagnetic iron oxide nanoparticles such as the clinically 
approved Resovist (Schering, Berlin, Germany) are used for contrast-enhanced magnetic 
resonance imaging (MRI) of the liver2 and magnetic labelling of stem cells, to monitor cell 
trafficking.3,4 Moreover, recent investigations showed the suitability of paramagnetic contrast 
agents like Gadofluorine M5 or Gadolinium-Fullerenol6 for stem cell labeling and MRI. 
Besides the excellent spatial resolution, one limitation of MRI is its low sensitivity for tracers 
or contrast agents, which are important for the detection of cellular or molecular changes in a 
nanomolar scale.7 This might lead to the underdiagnosis of early disease stages. The limited 
sensitivity of MRI can be overcome by the combination with fluorescence optical imaging 
methods. Optical imaging is being used in cell biology research for a long time and has 
entered now the field of in vivo diagnostic imaging. For example, the detection of both the 
Her-2/neu protein expressed in 30% of breast cancers8 as well as phosphatidylserin in 
apoptotic tumor cells9 in an animal model using high affinity contrast agents with covalently 
bound near infrared fluorescent dyes (Cy 5.5) were described recently. 
In the long term, the combination of both imaging technologies could provide a 
powerful tool for clinical diagnostics because the high sensitivity of the optical system may 
complement the superior spatial resolution of the magnetic resonance technique. In first 
studies, by using Cy5.5-labeled cross-linked iron oxide nanoparticles, apoptotic T cells could 
be successfully detected in vitro9 as well as in vivo in a gliosarcoma tumor model in mice.10 
Moreover, recent interesting developments of bimodal contrast agents were focused on 
functionalized quantum dots with a paramagnetic coating.11 
A new source of magnetic nanoparticles is provided by biomineralization. Here, we 
describe a bimodal contrast agent for MRI and fluorescence optical imaging, which consists 
of bacterial magnetic nanoparticles, so-called magnetosomes, isolated from the magnetic 
bacterium Magnetospirillum gryphiswaldense,12 to which a near infrared fluorescent dye is 
covalently bound. In contrast to most synthetic magnetic nanoparticles, the magnetite crystals 
of magnetosomes display a narrow size distribution (mean diameter of mature particles is 42 
± 9 nm). Their ferrimagnetic single domain permits detection with clinical MRI devices even 
at very low concentrations13 and because of their biologic membrane they are able to be 
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coupled to fluorochromes or even to be functionalized with antibodies. The fluorochrome DY-
676 (Dyomics GmbH, Jena, Germany) used in this study is characterized by its absorption 
and emission maxima of λabs./ λem. = 676 nm/701 nm, where an increased light penetration into 
tissue was reported.14 To demonstrate the bimodal features of contrast agent and its 
applicability in biologic systems, macrophages in culture were used. One of the typical 
features of these cells comprises their phagocytotic activity, by which it is possible to simply 
accumulate magnetic nanoparticles as described previously.15 Particularly the following issues 
were addressed: (1) What are the particle properties in relation to MR and NIR optical 
imaging and (2) is it possible to label macrophages with the bimodal magnetic nanoparticles 
in vitro and image them using both MR and NIR optical methods? 
 
Materials and Methods 
Preparation and Characterization of the Bimodal Contrast Agent FM676 
Magnetic nanoparticles were obtained from cells of the magnetic bacterium M. 
gryphiswaldense (Figure 1A), which were grown under microaerobic conditions in an oxystat 
fermentor as described previously.16 Bacteria were cultured in a medium containing 50 μM 
ferric citrate at 28°C. For isolation of magnetosomes, cells were disrupted in a French press 
and fractionated as described elsewhere.13,17 Purified magnetosomes were enveloped by the 
intact magnetosome membrane (Figure 1B), which prevents the isolated magnetic particles 
from agglomeration.14 The relaxivities and the potential to shorten T1 and T2 relaxation times 
of magnetosomes dissolved in water with 2% agarose have been estimated with the clinical 
1.5 T MR-scanner Magnetom Sonata (Siemens Medical Solutions, Erlangen, Germany) using 
a turbo flash sequence or a single echo spin echo sequence. Afterward, magnetosomes were 
covalently bound to the fluorochrome DY-676 via the activated NHS-ester according to the 
manufacturer’s protocol. A solution of 275 nmol reactive dye in 100 μL of 50 mM NaHCO3-
buffer (pH 9.0) was added to 900 μL of a suspension of magnetic nanoparticles containing 
about 1.44 mg Fe/mL (Figure 2). After 3 hours of reaction, magnetosomes were washed 
carefully with phosphate-buffered saline (0,1 M, pH 8.5) in a magnet stand (Promega, 
Mannheim, Germany) until no more dye was detected in the supernatant. Optical properties of 
these fluorescent magnetic nanoparticles named FM676 were tested on a FACSCalibur 
analytical instrument with the CellQuest software (Becton Dickinson, Heidelberg, Germany). 
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Figure 1. Light and electron microscopy image of magnetosomes. Top, magnetosomes located within the 
cytoplasm of M. gryphiswaldense. Bottom, isolated magnetosomes, which are enveloped by the magnetosome 
membrane. 
 
 
 
Figure 2. Schematic illustration on coupling the fluorescent dye DY-676 via reactive NHS-ester to 
magnetosome membrane. Amino groups in the magnetosomes biomembrane react with the activated ester of 
the fluorochrome forming a covalent amid bound. 
 
Cell Culture 
To assess the applicability of the bimodal contrast agent for the detection of labeled 
cells, we used the mouse macrophage cell line J774 (Cell lines service, Heidelberg, 
Germany). A total of 5 x 106 cells were cultured at 37°C in a 5% CO2 atmosphere and 
incubated with FM676 (each sample with 44 μg Fe per milliliter of medium), native 
magnetosomes, or with medium only for 3 hours. After washing carefully to remove all non 
phagocyted magnetosomes, cells were harvested for further characterization. 
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Imaging of Labelled and Unlabelled Macrophages 
To verify macrophage cell labeling, 105cells were sedimented, air-dried on Histobond 
object slides (Marienfeld, Bad Mergentheim, Germany), and embedded with Permafluor 
(Immunotech, Marseille, France). Confocal laser scanning microscopy (CLSM) was 
performed using a LSM510 system with the LSM510 image examiner software (Zeiss, Jena, 
Germany). For ultrathin section transmission electron microscopy, harvested cells were fixed 
with glutaraldehyde, embedded in Araldite CY212 (Agar Scientific Ltd., Stansted, Essex) and 
TEM was performed using the EM 900 electron microscope (Zeiss, Oberkochen, Germany). 
To assess the imaging feasibility of the bimodal contrast agent FM676, we used both a 
bio-optical planar near infrared fluorescence small animal imager (bonSAI, Siemens Medical 
Solutions, Erlangen, Germany) as well as the 1.5 T MR scanner Magnetom Sonata. 
Macrophages, which were previously incubated with native magnetosomes, with FM676 or 
with medium only, were placed in 1.5-mL reaction tubes and embedded in water with 2% 
(wt/vol) agarose to avoid signal artifacts caused by sedimentation of the cells during data 
acquisition. NIRF images were recorded using the 660/735 nm filter system for excitation and 
emission at an acquisition time of 0.5 seconds with binning factor 2 (matrix size 512 x 696 
pixel). Fluorescence signals were detected with a charge-coupled device camera (pixel size 
4.6 x 4.6 μm). Images were analyzed semiquantitatively on the basis of regions of interests 
using the integrated syngo software. MR imaging was performed with 0.5-mL reaction tubes 
containing either macrophages (0 and 107 cells/mL in 2% wt/vol agarose) labeled with 
FM676 or unlabeled controls using an inversion recovery sequence and a single echo spin 
echo sequence, respectively. 
 
Results 
Characterization of the isolated bacterial magnetosomes from M. gryphiswaldense 
revealed a longitudinal relaxivity of R1 = 3.2 ± 0.4 mM-1s-1 and a transversal relaxivity of R2 
= 526 ± 56 mM-1s-1 (Figure 3) as determined with a 1.5 T clinical MR scanner. 
Fluorochrome-coupled magnetosomes FM676 showed distinctly higher fluorescence 
intensities >670 nm in comparison to native magnetosomes as shown by histogram blots of 
the FACS analysis (Figure 4). 
Ultrathin section electron microscopic analysis of cultured mouse macrophages J774 
incubated with FM676 and fixed with glutardialdehyde showed electron dense granules inside 
the cytoplasmic region (Figure 5). The observed structures containing FM676 exhibited an 
endosomal character, which indicates an active uptake of the contrast agent. Moreover, the 
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use of CLSM showed that the cells that were incubated with FM676 revealed distinct 
fluorescence intensities >700 nm within intracellular compartments colocalized with 
accumulations of nanoparticles as detected by fluorescence and particle-filled dense structures 
as observed by phase-contrast microscopy (Figure 6A–C). In contrast to this, cells that were 
incubated with native magnetosomes revealed no fluorescence at all, although accumulations 
of nanoparticles were present (Figure 6D–E). 
The obtained NIRF macroscopic images (Figure 7) of reaction tubes containing each a 
suspension of 106 cells in water with 2% (wt/vol) agarose clearly showed that only those 
macrophages that had internalized FM676 exhibited increased fluorescence intensities (1768 
± 54 arbitrary units) in the near-infrared range as compared with controls incubated with 
medium or native magnetosomes only (136 ± 11 and 128 ± 5 a.u., respectively). The obtained 
semiquantitative values are presented as results of 3 different experiments ± standard 
deviations. 
The relaxation times of unlabeled cells were found to be of T1 = 2400 ± 32 
milliseconds and T2 = 70.0 ± 1.0 milliseconds by using a 1.5 T clinical MR scanner, whereas 
labeling with FM676 lead to a substantial decrease of relaxation times to T1 = 1258 ± 196 
milliseconds and T2 = 7.7 ± 0.9 milliseconds (Figure 8 right) and a successful detection by 
MRI. 
 
 
Figure 3. Longitudinal relaxivity R1 = 3.2 ± 0.4 mM-1s-1(left) and transversal relaxivity R2 = 526 ± 56 mM-1s-1 
(right) of magnetosomes in water with 2% (wt/vol) agarose as determined by using a clinical 1.5 T MR-scanner. 
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Figure 4. Fluoro-optical properties of native and fluorescent magnetosomes (FM676) as obtained by 
FACS analysis. Fluorochrome coupled magnetosomes FM676 showed distinctly higher fluorescence intensities 
>670 nm in comparison with native magnetosomes. 
 
 
Figure 5. Ultrathin section transmission electron microscopy micrograph of J774 macrophages incubated 
with fluorescent magnetosomes (FM676). Electron dense vesicle-like structures (endosomes) inside the 
cytoplasmic region contain phagocyted magnetosomes. The bar represents 1 μm (left) and 0.5 μm (right). 
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Figure 6. Fluorescence CLSM images of the macrophages J774 incubated either with fluorescent (FM676) 
(A) or unlabeled magnetosomes (D). Fluorescence emission at >700 nm is pseudocolored in red. Phase contrast 
and merged images are depicted in B and C and D and E, respectively (scale bar = 20 μm). Both fluorescence 
and phase contrast images show intracellular accumulation of FM676 in labeled macrophages whereas native 
magnetosomes are visible only with phase contrast. 
 
 
Figure 7. White light and near infrared fluorescence images of J774 macrophages incubated with either 
native, fluorescent magnetosomes (FM676) or with medium only as obtained with a preclinical bio-optical 
NIRF small animal imager. Corresponding ROI-based and semiquantitatively estimated fluorescence 
intensities are listed below. The cells which were incubated with FM676 showed over 10-fold increased 
fluorescence intensities as compared with controls. 
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Figure 8. Left, T1-weighted image of different concentrations of macrophages in water with 2% agarose 
which were incubated with fluorescent magnetosomes (FM676). Right, Corresponding relaxation times T1 
and T2 of labeled macrophages. Labelling of macrophages with FM676 leads to a substantial decrease both of T1 
and T2. 
 
Discussion 
The calculated relaxivities of the magnetosomes were nearly in the same range as 
compared with the values determined for the clinically approved MRI contrast agent Resovist 
(R1 = 25.4, R2 = 151 mM-1s-1, Schering, Berlin Germany). Interestingly, the transversal 
relaxivity of R2 = 526 ± 56 mM-1s-1 is substantially higher than the relaxivity of Resovist. 
Considering the relaxivities of synthetic nanoparticles (R1 = 10.2 mM-1s-1, 
R2 = 357.3 mM-1s-1) used by other groups,18 the determined values are nearly comparable 
between each other. Even though the underlying mechanisms for the aforementioned findings 
are not clear, our results strongly support the applicability of magnetosomes for molecular 
and cellular MR imaging. The data of the FACS analysis could show that magnetosomes from 
M. gryphiswaldense were successfully labeled with DY-676 by incubation with the reactive 
NHS-ester. We suggest that amino groups in the magnetosomes biomembrane react with the 
activated ester of the fluorochrome forming a covalent amid bound (Figure 2). This leads to a 
contrast agent FM676 which can be detected both with MRI and fluoro-optical devices. 
With the ultrathin section electron microscopic analysis, electron dense granules 
inside the cytoplasmic region of cultured mouse macrophages incubated with FM676 were 
observed. The granules are to be identified as endosomes containing large amounts of 
fluorochrome coupled magnetosomes. The phase contrast and fluorescence recordings labeled 
with FM676 showed a colocalization of NIR-fluorescence and particle-filled dense structures, 
respectively, within cells, supporting the results obtained by electron microscopy. These 
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results indicate that macrophages have been efficiently labeled and that the bimodal contrast 
agent is stable during cellular uptake. 
Using the bio-optical planar near infrared fluorescence small animal imager bonSAI, 
the macroscopic images of reaction tubes containing macrophages which had internalized 
FM676 clearly showed more than 10-fold increased fluorescence intensities as compared with 
controls. In analogy to this, an up to 10-fold decreased relaxation time of labeled 
macrophages as compared with the unlabeled controls was observed by MRI, and these 
findings are based on the internalized magnetosomes resulting in weakened signal intensities. 
This massive signal loss even in T1-weighted images is promising for an application of 
FM676 in the in vivo situation. 
According to our results, the designed bimodal contrast agent could comprise a useful 
tool in future molecular imaging approaches. The simultaneous development of both 
innovative imaging devices as well as highly potential and specific contrast agents is 
significant for implementation of this technique in the clinical practice in the long-term. Some 
of the new probes and techniques have entered the clinical routine already or are very close to 
it, such as single-photon emission computed tomography,19,20 positron emission tomography 
(PET)-CT,21 and PET-MR22 in association with appropriate contrast agents like, 18FDG.23,24 
Recent investigations also are considering optical methods alone or in combination with MR 
because of its high sensitivity.9,11 Furthermore, optical methods like intravital microscopy or 
fluorescence-mediated tomography25 or the planar fluorescence imaging system used in this 
study are characterized by a more convenient handling as compared with the single-photon 
emission computed tomography and PET techniques.26 To combine optical imaging with 
MRI, we used bacterial magnetic nanoparticles with a high R2 relaxivity allowing the 
detection of very low concentrations of contrast agent even in T1-weighted images. Many 
endeavors have been made to improve the structural properties as well as the biocompatibility 
of nanoparticles that are manufactured synthetically.27,28 Moreover, a recent study considered 
the impact of particle size and coating of iron oxide nanoparticles on the rate of liver 
clearance in an animal model.29 The magnetosomes used in this study with a narrow size 
distribution and equipped with a biomembrane can provide a biocompatible contrast agent for 
optical and MR imaging. Nevertheless, the risk of allergic reactions particularly caused by the 
magnetosome biomembrane as well as the aspects of the nanoparticle biodistribution have to 
be investigated in further in vivo studies to evaluate the suitability as contrast agent in 
patients. 
Ultrathin section transmission electron microscopy and CLSM data showed that 
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cultured macrophages could be successfully labeled using the bimodal contrast agent. 
Moreover, labeled macrophages have been effectively detected both with a preclinical planar 
bio-optical near infrared small animal imager as well as a clinical 1.5 T MR-scanner. 
 
Conclusion 
In conclusion, we demonstrated the isolation of bacterial magnetic nanoparticles from 
M. gryphiswaldense and their covalent labeling with the near infrared fluorescent dye DY-
676. The suitability of this bimodal contrast agent named FM676 for experimental optical and 
MR imaging purposes has been proven using both a bio-optical planar near infrared 
fluorescence small animal imager and a clinical 1.5 T MR scanner. Furthermore, fluorescent 
magnetic nanoparticles FM676 might probably be a suitable contrast agent for diagnosis of 
inflammatory processes by the concomitant utilization of 2 diagnostic modalities, but more 
investigation, particularly related to the in vivo situation, is necessary. 
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Abstract 
Accurate delivery of cells to target organs is critical for success of cell-based therapies 
with stem cells or immune cells such as antigen-presenting dendritic cells (DC). Labeling 
with contrast agents before implantation provides a powerful means for monitoring cellular 
migration using magnetic resonance imaging (MRI). In this study, we investigated the uptake 
of fully synthesized or bacterial magnetic nanoparticles (MNPs) into hematopoietic Flt3
+ 
stem 
cells and DC from mouse bone marrow. We show that (i) uptake of both synthetic and 
biogenic nanoparticles into cells endow magnetic activity and (ii) low numbers of MNP-
loaded cells are readily detected by MRI.  
 
Keywords 
Iron oxide nanoparticles, Magnetosomes, Stem cells, Dendritic cells, Nanoparticle uptake, 
Magnetic resonance imaging, Cell tracking 
 
Manuscript 
Engineered magnetic nanoparticles (MNPs) are currently emerging as promising tools 
in numerous applications for medical diagnosis and therapy, such as drug delivery systems or 
contrast agents for magnetic resonance imaging (MRI). Cellular therapies using stem cells 
and immune cells, such as dendritic cells (DC), are increasingly applied in clinical trials. DC 
are professional antigen-presenting cells that play a key role in the induction of primary 
immune responses and have been implicated in determining the balance between immunity 
and tolerance induction [1, 2]. This makes DC a particularly attractive target for the 
development of therapeutics in pathological situations, such as autoimmune diseases, cancer 
and cardiovascular diseases, and thus DC are readily used as cellular vaccines in clinical trials 
[3]. Accurate delivery of DC to target organs and migration of the cells for effective antigen 
presentation and activation of an immune response is essential for the success of such 
therapies [4]. However, the ability to non-invasively monitor cell trafficking or a specific 
cellular function at the target site after application is rather limited. MRI is well suited for 
obtaining three-dimensional (3D) high-resolution images and is now widely used in clinical 
practice [5]. Stable labeling of cells with contrast agents has proven successful for MRI-based 
detection of cell deposits and their migration [6-9]. Most applications provide information 
about the location but not about a cellular functional status. First attempts have been made to 
develop functionalized MNPs that combine labeling of stem cells and DC for monitoring 
cellular localization and additional activities (e. g. adjuvant function of DC and measuring of 
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DC function in vivo) in one MNP formulation [10, 11]. For this purpose two strategies are 
currently being considered. First, fully synthetic iron oxid-based MNPs are used that allow 
functionalization by chemical modifications. Second, magnetosomes from magnetotactic 
bacteria are taken into consideration. Magnetosomes are organelles that comprise 
nanometersized crystals of magnetite enveloped by a biological membrane composed of 
phospholipids and specific proteins. The magnetosome membrane is critical for magnetosome 
stability, the control of magnetite crystal size and morphology, and additionally provides a 
matrix for functionalization of magnetosomes. This can be achieved by chemical 
modifications but moreover, and potentially superior to chemical approaches, by genetic 
engineering of the magnetosome membrane proteins.  
We have recently described the synthesis and physicochemical properties of synthetic 
oleate stabilized magnetite MNPs [12], where the lipid-shell contributes to improved 
biocompatibility (in the following referred to as lipid-shell MNPs). Additionally, it has 
allowed further functionalization, such as biotin-conjugation and binding of the fluorescence 
tag streptavidin-fluorescein isothiocyanate (FITC) [10].  
In this study we investigated the uptake of fully synthetic lipid-shell MNPs and of 
magnetosome MNPs into hematopoietic Flt3+
 
stem cells and DC from mouse bone marrow 
[13-15]. We show (i) that uptake of both synthetic and biogenic nanoparticles into cells 
endow magnetic activity on Flt3+ stem cells and DC (ii) that low numbers of MNP-loaded 
cells are readily detected by MRI.  
Superparamagnetic magnetite lipid-shell MNPs were obtained by coprecipitation of 
Fe2+
 
and Fe3+
 
ions with NH3 and stabilized with cis-9-octadecenoic acid sodium salt (oleate) 
as described [12]. Magnetosomes, also referred to as biogenic MNPs, were isolated and 
purified from the magnetotactic bacterium Magnetospirillum gryphiswaldense strain MSR-1 
(DSM 6361) as described earlier [16]. Sterile solutions of MNPs containing 1 mg Fe/ml were 
used in 1:50 dilution for cell labeling.  
DC were differentiated from hematopoietic Flt3+
 
stem cells (referred to as Flt3+
 
stem 
cells) of bone marrow suspensions from C57BL/6 mice (Charles River, Sulzfeld, Germany) as 
described [14]. DC were seeded at 2x106 cells/ml in RPMI 1640 medium supplemented with 
10% FCS, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin (all from Gibco-BRL) and 
50 µM β-mercaptoethanol (Sigma-Aldrich, Taufkirchen, Germany) containing 200 U/ml of 
recombinant mouse GM-CSF and were incubated with sterile filtered and buffered aqueous 
solutions of magnetosomes or lipid-shell MNPs 24 h before analyses. Cell numbers were 
determined with an electronic cell counter device (CASY1, Schärfe System, Reutlingen, 
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Germany).  
MR images of agarose phantoms were acquired using a Bruker Biospin 7.0 T scanner 
(Ettlingen, Germany). MNP-labeled cells were suspended in 10 µl agarose (Sigma-Aldrich) 
and filled in 3.5 mm diameter drill holes of a 3.5 cm agarose phantom as described before 
[17]. Dissected lymphnodes (LN) from animal experiments were embedded into 1.6% agarose 
phantoms. MR images were acquired as described [17]. Phantoms were analyzed with 
T2*weighted 3D gradient echo FLASH sequences (TE = 12ms, TR = 200ms and TE = 14ms, 
TR = 500ms, respectively; flip angle 30°) with an isotropic resolution of 78 µm3 (for cell 
phantoms) and 55 µm3 (for LN).  
The interaction of MNPs with cells was first investigated by transmission electron 
microscopy (TEM) to determine uptake of MNPs into cells, intracellular localization and 
particle morphology before and after uptake. In aqueous solution, lipid-shell MNPs possess a 
mean iron core size of 8-10 nm whereas magnetosomes have a mean iron core size of 40-45 
nm (Figs. 1a and 1b). In initial studies, uptake of MNP into DC was determined since DC are 
particularly potent in incorporating particles by endocytosis. After co-culture with MNPs for 
24 h, DC were extensively washed with phosphate buffered saline (PBS) and fixed with 3% 
(w/v) glutaraldehyde. Cells were stained with OsO4 and viewed and recorded with a Philips 
EM 400 T electron microscope equipped with a CCD camera. Figs. 1c to 1f reveal that both 
lipid-shell MNPs and magnetosome MNPs are localized intracellularly in numerous vesicles 
confined to the cytosol. MNPs are not found at the cell surface or in the nucleus. These results 
demonstrate effective uptake of both synthetic and biogenic MNPs into DC and suggest an 
endocytotic uptake mechanism. However, particle size and iron core morphology remained 
unaltered 24 h after uptake into DC (Figure 1a, b, d and f).  
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Figure 1. Electron micrographs of synthetic and biogenic MNPs before and after uptake into DC. Lipid-
shell MNPs (a) and magnetosome MNPs (b) before uptake into cells. Scale bars in (a) and (b), 100 nm. DC 
incubated with synthetic MNPs (c and d) or magnetosome MNPs (e and f) for 24 h. Scale bars in (c) and (e), 2 
µm. Micrographs (d) and (f) show higher magnifications of MNP clusters found in (c) and (e), respectively. 
Scale bars in (d) and (f), 100 nm. 
 
We then proceeded to determine whether MNP-loaded Flt3+
 
stem cells and DC 
acquired magnetic activity and were retained in a magnetic field. Flt3+
 
stem cells and DC 
were treated with increasing concentrations of MNPs or left untreated for 24 h. MNPs 
exhibited no cytotoxicity on both Flt3+
 
stem cells and DC (data not shown). Cells were 
recovered and extensively washed with PBS to remove unbound MNPs and then applied to a 
magnetic field in Miltenyi MS columns placed in a MiniMACS separator (Miltenyi Biotec, 
Bergisch Gladbach, Germany). In this assay, only MNP-labeled cells are retained in the 
magnetic field of the column. Columns were washed with PBS and not-retained cells 
collected. Retained cells were eluted with elution buffer (PBS containing bovine serum 
albumin (BSA) and EDTA; Sigma-Aldrich) after withdrawal of magnet. The numbers of both 
retained and notretained cells were determined; untreated cells served as control. Unlike 
control cells, we only observed MNP-loaded Flt3+
 
stem cells and DC being retained in the 
magnetic field (Figure 2a). This was confirmed by Prussian-blue staining for iron in not-
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retained and retained DC populations after magnetic separation showing complete absence of 
MNPs in not-retained cells (Figure 2b). Retention of MNP-labeled cells was dose-dependent 
(data not shown) and Figure 2 shows results obtained with optimal conditions for DC labeling 
with both lipid-shell MNPs and magnetosomes. Under these conditions, the labeling 
efficiency of MNPs for Flt3+
 
stem cells yielded lower rates than for DC. Interestingly, 
magnetosomes and lipid-shell MNPs revealed different labeling potentials for Flt3+ stem cells 
with a 2-fold higher labeling of Flt3+ stem cells by magnetosomes (Figure 2a). These results 
suggest different uptake mechanisms for Flt3+ stem cells and DC, which probably critically 
depends on MNP shell composition.  
 
Figure 2. Differential uptake of MNPs and retention of cells in a magnetic field. (a) Flt3+ stem cells and DC 
were incubated with MNPs for 24 h and applied to a magnetic field. Number ofcells after magnetic separation 
Manuscript 7 
 
171 
were determined. Results are shown as mean ± SD (n=3). (b)Retained and not-retained cells were subjected to 
cytocentrifugation onto glass slides (1500rpm for 4 min) and stained with Prussian-blue for iron detection. 
Neutral red was used forcounterstaining. Scale bars, 5 µm. 
 
Next, we determined the intracellular iron concentration after MNP uptake into cells 
by employing a ferrozine-based colorimetric assay as a direct measure for MNP quantity [18]. 
Flt3+ stem cells and DC were cultured in the presence of lipid-shell MNPs or magnetosome 
MNPs comprising a total of 20 µg/ml iron (f. v.) or were left untreated. After 24 h cells were 
intensively washed and subjected to magnetic separation with Miltenyi MS columns. 
MNPlabeled cells were eluted from the columns and then lysed for iron release. Untreated 
cells were examined accordingly. Ascorbic acid was used to reduce Fe3+
 
to Fe2+
 
ions that form 
a chelate complex with ferrozine. Absorbance of Fe2+-ferrozine was measured at 550 nm and 
compared to the absorbance of FeCl3 standards. The minimum detection limit for Fe2+
 
ions in 
this assay set-up was 250 µMol/l, corresponding to 5 pg of iron per cell. Iron concentrations 
in untreated Flt3+ stem cells and DC were below the detection limit. The results obtained 
show a higher uptake capacity of DC for MNPs than Flt3+ stem cells (Figure 3). The 
intracellular iron concentration after labeling with lipid-shell MNPs was 77.9 ± 5.8 pg/cell in 
DC and 13.6 ± 1.6 pg/cell in Flt3+ stem cells, respectively. Interestingly, labeling with 
magnetosomes resulted in lower iron concentration in DC (31.3 ± 5.4 pg/cell) but led to 
slightly increased uptake in Flt3+ stem cells (16.8 ± 1.7 pg/cell) concomitant with the higher 
labeling efficiency of Flt3+ stem cells by magnetosomes (Figs. 2a and 3). These findings 
further support the notion of different uptake mechanisms for MNPs in Flt3+ stem cells and 
DC.  
 
Figure 3. Intracellular iron concentration before and after uptake of MNPs by Flt3+
 
stem cells and DC 
determined by ferrozine assay. Results are shown as mean ± SD (n=3). 
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Iron oxide nanoparticles are well known to possess longitudinal (T1) and transversal 
(T2 and T2*) relaxation time shortening effects in magnetic resonance (MR) that make them 
particularly attractive as potential contrast agents for MR imaging (MRI) [5]. MR relaxometry 
experiments with the lipid-shell MNPs and bacterial magnetosome MNPs used in this study 
have been recently performed. Low R1 relaxivities of 4.0 and 3.2 s-1
 
mM-1 and high R2* 
relaxivities of 729 and 1198 s-1
 
mM-1
 
were reported for lipid-shell MNPs and magnetosome 
MNPs, respectively, classifying them as potent contrast agents for both T1 and T2*-weighted 
MR imaging [12, 19]. Therefore, we investigated whether both lipid-shell and bacterial MNPs 
are particularly suitable contrast agents for cell tracking by MRI after uptake. To this end DC 
were labeled with lipid-shell MNP and magnetosome MNPs as before, magnetically separated 
and seeded at different cell numbers into agarose phantoms. T2*-weighted 3D gradient echo 
MR images were acquired and processed using Paravision 4.0 software (Bruker Biospin) and 
NIH ImageJ. Scan sequences revealed a strong hypointense contrast by MNP-labeled DC in 
3D T2*-weighted MRI. Comparable signal reduction was obtained with both lipid-shell MNPs 
and magnetosome MNPs (Figure 4). The minimum detection limit of labeled DC was 
estimated at 101 cells µl-1.  
 
Figure 4. Sections of T2* 3D gradient echo MR images of MNP-labeled DC in agarose phantoms. DC were 
labeled with MNPs for 24 h and after magnetic separation 102 o 105 cells were suspended in 10 µl agarose into 
3.5 mm drill holes. 
 
Migration from peripheral organs to regional draining LN after antigen uptake is an 
essential property of DC to initiate and regulate adaptive immune responses. Therefore, we 
investigated whether migration of MNP-labeled DC towards the draining LN after adoptive 
transfer into peripheral tissue is detectable by MRI. To address this question DC were labeled 
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with lipid-shell MNPs as before, magnetically separated and 2x106 cells were intradermally 
transplanted into left femoral hind legs of C57Bl/6 recipient mice. As control, 2x106 unlabeled 
DC were injected into the right femoral hind leg of the same recipient animal. A further 
control group of animals received 5x106 MNP-labeled DC intravenously. Four mice per group 
were used and sacrificed 24 h after adoptive transfer of cells. Draining inguinal LN and 
nondraining axillary and mesenteric LN were dissected and split into halves. One half was 
embedded into an agarose phantom and analyzed by T2*-weighted 3D gradient echo MR 
imaging. For histological comparison of MRI data, the second half was fixed, embedded into 
paraffin, sectioned and subjected to Prussian-blue staining for iron detection. We observed a 
significant intranodal signal reduction in MR images in the left inguinal draining LN 24 h 
after injection of MNP-labeled DC into the left hind leg (Figure 5a), whereas no signal 
reduction was detected in right inguinal LN where unlabeled DC were injected (data not 
shown). Furthermore, we found neither hypointense contrasts in non-draining LN nor after 
intravenous injection of MNP-labeled DC (data not shown). To corroborate whether the 
intranodal hypointense contrast was elicited by MNPs, Prussian-blue staining of the second 
halves of dissected LN were performed. No blue staining was detectable in all control LN 
indicating complete absence of MNP label. By contrast, a clear blue staining was localized in 
the T cell area of draining inguinal LN from MNP-loaded DC injection sites confirming the 
presence of MNPs (Figure 5b). Taken together, these results provide evidence that tracking of 
MNP-labeled DC towards target organs or tissues in living organisms can be achieved using 
MRI. Consequently, initial experiments for tracking of lipid-shell and magnetosome labeled 
DC in vivo to monitor their migration dynamics are currently under investigation.  
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Figure 5. Detection of MNP-labeled DC after migration to draining lymphnodes. (a) T2*weighted 3D 
gradient echo MR images of a single inguinal draining LN where MNP-labeled DC were injected into hind leg. 
Arrowheads indicate intranodal signal reduction. (b) Histochemical staining with Prussian-blue of the second 
half of LN as in (a). Right image shows 4 x higher magnification. Scale bars, 50 µm. 
 
In summary, this study demonstrates effective uptake of both synthetic and biogenic 
MNPs into Flt3+
 
stem cells and DC. Additionally, magnetosome MNPs were found to label 
hematopoietic Flt3+
 
stem cells, albeit to a lower extent than DC. Electron microscopy analysis 
showed that subcellular localization of MNPs after uptake into DC was confined to 
intracellular vesicles. This result is in accordance to our previous study that showed 
colocalization of MNPs within the endosomal/lysosomal compartment, suggesting an uptake 
mechanism via endocytosis [10]. DC have a central role in antigen specific immune responses 
and detect and take up invading pathogens by specific cell surface receptors [1]. Pathogens 
exhibit highly conserved molecules referred to as pathogen associated molecular patterns 
(PAMPs; bacterial and fungal wall components, viral RNA or DNA etc). PAMPs bind to 
pattern recognition receptors on DC, such as Toll-like receptors (TLRs) and C-type lectins 
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(mannose receptor, DEC205, DC-SIGN etc.) and thus provoke antimicrobial and antiviral 
immune responses [20, 21].  
Obviously, DC can be expected to sense MNPs through similar or identical pathways. 
Additionally, functional expression of PAMP recognition receptors (i.e. TLR2 and TLR4) 
was demonstrated on hematopoietic stem/progenitor cells [22]. Thus, depending on the 
molecular pattern of the particle shell, both synthetic and biogenic MNP might activate 
different pathways, leading to differentially regulated immune and/or cellular responses. 
Therefore, central questions that clearly have to be addressed are (i) to ascertain the molecular 
determinants on DC and stem cells that are important for the MNP/DC and MNP/stem cell 
interaction and (ii) how the physicochemical properties of MNP such as size, surface charge 
and particle shell composition determine their impact on cellular functions. Results obtained 
from such studies can be expected to form the foundation for further optimization and 
development of engineered MNPs with improved biocompatibility and labeling specificities 
for use in clinical therapies.  
Magnetosomes represent yet another class of MNPs originating from magnetotactic 
bacteria as complex organelles composed of a magnetite crystal core enveloped by a 
biomembrane. Most fundamental, crystal mineralization and membrane composition of 
magnetosome MNPs are genetically determined by the bacterial strain. This opens the 
perspective to further enlarge MNP function by genetic engineering. Recently, this approach 
has been successfully used to fuse enhanced green fluorescent protein to the mamJ gene 
product from M. gryphiswaldense resulting in magnetosomes with bimodal imaging 
properties [23]. Apparently, magnetosome MNPs are emerging as a promising tool for various 
biotechnological and biomedical applications including MRI.  
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Abstract 
The ability of magnetotactic bacteria (MTB) to orient and migrate along magnetic 
field lines is caused by magnetosomes, which are membrane-enclosed intracellular crystals of 
a magnetic iron mineral. The biomineralization of magnetosomes is a process with genetic 
control over the accumulation of iron, the deposition of the magnetic crystal within a specific 
compartment, as well as the assembly, alignment and intracellular organization of particle 
chains. Magnetite crystals produced by MTB have uniform species-specific morphologies and 
sizes, which are mostly unknown from inorganic systems. The unique characteristics of 
magnetosome particles have attracted a great interdisciplinary interest and inspired numerous 
ideas for their biotechnological application. In this chapter, we summarize the current 
knowledge of the physicochemical and molecular genetic basis of magnetosome 
biomineralization. In addition, we give an overview over current examples and the potential 
for  future applications of magnetic nanoparticles produced by bacteria. 
 
Introduction 
One of the most intriguing examples for the microbial synthesis of nanostructures is 
the biomineralization of magnetosomes. These inorganic structures are formed intracellularly 
in magnetotactic bacteria (MTB), in which they serve as a navigational device for spatial 
orientation along chemical gradients in stratified aquatic habitats, probably by interaction with 
the earth’s magnetic field (Bazylinski and Frankel, 2004; Flies et al., 2005a). Magnetosomes 
comprise a magnetic mineral crystal enveloped by a biological membrane containing 
phospholipids and specific proteins. MTB not only exert a high degree of biological control 
over the design of the inorganic particles, but also the assembly, alignment and intracellular 
organization of magnetosomes is under genetic control, resulting in complex chain-like 
superstructures. Magnetosomes, which can be isolated from cells in larger quantities, also 
represent a new class of magnetic nanoparticles (MNP) with exceptional properties. In 
general, MNP provide numerous attractive possibilities in biotechnology, which is due to their 
unique characteristics. Their dimensions are within the order of magnitude of large 
biomolecules or viruses, and they can be manipulated by external magnetic field gradients and 
obey Coulomb’s law (Tartaj et al., 2005). In addition they have a large surface, which can be 
used for modification. As intermediates between the molecular and solid state, nanosized 
magnetic particles have physical and chemical properties that are characteristic of neither the 
atom nor the bulk counterparts (Gupta and Gupta, 2005). In nanobiotechnology, they are ideal 
components for the construction of nanostructured materials and devices with adjustable 
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physical properties. Synthetic MNP are currently widely studied and applied in various fields 
of biotechnology such as magnetic drug targeting, magnetic resonance imaging (MRI), 
diagnostics, immunoassays, magnetic separation, and magnetic hyperthermia treatment. Using 
conventional inorganic synthesis, particles of magnetic iron oxide can be produced by the 
coprecipitation of Fe2+ and Fe3+ aqueous salt solutions (Cornell and Schwertmann, 2003). A 
major problem of the bulk solution synthesis is that the pH needs to be adjusted during 
synthesis and particle purification. Another obstacle is that the particles form aggregates 
during synthesis, which requires the application of nanostructured boundaries for particle 
formation by the use of sol-gel systems, polymer matrix-mediated synthesis or oil-in-water 
microemulsions. Other methods rely on aerosol-based techniques such as laser pyrolysis (for 
review (Gupta and Gupta, 2005; Tartaj et al., 2005). Although enormous efforts were spent 
during the last years to generate particles of nearly uniform size and shape, the synthesis of 
advanced nano-sized magnetic materials with innovative properties that can be tailored and 
functionalized according to the desired application has remained a challenge. As an 
alternative route, biomineralization processes have been suggested for the biosynthesis of 
MNP. One well studied example is the use of the iron-storage protein ferritin for the 
production of MNP. The demetallated protein shell of apoferritin assembles into a multi-
subunit protein shell to form a hollow cage of about 8 nm in diameter. This represents a 
natural nanometer-sized bioreactor, which has been used by Mann and coworkers for the 
biomimetic reconstitution of the ferrimagnetic iron oxides magnetite (Fe3O4) and maghemite 
(γ-Fe2O3) (Meldrum et al., 1992) as well as the magnetic alloy cobalt platinum CoPt within 
the cores (Mayes and Mann, 2004). As a result, crystalline nanoparticles were formed with 
narrow size distribution and magnetic properties with promising potential for applications 
such as ultrahigh-density data storage. Another attractive alternative for the production of 
MNP by biomineralization is the use of magnetosomes produced by MTB. The current 
understanding of MTB biology as well the potential for future applications of magnetosomes 
are discussed in the following. 
 
Magnetotactic bacteria 
Magnetotactic bacteria represent a heterogeneous group of aquatic prokaryotes with a 
variety of morphological types, which can be assigned to various phylogenetic lineages. 
Commonly observed morphotypes include coccoid cells as well rods, vibrios and spirilla of 
various dimensions (Schüler, 1999). All known MTB are motile by means of flagella and 
have a cell wall resembling that of typical Gram-negative bacteria. In the environment, they 
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occur in highest numbers at or closely below the oxic-anoxic transition zone of marine and 
freshwater environments (Flies et al., 2005a). Magnetotaxis, the orientation along magnetic 
field lines, is thought to aid the bacteria in the navigation along the multiple and steep 
chemical gradients commonly found in that zone. Despite of their high abundance and 
ubiquitous occurrence, most MTB have proven recalcitrant to isolation and only very few 
species have been isolated in pure culture (Flies et al., 2005b). Difficulties in isolating and 
cultivating MTB arise from their lifestyle, which is adapted to complex chemical gradients 
that are typically encountered in stratified sediments. Accordingly, only a few species of 
MTB are available in pure culture. The microaerophilic alphaproteobacterium 
Magnetospirillum gryphiswaldense that has been isolated from a freshwater sample (Schleifer 
et al., 1991) can be grown in the lab more readily then other MTB. The cells produce a single 
a single chain of up to 60 magnetosome particles consisting of cubo-octahedral magnetite 
crystals (Figure 1). M. gryphiswaldense has recently emerged as a model organism both for 
the analysis of magnetite biomineralization and for the production of large quantitities of 
magnetosome particles. This has become possible by the establishment of techniques for mass 
cultivation and genetic manipulation as well as the availability of genome sequence data. 
 
Figure 1: Magnetosomes of Magnetospirillum gryphiswaldense. Transmission electron micrographs displaying 
(A) a helically shaped cell with flagella and a single magnetosome chain, (B, C) the intracellular organization of 
the magnetosome chain and (D) isolated magnetosome particles with surrounding membrane. The membrane is 
indicated by a arrows. 
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Structure and biomineralization of magnetosome mineral crystals  
The ability to align along magnetic field lines is based on the presence of 
magnetosomes, which are membrane-enclosed inorganic crystals consisting either of the 
magnetic mineral magnetite (Fe3O4) or greigite (Fe3S4) (Posfai et al., 1998, Schüler and 
Frankel, 1999). The particles are usually arranged along the cell axis in one or multiple 
chains, which are often located adjacent to the cytoplasmic membrane (Schüler, 1999). The 
particle sizes are typically 35-120 nm, which is within the single-magnetic domain-size for 
magnetite and greigite (Dunin-Borkowski et al., 2001; Moskowitz, 1995). The morphology, 
size and intracellular organization of the crystals is subject to a species-specific genetic 
control, and a large variety of crystal morphologies such as cubo-octahedral, elongated 
hexagonal-prismatic and bullet-shaped morphologies were reported (Schüler and Frankel, 
1999) (Figure 2). 
 
Figure 2: Diverstiy of magnetotactic bacteria and magnetosomes. A – D. Transmission electron micrographs 
of a variety of different morphological forms of magnetotactic bacteria, including large rod shaped bacteria with 
a one or several magnetosome chains (A, B), coccoid cell forms (C) and spirilla (D). E – H Electron micrographs 
of crystal morphologies of magnetosomes found in various magnetotactic bacteria.  
 
It was demonstrated by high resolution transmission electron microscopy, electron 
diffraction and electron holography that the morphologies of magnetite crystals in 
magnetosomes are derived from combinations of the isometric forms {1 1 1}, {1 1 0} and {1 
0 0} (Devouard et al., 1998; Moskowitz, 1995). Morphological variations such as elongated 
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and prismatic structures are due to anisotropic crystal growth, which could be explained by 
chemical gradients and unequally distributed ion influx into the magnetosome vesicle. 
Alternatively, growth of particular crystal lattice planes could be selectively favored or 
inhibited by the specific interaction with biomineralization-mediating proteins. For magnetite 
biomineralization, iron can be taken up by the cell as Fe(III) or Fe(II) from the medium. 
Fe(III) ions are then thought to be reduced to Fe(II) during uptake or in the cytoplasm and 
subsequently transported to the magnetosome vesicle (Bazylinski and Frankel, 2004). A part 
of the iron is then reoxidized to form a highly reactive Fe(III) oxide, probably ferrihydrite, 
which may react with dissolved Fe2+ to form magnetite by a via-solution process (Cornell and 
Schwertmann, 2003). Iron for magnetite synthesis is assimilated very efficiently from 
relatively low environmental concentrations. In M. gryphiswaldense, ferric iron is 
incorporated by a high-affinity uptake system, which is saturated at extracellular iron 
concentrations of 15-20 µM Fe (Schüler and Baeuerlein, 1996). Notably, the growth of a 
mutant, which lost the ability to form magnetosomes, was more sensitive to elevated 
concentrations of iron (Schübbe et al., 2003). This might be indicative of a contribution of 
magnetite formation to iron homeostasis and detoxification of potentially harmful high 
intracellular levels, similar, for instance, to the iron-storage proteins ferritin and 
bacterioferritin (Andrews et al., 2003). The number of magnetite particles per cell is variable 
depending on growth conditions. Besides the availability of micromolar amounts of iron, 
microaerobic conditions are required for magnetite formation. 
Electron holographic studies of M. magnetotacticum MS-1 demonstrated that the 
magnetosome particles are in a single domain magnetic state in the cell and are uniformly 
magnetized to the saturation magnetization of magnetite (Dunin-Borkowski et al., 2001).    
The magnetite particles are oriented with the [1 1 1] magnetic easy axis along the chain 
direction within the cell, and one or more straight chains are present parallel to the long axis 
of the cell (Blakemore and Frankel, 1981). In this organization, an average magnetosome 
chain of M. magnetotacticum MS-1 confers a magnetic dipole moment of 5 x 10-16 Am2 to the 
cell (Dunin-Borkowski et al., 2001). The torque exerted by the geomagnetic field on the 
cellular dipole is sufficient for the passive orientation of the cell in the earth magnetic field 
(Frankel, 1984). Thus, mechanisms for the tight control of the mineral type of iron, the size 
and the shape of the magnetosomes as well as the length and orientation of the magnetosome 
chain developed in magnetotactic bacteria to generate a magnetic dipole which permits 
efficient migration along magnetic field lines. 
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Structure and biochemical composition of the magnetosome membrane, a unique 
subcellular structure in prokaryotes 
Compartmentalization through the formation of membrane vesicles enables the 
processes of magnetite mineralization to be regulated by biochemical pathways. The MM is 
the crucial component in the control of crystal growth, thereby providing spatial constraints 
for shaping of species-specific crystal morphologies. Biomineralization of magnetite requires 
a precise regulation of both the redox potential and the pH. The growth of magnetite crystals 
is ultimately regulated by the uptake mechanisms and depends on a controlled flux of ions 
over the MM to provide a supersaturating iron concentration within the vesicle. Thus, the MM 
has to perform specific functions in the transport and accumulation of iron, nucleation of 
crystallization, and redox and pH control (Gorby et al., 1988; Schüler, 2002). Most of the 
knowledge of the MM comes from the analysis of M. gryphiswaldense. However, there are 
indications that the structure and mechanism of its formation is highly similar in related 
Magnetospirilla and other MTB (Gorby et al., 1988). 
Isolated magnetosomes have a strong tendency to form chains, indicating that an inter-
particle connection mediated by MM components is involved in the organization of chains. A 
number of common fatty acids were identified in extracts of the magnetosome membrane 
from M. gryphiswaldense (Grünberg et al., 2004). Phosphatidylethanolamin and 
phosphatidylglycerol were identified as the most abundant polar lipids, whereas 
ornithinamidlipid and an unidentified aminolipid are less abundant in the MM compared to 
the fraction of lipids from the outer and cytoplasmic membrane (Baeuerlein, 2000; Grünberg 
et al., 2004). Analysis of the extracted membrane revealed that the magnetosome is associated 
with a highly specific and complex subset of proteins, which are present in various quantities. 
The amount of MM-bound polypeptides approximately represents 0.1 % of the total cellular 
protein (Grünberg et al., 2001). Biochemical analysis in combination with various proteomic 
techniques have lead to identification of all major magnetosome membrane proteins (MMPs) 
(Grünberg et al., 2004; Grünberg et al., 2001; Schübbe et al., 2003). Approximately 20 major 
polypeptides have been identified in the magnetosome subproteom, several of them occurring 
in various posttranslational modifications of the same gene product. A number of minor 
constituents were occasionally found bound to isolated magnetosomes (Schultheiss et al., 
2005). The different resistance of magnetosome proteins towards proteases and detergents 
indicates that some proteins (e. g., MamC, MamF) are very tightly bound to the magnetosome 
crystals and/or embedded within the membrane. Others, like for instance MamA, seem to be 
loosely attached and can be selectively solubilized by mild detergents (Grünberg et al., 2004). 
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Several of the proteins contain covalently bound c-type heme as revealed by peroxidase 
staining. No glycoproteins, which are common constituents of other biomineralizing systems, 
have been detected so far. 
Based on sequence analysis, most MMPs can be assigned to a number of characteristic 
protein families, which seem to be shared by all MTB. MamA, which has been also identified 
in the MM of other Magnetospirillum species (Okuda et al., 1996), is an abundant protein of 
the MM and contains 4-5 copies of the TPR (tetratricopeptide repeat) motif. TPR motifs, 
which have been identified in a growing number of proteins with diverse functions, are 
known to mediate protein-protein interactions (Blatch and Lassle, 1999). It therefore has been 
speculated that MamA acts as a receptor in the MM interacting with cytoplasmic proteins or 
is involved in the assembly of multiprotein complexes within the MM (Okuda et al., 1996; 
Okuda and Fukumori, 2001). However, mutants of Magnetospirillum strain AMB-1 in which 
the mamA gene was deleted, produced magnetosome particles indistinguishable in 
morphology and organization from those of the wild type cells, albeit in slightly reduced 
numbers (Komeili et al., 2004). This clearly argues against an essential role of the MamA 
protein in magnetosome biomineralization. 
Both MamB and MamM are members of the CDF (cation diffusion facilitator) family 
of metal transporters, which comprises proteins that function as efflux pumps of toxic divalent 
cations, such as zinc, cadmium, cobalt and other heavy metal ions. Specifically, MamB and 
MamM have greatest similarity to the CDF3 subfamily, which was postulated to comprise 
putative iron transporters (Nies, 2003). It has been speculated that MamB and MamM are 
involved in the magnetosome-directed uptake of iron, and preliminary evidence obtained from 
mutant analysis seems to support this assumption (Junge et al. unpublished). MamE and 
MamO display sequence similarity to HtrA-like serine proteases. The mamP gene, encoding a 
further deduced protein with similarity to this family, is colocated with mamE and mamO 
within the same operon. HtrA-like proteins share a conserved trypsin-like protease domain 
and one or two PDZ domains. They act as molecular chaperones and heat-shock induced 
proteases, which degrade misfolded proteins in the periplasm (Clausen et al., 2002). It has 
been suggested that MamE and MamO are involved in magnetosome formation, perhaps by 
the processing, maturation and targeting of MMPs during MM assembly (Grünberg et al., 
2001). 
The most abundant MM-associated proteins MamC, MamD, MamG, and MamF have 
no known homologues in organisms other than MTB, and thus represent unique, MTB-
specific protein families. One noticeable feature common to several of these proteins is the 
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presence of repetitive motifs. Examples are MamD, Mms6 and MamG, which share 
conspicuous hydrophobic sequence motifs that are rich in repeated leucine and glycine 
residues. Similar motifs containing LG-rich repetitive sequences have been found in other 
proteins that have a tendency for self-aggregration or are involved in the formation of 
supramolecular structures (Schüler, 2004). The Mms6 protein of Magnetospirillum strain 
AMB-1 is a tightly bound constituent of the MM, which exhibits iron binding activity and has 
an effect on the morphology of growing magnetite crystals in vitro (Arakaki et al., 2003). 
Another conspicuous sequence pattern is found in MamJ. MamJ, which displays extensive 
self-similarity, is particularly rich in repeats of the acidic amino acid residues glutamate and 
aspartate. A number of additional conspicuous proteins with highly repetitive and/or acidic 
sequence motifs can be deduced from the genome assemblies of M. gryphiswaldense and 
other MTB. Clusters of polyelectrolytic groups are commonly found in proteins interacting 
with minerals (Baeuerlein, 2003). Thus, it can be speculated that MamJ is bound by 
electrostatic interactions to the surface of magnetite crystals. 
 
Genetic organization of mam-genes and genetic manipulation of magnetite 
biomineralization 
All identified MMPs are encoded within a single genomic region, which represents a 
hypervariable ”magnetosome island” that could be functionally linked to magnetosome 
synthesis in a nonmagnetic mutant strain harboring a large chromosomal deletion (Schübbe et 
al., 2003). Magnetosome genes are colocated in three different operons, which are linked 
within less than 35 kb in the genome of M. gryphiswaldense (Figure 3). 
As can be inferred from the available genome data of different MTB, the gene order 
and amino acid sequences of the predicted Mam proteins are conserved in other MTB 
including M. magnetotacticum and the remotely related magnetic coccus strain MC-1 
(Grünberg et al., 2001). Remarkably, the regions within flanking these clusters are 
characterized by the presence of numerous genes encoding mobile DNA elements such as 
insertion elements and phage-associated integrases, which account for more than 22 % of the 
coding sequence and are involved in the extreme genetic instability of this region under 
conditions of stationary growth (Schübbe et al., 2003). In summary, all these features are 
strongly reminiscent of those described for genome islands in other bacteria. They often 
encode “accessory” gene functions, are genetically unstable and can transfer horizontally 
(Dobrindt et al., 2004). Thus, it seems that essential gene functions for magnetite synthesis are 
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organized within a large genomic "magnetosome island", which may have been distributed by 
lateral gene transfer. 
 
 
Figure 3: Molecular organization of the M. gryphiswaldense MSR-1 ‘magnetosome island’. The 35 kb 
genomic region comprises the mms6-cluster, the mamGFDC cluster and the mamAB cluster, which encode for 
most proteins found in the magnetosome membrane (indicated by black-filled arrows). 
 
Cultivation of MTB and biotechnological production of magnetosomes  
MTB can be enriched and collected from their natural environment sources such as 
mud samples by exploiting their active migration along magnetic field lines for example in 
‘racetrack’ methods (Schüler et al., 1999; Wolfe et al., 1987). Thus, early attempts for the 
study and applications of the bacteria and the magnetic particles derived from them relied on 
magnetically collected MTB from heterogeneous natural populations without their axenic 
cultivation in the laboratory (Matsunaga and Kamiya, 1987; Moench and Konetzka, 1978). 
However, for a biochemical and molecular analysis of the magnetosome biomineralization as 
well as for the development of advanced applications, the isolation of appropriate strains and 
the establishment of for their mass cultivation was an essential requirement. Despite 
numerous efforts to isolate various abundant MTB from different habitats, only a limited 
number of isolates is available as pure cultures and most of the isolates are poorly 
characterized in terms of growth conditions. Problems in their cultivation are due to the fact 
that MTB strictly depend on complex patterns of vertical chemical and redox gradients 
present in their natural habitats, which are difficult to reconstruct in laboratory systems (Flies 
et al., 2005b; Flies et al., 2005a). Therefore, Magnetospirillum strains have been most widely 
used for the isolation of magnetosomes (Blakemore et al., 1979; Matsunaga, 1991; Matsunaga 
et al., 1990; Schüler and Baeuerlein, 1996; Schüler and Köhler, 1992). These strains can be 
grown microaerobically on simple liquid media containing short organic acids as a carbon 
source and ferric iron chelates as iron sources. However, although the cells have anoxygen-
dependent respiratory metabolism, they do not tolerate the oxygen pressure of air. As growth 
and magnetosome formation depend on microaerobic conditions, the control of a low oxygen 
concentration in the growth medium is of critical importance and requires specific 
methodology. For example, cultivation on solid media is a necessary prerequisite for clonal 
ORF
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selection in genetic experiments, which is not easily achieved with MTB and required the 
establishment of a special plating technique (Schultheiss and Schüler, 2003). 
Initial attempts to scale-up growth and magnetosome production were done with strain 
Magnetospirillum sp. AMB-1. Growth in a 1000 L fermenter yielded 2.6 mg l-1 (dry weight) 
magnetosomes with maximum cell densities of 1.8 x 108 cells per liter (Matsunaga et al., 
1990). Several modifications resulted in an increase of magnetosome production to about 145 
mg per liter of culture and a productivity of 1.85 mg magnetite l-1 day-1 in a 10 l fermenter 
(Matsunaga et al., 1996; Yang et al., 2001). Fermenter-scale fermentation of 
M. gryphiswaldense MSR-1 was first reported by Schüler and Baeuerlein (Schüler and 
Baeuerlein, 1997). A sophisticated technology for mass cultivation of MTB in an automated 
oxygen-controlled fermenter was established later, which allows the continuous maintenance 
of low pO2 concentrations (Heyen and Schüler, 2003). This was achieved by a gas control 
regime that exactly maintains very low pO2 tensions over a wide range of cell densities with 
fluctuations less then 5% of the set value. In a comparative study, a productivity of 6.3 mg 
magnetite l-1 day-1 was reported for M. gryphiswaldense compared to 3.3 and 2.0 mg 
magnetite l-1 day-1 for Magnetospirillum sp. AMB-1 and M. magnetotacticum MS-1, 
respectively (Heyen and Schüler, 2003). Among these strains, M. gryphiswaldense exhibited 
the highest oxygen tolerance, and growth was unaffected by oxygen concentration over a 
wide range (0.25 up to 150 mbar). However, magnetite formation occurred only below a 
threshold value of 10 mbar, whereas it was inhibited at higher oxygen concentrations. A clear 
correlation between the amount of magnetite formed and pO2 exists, and most favorable 
conditions for magnetite biomineralization were found at 0.25 mbar (Figure 4). Interestingly, 
reduced particle sizes (20 nm diameter in comparison to 42 nm of particles produced under 
optimal conditions) and irregular particle shapes were observed when cells were grown at 
intermediate pO2 tensions of 10 mbar. Hence, the size and morphology can be controlled by 
growth conditions within a certain range. 
Compared to organic cell constituents, magnetosome particles are distinguished by (i) 
their high density (Magnetite: 5.1 g ml-1) and (ii) their unique ferrimagnetic properties. This 
can be employed for their purification from disrupted cells using a straight-forward isolation 
protocol. After cell disruption the magnetosomes can be easily separated from the crude 
extracts by magnetic separation columns (Grünberg et al., 2004. Magnetic separation is 
followed by ultracentrifugation into a 55 % [w/w] sucrose cushion. This procedure results in 
suspensions of purified magnetosome particles with intact enveloping membrane structures 
(Fig 5). Isolated magnetosomes are relatively stable in the presence of mild detergents. The 
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MM can be easily solubilized by treatments with 1% SDS or organic solvents, which results 
in the agglomeration of membrane-free magnetite particles (Grünberg et al., 2004). 
 
 
Figure 4: Oxygen dependence of cell yield and magnetosome formation in oxystat-grown M. 
gryphiswaldense MSR-1 
 
Figure 5: Magnetosome isolation from mass cultivated M. gryphiswaldense MSR-1. 
A. Magnetic fractionation of total cell lysate (flask A) into non-magnetic cell-debris (flask B) and the 
magnetosome fraction (flask C). Isolated magnetosome particles with intact membranes display a strong 
tendency to chain formation (B) and form large aggregates if the membrane is removed after treatment with hot 
SDS (C). 
 
Characteristics and biotechnological applications of bacterial magnetosomes  
A wide range of technological and biomedical applications are based on magnetic 
nanoparticles (MNP). Technical applications included the use of particles in form of 
ferrofluids as magnetic inks, in magnetic recording media, as liquid sealings, as dampers in 
motors and shock absorbers, and for heat transfer in loudspeakers (Raj et al., 1995; Zahn, 
2001). Another recent trend has been the development of MNP for biomedical applications 
(reviewed in (Berry and Curtis, 2003; Gupta and Gupta, 2005; Pankhurst et al., 2003; Safarik 
and Safarikova, 2002; Tartaj et al., 2003). Despite the large diversity of applications some the 
a) b) c)
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following basic properties of MNP are desired in nearly all cases: Narrow size distribution, 
high magnetic susceptibility, uniform sizes and shapes, low toxicity, good dispersibility, 
tailored surface chemistry. 
Since their discovery, the unique features of MTB have inspired numerous ideas for 
the application of MNP produced by bacteria. Magnetosome crystals display narrow size 
distributions and uniform morphologies. Typical sizes of the monocrystalline particles are in a 
range, which is not easily accessible to chemical synthesis. Moreover, the highly controlled 
pathway of biosynthesis has resulted in a morphological diversity and, in some bacteria, shape 
anisotropies, which are unknown from inorganically produced magnetite crystals. Studies on 
magnetosome suspensions by magnetorelaxometry, DC-magnetometry and atomic force 
microscopy as well magnetic force microscopy revealed that the particles have a high 
magnetization, and the magnetic moments of single-domain magnetosome particles are 
predominantly in a blocked state (Eberbeck et al., 2004; Hergt et al., 2005). Particle sizes 
from 5-15 nm are considered ideal for many biomedical uses of MNP (Berry and Curtis, 
2003; Gupta and Gupta, 2005). Particles of this size can not only diffuse through most tissues 
in the human body, but also display unique magnetic properties (Berry and Curtis, 2003), as 
they are superparamagnetic at room temperature (Chatterjee et al., 2003). This means that the 
particles have high saturation magnetization values if an external magnetic field is applied, 
but upon removal from the magnetic field the magnetic moment fluctuates freely in response 
to the thermal energy (Pankhurst et al., 2003). While mature magnetosome crystals are mostly 
within the ferrimagnetic size range, the crystal sizes are under biological control and can be 
genetically modified. Mutants are already available, which display altered magnetic 
characteristics. As revealed by Small Angle Scattering using polarized neutrons (SANSPOL), 
magnetic particles from a mutant not only exhibit a narrower size distribution then those from 
the wild type, but with an average core diameter of 15.6 nm mutant particles predominantly 
fall into the superparamagnetic size range (Hoell et al., 2004). As the particles are produced 
by a biological process, the iron oxide cores can generally assumed to have low toxicity 
compared to the alloys (neodymium-iron-boron, samarium-cobalt, nickel or cobalt 
compounds) used for the chemical synthesis of some MNP (Tartaj et al., 2003). 
On of the most interesting features of bacterial magnetosomes is the presence of a 
biological membrane of defined biochemical composition. The encapsulation of the magnetic 
crystal within the MM provides a natural ”coating”, which ensures superior dispersibility of 
the particles and provides an excellent target for modification and functionalization of the 
particles. Despite the enormous efforts in chemical synthesis of MNP, some unique properties 
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of bacterial magnetosomes are currently unmatched. These remarkable features may designate 
bacterial magnetic nanoparticles as an appealing alternative for numerous sophisticated 
applications, which rely on small amounts of highly functionalized magnetic material with 
extraordinary magnetic and biochemical characteristics. In the following, we summarize 
several studies on the application of bacterial magnetosomes, which have been reported over 
the last two decades. 
MNP have been used in a number of in vitro methods, such as magnetic separation and 
procedures for labeling and immobilization of various biomolecules. The use of 
Magnetosomes has been also described for numerous purification procedures such as the 
extraction of mRNA and DNA from biological samples such as tissues, blood and bacterial 
cells. For instance, the efficiency of DNA recovery with dendrimer-modified magnetosome 
particles was 6-fold higher with bacterial particles than with artificial particles (Yoza et al., 
2003c). The automation of a DNA extraction procedure based on dendrimer-modified 
particles has been reported recently (Yoza et al., 2003a; Yoza et al., 2003b). The isolation of 
mRNA was facilitated by oligo(dT) modified magnetosomes (Sode et al., 1993). 
Magnetosomes similarly modified with oligonucleotides have been employed in an automated 
magnetic microarray for the detection of different cyanobacterial DNA with genus specific 
probes (Matsunaga et al., 2001).  
Another set of biotechnological applications is based on the immobilization of 
proteins, peptides and enzymes on magnetic particles, which allows the selective separation 
and reuse of immobilized enzymes from a reaction mixture. Compared to micrometric 
particles the use of nanosized particles is preferred due to (i) their higher specific surface area 
and therefore higher binding capacity and (ii) their lower mass transfer resistance. Because of 
their large surface-to-volume ratio bacterial magnetosomes particles could be successfully 
harnessed for immobilization of the enzymes glucose oxidase and uricase as early as 1987 
(Matsunaga and Kamiya, 1987). Likewise, the immobilization of immunoglobulins has 
received great attention and inspired the development of diverse applications. One approach 
of immunoglobulin immobilization on magnetic particles relied on chemical crosslinking of 
the antibody with the magnetosome membrane (Nakamura and Matsunaga, 1993). Another 
approach attempted the genetic modification of magnetosome membrane proteins to generate 
protein fusions of a magnetosome membrane protein and an immunoglobulin binding protein 
such as the Z domain of protein A or protein G (Tanaka and Matsunaga, 2000; Yoshino et al., 
2004). The second approach is potentially superior to chemical crosslinking, as the antibody 
is oriented more accurately, although it remains to be shown that the polypeptides used for the 
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genetic fusion are in fact native constituents of the MM. Antibody-magnetosome conjugates 
were employed for automated immunoassays to detect environmental pollutants, hormones 
and toxic substances (Tanaka and Matsunaga, 2000; Tanaka et al., 2004). In addition, 
antibody-modified magnetosomes have been used successfully for the specific separation of 
target cells from human blood (Kuhara et al., 2004). Another application is the use of 
streptavidin-modified magnetosomes for the automated discrimination of single nucleotide 
polymorphism. The streptavidin-modified particles were coupled to biotinylated 
oligonucleotides to facilitate magnetic separation of DNA hybrids. Single nucleotide 
polymorphisms were detected as decreased fluorescent intensities in a fluorescence resonance 
energy transfer (FRET) system with FITC (donor)-labeled DNA and a POPO-3 (acceptor), 
which preferentially intercalates double stranded sequence of complementary strands (Tanaka 
et al., 2003) 
MNP have been also attracted an increasing interest for their use in a number of 
biomedical in vivo applications. One field, in which synthetic MNP have already found 
commercial application is magnetic resonance imaging (MRI). MRI enables the 
discrimination of tissues which is facilitated by the utilization of MRI contrast agents such as 
iron oxide particles. Tumor cells can be detected by MRI because they do not accumulate 
resonance enhancing particles due to the lack of an effective reticuloendothelial system 
(reviewed in (Pankhurst et al., 2003)). The potential of biomineralization for this purpose has 
been recognized a few years ago (Bulte and Brooks, 1997; Bulte et al., 1994a; Bulte et al., 
1994b). The usefulness of magnetosomes for the detection of microtumors in rats by MRI has 
been already demonstrated and might provide the application of lower doses due to the 
superior magnetic properties of bacterial particles (Baeuerlein et al., 2001; Reszka, 2000). 
Magnetic particles bearing pharmaceutical drugs comprise a promising tool for targeted drug 
delivery. In principle, drug-modified particles are injected into the blood stream and 
concentrated at a target tissue by strong external magnetic fields. The drug can then be 
released by enzymatic activity or changes of temperature, pH or osmolarity. Based on a 
similar principle as drug targeting is the magnetofection approach for targeted in vivo and in 
vitro gene delivery (”Magnetofection”). Here, magnetic fields are employed to concentrate 
genetic vectors immobilized on MNP in target tissues and enhance the efficiency of gene 
delivery (reviewed in (Plank et al., 2003). In preliminary studies it was observed that 
magnetosomes modified by encapsulation in liposomes can efficiently capture organic model 
substances such as FITC labeled DNA and chemotherapeutic drugs and release of the 
substances can be induced by application of a rotating magnetic field (Matsunaga et al., 
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2004). Despite these promising results in vivo studies to demonstrate the efficient magnetic 
drug targeting with bacterial magnetic particles are still not available. 
Another promising biomedical application for biogenic magnetic particles is the 
method of hyperthermia treatment, in which MNP are used for controlled tissue heating to 
promote cell necrosis. After MNP are applied to the target tissue, an alternating external 
magnetic field is applied. Due to loss processes resulting from the reorientation of the 
magnetic moments of the particles, heat is generated, which results in cell necrosis in tumor 
cells (Hilger et al., 2000). The method relies on the development of magnetic nanoparticles 
with high specific loss powers (Hergt et al., 2005). In comparison to artificial magnetic 
particles bacterial magnetosome particles display an enormous hysteresis, which corresponds 
to a coercive field of 6500 A m-1 in comparison to 20 A m-1 of the artificial particles 
(Eberbeck et al., 2004). In a recent study of magnetosomes from M. gryphiswaldense in 
biomedical applications such as hyperthermia and thermoablation, Hergt and coworkers found 
exceptionally high specific powers losses (960 g W-1 at 10 kA m-1 and 410 kHz), which 
substantially exceed the results obtained with artificial particles (Hergt et al., 2005). The 
broad hysteresis and high coercivity indicates that the particles are promising candidates for 
heating applications. 
 
Conclusions and Outlook 
Magnetotactic bacteria have solved the problem of intracellularly synthesizing 
magnetic nanostructures with unique characteristics that cannot yet be fully replicated by 
inorganic approaches. The solution involves a hierarchical structure –the magnetosome chain- 
and a mineralization process with control over the chemical composition, morphology, size 
and intracellular location of the magnetic mineral. In this chapter, we have highlighted much 
of the current knowledge about the physiological and genetic basis of magnetosome 
biomineralization as well as potential uses of magnetosome particles in a number of 
biotechnological applications. Research progress in this field has increased tremendously over 
the last few years and we can expect to see many new insights within this exciting field of 
research. Beside the establishment of techniques for the improved handling and cultivation of 
MTB in the laboratory, the establishment of methods for genetic manipulations for several 
MTB species as well as efforts in the determination of their genome sequence represented 
major breakthroughs. This has contributed much to the advancement of this field, although 
there are many open questions left. For instance, functions of many of the genes identified 
within the magnetosome island and of several MMPs have remained cryptic. However, with 
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the recent advent of genetic technology for transformation and site-directed mutagenesis for 
MTB (Schultheiss et al., 2005; Schultheiss et al., 2004; Schultheiss and Schüler, 2003), 
genetic analysis has become a powerful tool in the study of magnetosome formation. The 
capabilities of MTB to precisely control the composition and morphology of inorganic of 
particles has been explored only recently, and has contributed to the development of a new 
and largely unexplored area based on the use of MTB in biosynthesis of magnetic 
nanomaterials. The available genetic technology will not only allow to elucidate the pathways 
of magnetosome formation at molecular level, but also holds great promise for the design of 
biogenic magnetic nanoparticles with desired properties by genetic engineering. An in vivo 
”tailoring” can be applied both to organic and inorganic constituents of magnetosomes. It has 
already been demonstrated that certain mutants produce magnetite crystals that are superior to 
wild-type magnetosome in terms of morphology, size distribution and magnetic 
characteristics (Hoell et al., 2004). The site-directed mutagenesis of identified iron-
transporting magnetosome proteins might be used to generate magnetosome with a modified 
specificity for the magnetosome-directed uptake of different metals, potentially resulting in 
inorganic magnetic cores with an altered chemical composition. Likewise, the biochemical 
composition of the magnetosome membrane may be altered in vivo by genetic engineering. A 
highly attractive and promising approach will be the design of magnetosomes with 
functionalized surfaces. This can be achieved for instance by the generation of chimeric 
proteins, which are specifically displayed on the surfaces of isolated magnetosomes. It has 
been already demonstrated that magnetosome proteins can be used for the construction of 
functional genetic fusions with the green fluorescent protein, which do not interfere with the 
formation of magnetite crystals (Komeili et al., 2004; Schultheiss et al., 2005). In an 
analogous manner, coupling to magnetosomes proteins, either in vivo by genetic technology 
or in vitro by chemical means, might be used for the introduction of functional moieties, as 
for instance biomolecular recognition groups such as the biotin-streptavidin system  (Fig 6). 
This would endow improved functionality to isolated magnetosome particles, which would be 
extremely useful as building blocks in a variety of nanotechnological approaches, where 
controlled self-assembly of magnetic MNP into ordered structures are required (Lee et al., 
2004; Niemeyer, 2001). 
Although the in vivo fabrication of engineered and functionalized magnetosome holds 
great promise, the production and processing of bacterially synthesized particles is still 
relatively laborious and costly. Therefore, another attractive approach is the biomimetic 
synthesis of MNP with properties comparable to bacterial magnetosomes. The in vitro 
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reconstitution of bacterial magnetite precipitation will not only help to elucidate the chemical 
pathway of biomagnetite formation, but could also be used for the production of magnetic 
nanomaterials with advanced properties. In initial biocrystallization experiments, a 
magnetosome protein (Mms6) was shown to affect in vitro the morphology of magnetite 
crystals (Arakaki et al., 2003). Mms6 and several more candidates that potentially might 
provide control over nucleation and growth of magnetite crystals were identified among 
magnetosome-associated proteins (Schüler, 2004). The use of biomolecular-mediated 
synthesis may offer a variety of morphologies and sizes and could provide the design of 
desired magnetic and crystalline properties in the future. 
 
Figure 6: Schematic illustration of a notional magnetosome particle featuring a variety of functional 
moieties. Conceivable modifications of magnetosome particles are (I) the expression of genetically-engineered 
magnetosome membrane proteins fused to enzymes and fluorophores, (II) the biotinylation of membrane lipids 
and proteins, which facilitate the streptavidin-mediated coupling of various molecules such as nucleic acids or 
immunoglobulins, (III) the attachment of gold particles and quantum dots (IV) the expression of fusion tags as 
anchor groups for the in vitro modification of the particles. Au – gold particle, BD – biotinylated DNA, Fe3O4 – 
magnetite crystal, ML – magnetosome lipid, MM – magnetosome membrane, MMP – magnetosome proteine, 
SV – streptavidin, TMMP – tagged magnetosome proteine  
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Abstract    
The ability of magnetotactic bacteria (MTB) to navigate along magnetic field lines is 
based on unique nano-sized organelles (magnetosomes), which are membrane-enclosed 
intracellular crystals of a magnetic iron mineral that assemble into highly ordered chain-like 
structures. The biomineralization of magnetosomes is a process with genetic control over the 
accumulation of iron, the deposition of the magnetic crystal within a specific compartment, as 
well as the assembly, alignment and intracellular organization of particle chains. Magnetite 
crystals produced by MTB have uniform species-specific morphologies and sizes, which are 
mostly unknown from inorganic systems. The unusual characteristics of magnetosome 
particles have attracted a great interdisciplinary interest and inspired numerous ideas for their 
biotechnological application. In this article, we summarize the current knowledge of 
magnetosome biomineralization in bacteria. In addition, we will present results on the mass 
production, as well as the biochemical and physico-chemical analysis and functionalization of 
bacterial magnetosomes, with emphasis on their charcterization as a novel class of magnetic 
nanoparticles. Finally, we describe the potential of magnetosomes in various biomedical and 
technological applications. 
 
1. Introduction 
An intriguing example for the biological synthesis of nanoparticles is the 
biomineralization of magnetosomes. These structures are formed intracellularly in 
magnetotactic bacteria (MTB) (Figure 1(a)), in which they serve as a navigational device for 
spatial orientation in marine and freshwater habitats by interaction with the earth’s magnetic 
field [1]. Only recently, techniques have become available for the production and isolation of 
magnetosomes. The particles represent a new class of magnetic nanoparticles with 
exceptional properties. Magnetosomes provide numerous attractive possibilities in various 
applications, due to their unique magnetic and biochemical characteristics.  
 
1.1. Biomineralization and structure of magnetosomes 
Magnetosomes are membrane-enclosed inorganic crystals consisting either of the 
magnetic minerals magnetite (Fe3O4) or greigite (Fe3S4) [1-3]. The particles are usually 
arranged along the cell axis in one or multiple chains (Figure 1) that are oriented with the [1 1 
1] magnetic easy axis along the chain direction [4], and are organized along a cytoskeletal 
filamentous structure [5, 6]. Particle sizes are typically 35-120 nm, which is within the single-
magnetic-domain size for magnetite and greigite [7, 8]. A large variety of crystal 
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morphologies such as cubo-octahedral, elongated hexagonal-prismatic, and bullet-shaped 
morphologies were reported [9]. It was shown by high resolution transmission electron 
microscopy, electron diffraction and electron holography that the morphologies of magnetite 
crystals in magnetosomes are derived from combinations of the isometric forms {1 1 1}, {1 1 
0} and {1 0 0}. Morphological variations such as elongated and prismatic structures are due 
to anisotropic crystal growth [10]. The morphology, size and intracellular organization of 
magnetosome crystals is subject to a species-specific biological control, which is genetically 
regulated by a complex and specific set of genes that have been identified within the 
”magnetosome island” within the genome of MTB [11, 12]. For magnetite biomineralization, 
iron is taken up as Fe(III) or Fe(II) from the medium and subsequently transported to the 
magnetosome vesicle [1]. Presumably, a part of the iron is then reoxidized to form a highly 
reactive Fe(III) oxide, probably ferrihydrite, which may react with dissolved Fe(II) to form 
magnetite by a via-solution process [13]. Compartmentalization through the formation of 
membrane vesicles enables the processes of magnetite mineralization to be regulated by 
biochemical pathways. The magnetosome membrane (MM) is crucial in the control of crystal 
growth by providing spatial constraints for shaping of species-specific crystal morphologies. 
Biomineralization of magnetite requires a precise regulation of the redox potential, pH, and 
the prevalence of a supersaturating iron concentration within the vesicle. Thus, the MM 
performs specific functions in the transport and accumulation of iron, nucleation of 
crystallization, and redox- and pH-control [14, 15].  
 
1.2 Applications of magnetosomes 
Bacterial magnetic nanoparticles have been suggested for a number of in vitro 
applications, such as magnetic separation and procedures for labeling and immobilization of 
various biomolecules. The use of magnetosomes has been described for numerous purification 
procedures such as the extraction of mRNA and DNA from biological samples such as 
tissues, blood and bacterial cells. For instance, the efficiency of DNA recovery with 
dendrimer-modified magnetosome particles was 6-fold higher with bacterial particles than 
with artificial magnetic particles [16]. The automation of a DNA extraction procedure based 
on dendrimer-modified particles has been reported recently [16, 17]. The isolation of mRNA 
was facilitated by oligo(dT) modified magnetosomes [18]. Magnetosomes similarly modified 
with oligonucleotides have been employed in an automated magnetic microarray for the 
detection of different cyanobacterial DNA with genus specific probes [19].  
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Another set of biotechnological applications is based on the immobilization of 
proteins, peptides and enzymes on magnetic particles, which allows the selective separation 
and reuse of immobilized enzymes from a reaction mixture. Compared to micrometric 
particles, the use of nanosized particles is preferred due to (i) their higher specific surface area 
and therefore higher binding capacity and (ii) their lower mass transfer resistance. Because of 
their large surface-to-volume ratio, bacterial magnetosomes particles were successfully 
harnessed for immobilization of the enzymes glucose oxidase and uricase in early 
experiments [20]. Likewise, the immobilization of immunoglobulins has received great 
attention and inspired the development of diverse applications. One approach of 
immunoglobulin immobilization on magnetic particles relied on chemical crosslinking of the 
antibody with the MM [21]. Another approach attempted the genetic modification of 
magnetosome membrane proteins (MMP) to generate protein fusions of a MMP and an 
immunoglobulin binding protein such as the staphylococcal protein A or streptococcal protein 
G [22, 23]. The second approach is potentially superior to chemical crosslinking, as the 
antibody is oriented more accurately, although it remains to be shown that the polypeptides 
used for the genetic fusion are in fact native constituents of the MM. Antibody-magnetosome 
conjugates were employed for automated immunoassays to detect environmental pollutants, 
hormones and toxic substances [22, 24]. In addition, antibody-modified magnetosomes have 
been used successfully for the specific separation of target cells from human blood [25]. 
Another application is the use of streptavidin-modified magnetosomes for the automated 
discrimination of single nucleotide polymorphism. The streptavidin-modified particles were 
coupled to biotinylated oligonucleotides to facilitate magnetic separation of DNA hybrids. 
Single nucleotide polymorphisms were detected as decreased fluorescent intensities in a 
fluorescence resonance energy transfer (FRET) system with FITC (donor)-labeled DNA and a 
POPO-3 (acceptor), which preferentially intercalates double stranded sequence of 
complementary strands [26]. The magnetic properties of the particles cannot only be used for 
the purification and immobilization of biomolecules but also for their detection. Magnetic 
force microscopy was used for the highly sensitive detection and quantification of streptavidin 
immobilized on glass slides with biotin conjugated magnetosomes [27]. The magnetosome 
chain is one of the most complex and highly ordered structures found in a bacterium, and it 
has been suggested that biomimetic approaches could be used for the fabrication of self-
assembling magnetic nanostructures inspired by magnetosome chains, such as magnetic 
nanowires and nanotubes as building blocks in magnetic devices. In fact, it has been recently 
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shown by Banerjee and coworkers that magnetic nanotubes can be assembled by the 
incorporation of isolated bacterial magnetosomes into peptide nanotubes [28].  
In summary, these examples impressively demonstrate the tremendous bio- and 
nanotechnological potential of bacterial magnetic nanoparticles. However, numerous 
fundamental questions, that have remained unsolved thus far, have prevented an application 
of magnetosomes at technical scale. Thus, our project aimed to produce and thoroughly 
characterize bacterial magnetosome particles for their use in a number of applications. This 
was done in a combined and collaborative approach, which is described in the following.  
 
Figure 1: Transmission electron micrographs of negatively-stained cells of M. gryphiswaldense displaying 
the magnetosome chain and isolated magnetosomes. (a) single M. gryphiswaldense cell with the 
magnetosome chain localized at midcell, (b) enlarged view of the magnetosome chain, (c) ultrathin-section of a 
M. gryphiswaldense cell with magnetosomes, (d) isolated magnetosome particles with intact magnetosome 
membranes. The magnetosome membrane is indicated by arrows. The bars are 0.5 µm (a) and 0.1µm (b & c). 
 
2. Production of magnetosome particles 
Previous attempts to characterize and apply magnetosome particles were hampered by 
their limited availability. In addition, the particles were poorly characterized in terms of their 
biochemical and physico-chemical properties. The efforts of our group to establish protocols 
for the large scale production of magnetic bacteria and magnetosomes which facilitated the 
detailed biochemical and physical characterization of magnetosomes are summarized in the 
following. We also outline novel routes for the generation of functionalized magnetosomes 
with high technological significance.  
 
2.1. Development of methods for mass cultivation of MTB 
High yields of magnetosomes from large quantities of cells cultivated under defined 
growth conditions are required for both the biochemical and biophysical characterization of 
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magnetosomes. MTB are fastidious organisms and the few strains that are available in pure 
culture are difficult to grow. M. gryphiswaldense (Figure 1(a)) was selected as a 
magnetotactic model organism because it can be grown in simple liquid media containing 
short organic acids as a carbon source. In addition, this organism is amenable to genetic 
analysis, and the determination of its genome sequence has been nearly completed [12, 29]. 
Therefore we seeked to establish optimum conditions for the mass cultivation of the 
microaerophilic M. gryphiswaldense in flasks and in a fermenter. The first step was the 
optimization of the medium to increase cell yield, magnetism, resulting in a defined medium 
in which high yields of cells and magnetosomes can be obtained at moderate costs. 
The magnetotactic strains M. magnetotacticum, M. magneticum and M. 
gryphiswaldense produce magnetite only under microaerobic conditions, whereas higher (e.g. 
atmospheric) oxygen concentrations inhibit growth and repress magnetite formation. Among 
the strains tested in our study, M. gryphiswaldense exhibited the highest oxygen tolerance, 
and growth was unaffected by oxygen concentration over a wide range (0.25 up to 150 mbar). 
However, we observed an increased mutability within the magnetosome island if cells were 
grown at higher oxygen levels, leading to the irreversible loss of the capability to form 
magnetosomes [12]. In initial growth experiments, cells were cultivated in flasks under a 
microaerobic gas mixture containing 1% oxygen in 99% nitrogen [30]. These conditions are 
only of limited use for growth experiments and large-scale cell production, because the 
oxygen supply cannot be kept constant during the incubation period. In fact, the oxygen 
partial pressure decreases due to cellular respiration, resulting in a metabolic shift from 
microaerobic to anaerobic growth and a decreased growth rate. Hence, the control of a 
microoxic environment is a crucial parameter for growth and magnetosome formation, which 
however, cannot be maintained during cultivation in conventional flasks. Therefore, a 
protocol for mass cultivation of MTB in an automated oxygen-controlled fermenter (Figure 2) 
was established, which allows the continuous maintenance of low pO2 concentrations [30]. A 
Biostat A Twin (B. Braun Biotech International, Melsungen Germany) Bioreactor was 
specifically adapted for the microaerobic cultivation of microaerophilic bacteria under oxystat 
conditions. This was achieved by the installation of a highly susceptible oxygen amplifier and 
accessory equipment for the gas supply. Defined low oxygen partial pressures were regulated 
by a cascade control via separate and independent gassing with nitrogen and air. Nitrogen 
supply was controlled by means of a flowmeter (DK 46N; Krohne, Duisburg, Germany) 
installed in line with a pulsed solenoid gas valve (Bürker, Ingelfingen, Germany). The air 
supply was regulated by a thermal massflow controller (BRA-001F; Bronkhorst, Ruurlo, 
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Netherlands), and an additional pulsed solenoid control valve. The switch between nitrogen 
and oxygen gassing depends on the actual oxygen partial pressure in the medium. At oxygen 
partial pressures of 0.5% above the set value nitrogen was sparged into the fermenter at a 
constant rate and at oxygen partial pressures below 99.5% of the set value the aeration rate 
was regulated via the massflow controller and the pulsed solenoid valve. The system allows 
the precise maintenance of pO2 tensions ranging from 0.25-212 mbar over a wide range of 
cell densities with fluctuations less then 5% of the set value. This oxystat fermenter has been 
used to determine optimal oxygen partial pressures for magnetite production and cultivation 
of M. gryphiswaldense. Magnetite formation occurred only below a threshold value of 10 
mbar, whereas it was inhibited at higher oxygen concentrations. We found a clear correlation 
between the amount of magnetite formed and pO2 exists, and most favorable conditions for 
magnetite biomineralization at 0.25 mbar (Figure 3) [29]. Interestingly, particles grown at 10 
mbar displayed smaller sizes (c. 20 nm) compared to 42 nm of particles produced under 
optimal conditions (0.25 mbar), indicating that morphology and size of particles can be 
controlled by growth conditions. Likewise, reduced particle sizes were obtained under 
conditions of iron limitation, or if magnetite formation was synchronized by the addition of 
iron to iron-starved cells shortly before cell harvest. 
In a comparative study, a productivity of 6.3 mg magnetite l-1 day-1 was found for M. 
gryphiswaldense compared to 3.3 and 2.0 mg magnetite l-1 day-1 for Magnetospirillum 
magneticum AMB-1 and M. magnetotacticum MS-1, respectively [30]. Cultivation of M. 
gryphiswaldense in the oxystat with the improved medium increased the maximum cell yield 
to 0.40 g dry weight l-1 compared to 0.33 g dry weight l-1, which were reported earlier [31]. 
Thus, the protocol established for M. gryphiswaldense allows mass production of 
magnetosomes in amounts sufficient for their characterization and applications, which are 
described in the following.  
 
Figure 2: Dual -vessel (2x10l) laboratory fermenter system for mass culture of M. gryphiswaldense 
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Figure 3: Biomass production (OD) and cell magnetism of oxystat grown M. gryphiswaldense at different 
constant oxygen concentrations. 
 
2.2. Isolation and purification of magnetosomes 
We have developed a protocol for the purification of magnetosomes from M. 
gryphiswaldense. Magnetosome particles are distinguished from organic cell constituents by 
their high density and their magnetism. These properties can be harnessed for their 
purification from cells by a straight-forward isolation protocol. After cell disruption by french 
press and removal of cell debris by centrifugation the magnetosomes can be easily separated 
from the crude extracts by magnetic separation columns [32]. Magnetic separation is followed 
by ultracentrifugation into a 55 % [w/w] sucrose cushion. This procedure results in 
suspensions of purified magnetosome particles with intact enveloping membrane structures 
(Figure 1(d)). The isolated magnetosomes are relatively stable in the presence of mild 
detergents. However, treatment with strong detergents (1% SDS at 95°C) or organic solvents 
solubilizes the MM, which results in the agglomeration of membrane-free magnetite particles 
(Figure 4) [32, 33]. 
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Figure 4: (a) Isolated magnetosome particles with intact MM display a strong tendency for chain 
formation, whereas removal of the MM by SDS treatment results in the agglomeration of membrane-free 
particles (b). 
 
3. Characterization of magnetosomes 
3.1. Biochemical characterization of magnetosomes 
For any functionalization and subsequent application, a detailed knowledge of the 
biochemical composition and protein content of the isolated magnetosomes is an essential 
requirement. Therefore, the biochemical characteristics were thoroughly analyzed. A number 
of common fatty acids are present in the MM from M. gryphiswaldense [32, 33]. The most 
abundant polar lipids in the MM are phosphatidylethanolamine and phosphatidylglycerol 
which are also the most abundant polar lipids in whole-cell extracts. The fatty acid 
composition of the MM is very similar to the fatty acid composition of the whole cell in that 
the most abundant fatty acids are identical. However certain fatty acids, that are found in 
whole cells e.g. 3-hydroxyhexadecanoic acid (3 OH 16:0), 3-hydroxyoctadecanoic acid (3OH 
18:0) and 2-hydroxydecenoic acid (2OH 18:1), are absent from the MM. These amide-linked 
fatty acids are typically present in the outer membrane of gram-negative bacteria. These 
results indicate that the MM originates from the cytoplasmic membrane. This has recently 
been confirmed directly by cryo-electron tomography, which demonstrated that 
magnetosomes are membrane invaginations originating from the cytoplasmic membrane [5]. 
For the identification of magnetosome-asssociated proteins, the MM of isolated 
magnetosomes was analyzed as described in detail in reference [31]. Briefly, the MM was 
solubilized by boiling in a buffer containing 2% w/w (SDS) and 5% (w/v) 2-mercaptoethanol. 
The samples were subsequently subjected to one dimensional SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) according to the procedure of Lämmli (Figure 5A) [34] or to 
Tricine-SDS-PAGE according to Schägger and Jagow (Figure 5B,C) [35]. In order to obtain 
improved protein separation, two-dimensional gel electrophoresis was carried out additionally 
(Figure 5D) [32]. After electrophoresis the proteins were blotted onto a membrane and the N-
termini of separated proteins were sequenced by Edman degradation. Additionally, 
magnetosome-associated proteins were identified by mass spectroscopy, either after size 
separation from single spots or bands, or from total tryptic digests of entire magnetosome 
preparations. For the latter purpose, magnetosomes were reduced with dithiotreitol, alkylated 
with iodacetamid and digested with trypsin to completion. Afterwards the magnetic moiety 
was removed, and the supernatant was chromatographically separated using a capillary liquid 
Manuscript 9 
 
 212
chromatography system. The eluted peptides were analyzed by a Q-TOF hybrid mass 
spectrometer.  
The peptide profiles were correlated with the preliminary M. gryphiswaldense genome 
sequence [32]. Analysis of the extracted membrane revealed that the magnetosome is 
associated with a highly specific and complex subset of proteins, which are present in various 
quantities. The amount of MM-bound polypeptides approximately represents 0.1 % of the 
total cellular protein [33]. The combination of these proteomic techniques resulted in the 
identification of 18 major polypeptides in the magnetosome subproteom (Figure 5) [11, 12, 
32, 33]. The different resistance of magnetosome proteins towards proteases and detergents 
indicates that some proteins are very tightly bound to the magnetosome crystals and/or 
embedded within the membrane. The highly abundant proteins MamC, MamF and Mms16 
which have electrophoretic mobilities corresponding to sizes of 15 to 19 kDa are the most 
stable MMP. Others, as for instance MamA, are loosely attached and can be selectively 
solubilized by mild detergents. Based on sequence analysis, MMP can be assigned to a 
number of characteristic protein families, which are presumed to perform specific functions in 
MM vesicle formation and assembly, iron transport, and control of nucleation and growth of 
magnetite crystals. Several of the proteins contain covalently bound c-type heme as revealed 
by peroxidase staining. No glycoproteins, which are common constituents of other 
biomineralizing systems, have been detected so far. Both MamB and MamM are members of 
the CDF (cation diffusion facilitator) family of metal transporters, which comprises proteins 
that function as efflux pumps of toxic divalent cations, such as zinc, cadmium, cobalt and 
other heavy metal ions. Specifically, MamB and MamM have greatest similarity to the CDF3 
subfamily, which was postulated to comprise putative iron transporters [36]. It has been 
speculated that MamB and MamM are involved in the magnetosome-directed uptake of iron, 
and preliminary evidence obtained from mutant analysis seems to support this assumption 
(Junge et al. unpublished). MamE and MamO display sequence similarity to HtrA-like serine 
proteases. The mamP gene, encoding a further deduced protein with similarity to this family, 
is colocated with mamE and mamO within the same operon. HtrA-like proteins share a 
conserved trypsin-like protease domain and one or two PDZ domains. They act as molecular 
chaperones and heat-shock induced proteases, which degrade misfolded proteins in the 
periplasm [37]. It has been suggested that MamE and MamO are involved in magnetosome 
formation, perhaps by the processing, maturation and targeting of MMP during MM assembly 
[33]. 
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The most abundant MM-associated proteins MamC, MamD, MamG, and MamF have 
no known homologues in organisms other than MTB, and thus represent unique, MTB-
specific protein families. One noticeable feature common to several of these proteins is the 
presence of repetitive motifs. Examples are MamD, Mms6 and MamG, which share 
conspicuous hydrophobic sequence motifs that are rich in repeated leucine and glycine 
residues. Similar motifs containing LG-rich repetitive sequences have been found in other 
proteins that have a tendency for self-aggregration or are involved in the formation of 
supramolecular structures [38]. The Mms6 protein of Magnetospirillum magneticum AMB-1 
is a tightly bound constituent of the MM, which exhibits iron binding activity and has an 
effect on the morphology of growing magnetite crystals in vitro [39]. Another conspicuous 
sequence pattern is found in MamJ. This protein displays extensive self-similarity and is 
particularly rich in repeats of the acidic amino acid residues glutamate and aspartate. These 
features are typical for other proteins involved in biomineralization processes and originally 
lead to the speculation that MamJ might mediate nucleation and growth of magnetite crystals. 
However, the targeted deletion of the mamJ gene revealed its involvement in the alignment of 
the magnetosome chain in the cell, probably by interaction with a filamentous structure [6].  
 
 
Figure 5: MM-associated proteins separated by one- and two-dimensional PAGE (redrawn after Grünberg 
et al., 2004). (A) Summary of MM-proteins detected by Coomassie stain in 1D SDS-PAGE (16%). Proteins from 
indicated bands were identified by N-terminal amino acid analysis (Edman degradation). (B) Coomassie and C) 
silver stained SDS-Tricine gels (16.5 %) of MM proteins. (D) Silver-stained 2D-PAGE of MM proteins from M. 
gryphiswaldense. Proteins from marked spots were identified by mass spectrometric sequencing (2D PAGE 
analysis was performed by R. Reszka, MDC Berlin).  
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3.2. Physico-chemical characterization of magnetosome particles 
The analysis of the physico-chemical and magnetic properties of magnetosomes is of 
great relevance for technological application, because biogenic magnetosomes can be 
expected to have unique magnetic characteristics as they have evolved as a navigational 
device in magnetic bacteria that is sensitive to the geomagnetic field and provides a magnetic 
moment sufficient to align bacterial cells [40]. The magnetic characteristics of the particles 
were subject to several studies. The hysteresis of isolated magnetosome particles was 
measured in different magnetometers by Eberbeck et al. and Hergt et al. [41, 42]. In the first 
study a hysteresis corresponding to a coercive field of 6500 A/m was measured at room 
temperature. In the study carried out by Hergt et al. coercivities of 2600 A/m were obtained 
for gelatine immobilized magnetosomes. Hysteresis loops for immobilized magnetosomes 
further were measured at frequencies between 100Hz and 1MHz in a vibrating sample 
magnetometer. The coercivity of magnetosomes is extremely high compared to commercially 
available magnetic nanoparticles (Resovist®, trademark of Schering AG, Germany) with 20 
A/m [42]. 
Another magnetic characteristic of magnetosomes, which is of potential relevance for 
various applications is their relaxation time. In a fluid state a relaxation time of 80 ms was 
measured, which is attributed to Brownian relaxation. Néel relaxation was largely beyond the 
measurement time window of the instrument which suggests that the particles can be 
considered blocked [42].  
Atomic force microscopy and magnetic force microscopy were used to determine if 
the blocking behaviour is attributable to the formation of aggregates or if single 
magnetosomes possess remanent magnetic moments. Particles with a size of about 27 nm still 
bear a remanent magnetic moment [42, 43]. The presence of single magnetosomes was 
verified with the same methods by Albrecht et al [41]. 
While mature magnetosome crystals are mostly within the ferrimagnetic size range, 
the crystal sizes are under biological control and can be genetically modified. For instance, 
magnetic particles from a mutant exhibit a narrower size distribution and smaller diameters 
(figure 6) that predominantly fall into the superparamagnetic size range, as revealed by Small 
Angle Scattering using polarized neutrons (SANSPOL) [44]. 
So far the analysis of the magnetic properties of the particles has shown that 
magnetosomes are single magnetic domain particles with unique magnetic characteristics, 
which are hardly matched by synthetic magnetic particles. These properties designate them 
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for medical applications such as hyperthermia and magnetic resonance imaging. An outline of 
the recent developments in this field will be given in the next section.  
 
Figure 6: TEM picture of magnetosomes isolated from a M. gryphiswaldense mutant strain (MSR1K (a)) 
with reduced particle size and from the wild type strain (MSR-1 (b)). The bar size is 150 nm.  
 
4. Evaluation of magnetosomes for medical applications  
Superparamagnetic nanoparticles are used as magneto-pharmaceuticals for diagnostic 
purposes. They serve as contrast agents in magnetic resonance imaging to enhance the 
contrast between normal and diseased tissue or to indicate the status of an organ. 
Magnetosome-based ferrofluids are promising candidates for Magnetic Resonance 
Tomography contrast agents, which can be detected at very low concentrations in clinically 
employed MR tomographs. That magnetosomes are an expedient alternative to synthetic 
ferrofluids was shown in in vitro experiments by Herborn et al. [45]. The longitudinal and the 
transversal relaxivity (R1 = 7.688 mmol-1 s-1; R2 145.67 mmol-1 s-1) were calculated after 
studying different magnetosome dilutions in a clinical 1.5 T MR tomography (63 Mhz, 21°C). 
The low detection limit of magnetosomes in MRI systems can be harnessed for MR molecular 
imaging. An approach for the twofold labeling of macrophages with fluorescence labeled 
magnetosomes by MRI and near infrared fluorescence was presented recently. The modified 
macrophages may find application in the simultaneous detection of inflammations by NIRF 
and MRI [46].  
Another promising application for magnetosomes might be the method of 
hyperthermia treatment, in which magnetic nanoparticles are used for controlled tissue 
heating to promote cell necrosis in tumors. After magnetic nanoparticles are applied to the 
target tissue, an alternating external magnetic field is applied. Due to loss processes resulting 
from the reorientation of the magnetic moments of the particles, heat is generated, which 
results in cell necrosis in tumor cells [47]. The method relies on the development of magnetic 
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nanoparticles with high specific loss powers [41]. In a recent study of magnetosomes from M. 
gryphiswaldense in biomedical applications such as hyperthermia and thermoablation, Hergt 
and coworkers found exceptionally high specific powers losses (960 g W-1 at 10 kA m-1 and 
410 kHz), which substantially exceed the results obtained with artificial particles [41].  
 
5. Functionalization of magnetosomes 
The encapsulation of the magnetic crystal within the MM provides a natural ”coating”, 
which ensures superior dispersibility of the particles and provides an excellent target for 
modification and functionalization of the particles. Besides in vivo “tailoring” of magnetite 
crystals, also the biochemical composition of the MM can be altered by genetic engineering. 
A highly promising approach is the design of magnetosomes with functionalized surfaces 
(Figure 7). This can be achieved by the generation of chimeric proteins, which are specifically 
displayed on the surfaces of isolated magnetosomes. It has been demonstrated that 
magnetosome proteins can be used for the construction of functional genetic fusions [48, 49]. 
In initial experiments we were able to specifically label magnetosomes with a fusion of a 
green fluorescent protein and a MMP (Figure 8). Replacement of the GFP-function with other 
relevant polypeptide sequences could be used for the introduction of functional moieties, as 
for instance biomolecular recognition groups such as the biotin-streptavidin system [50] 
 
Figure 7: Potential modifications of magnetosome particles by the introduction of different functional 
moieties resulting in hybrid bacterial magnetic nanoparticles (modified after Lang and Schüler, 2006). 
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Magnetosomes could be modified by (a) magnetosome-specific expression of enzyme and fluorophore proteins 
(e. g. GFP) by genetic fusion to MMP, (b) expression of fusion tags such as intein- or strep-tags as anchor 
groups for subsequent conjugate formation with various biomolecules, (c) formation of conjugates with gold 
particles or quantum dots via a DNA linker, (d) biotinylation of membrane lipids and proteins, which would 
facilitate the subsequent streptavidin-mediated conjugation to various molecules such as nucleic acids or 
antibodies. MM – magnetosome membrane, MMP – magnetosome protein, SAV – streptavidin 
 
 
Figure 8: Fluorescent micrograph of M. gryphiswaldense expressing enhanced green fluorescent protein 
(EGFP) fused to a MMP. The green fluorescence signal originates from the magnetosome chain displaying 
EGFP at midcell. Cell membranes (red) were stained with the fluorescent dye FM4-64 (Invitrogen). This 
demonstrates that heterologous proteins can be fused to functional MMP for magnetosome-specific display. In 
future this approach could be extended to the immobilization of enzyme proteins or the introduction of protein 
tags that facilitate secondary in vitro functionalization of magnetosome particles by coupling to a variety of 
biomolecules. 
 
6. Conclusions 
Magnetosome formation in MTB provides a novel magnetic nanomaterial that is 
generated by a mineralization process with control over the chemical composition, 
morphology, size and intracellular location of the magnetic mineral. In summary, our work 
supported by the DFG priority program ”Colloidal Magnetic Fluids” has contributed to a 
greatly improved knowledge about the production and characterization of these particles, 
which will facilitate their future application. In this article, we have highlighted much of the 
current knowledge about the physiological and genetic basis of magnetosome 
biomineralization as well as potential uses of magnetosome particles in a number of 
biotechnological applications. Beside the establishment of techniques for the improved 
handling and cultivation of MTB in the laboratory, the establishment of methods for genetic 
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manipulations for several MTB species as well as efforts in the determination of their genome 
sequence represented major breakthroughs. With the recent advent of genetic technology for 
transformation and site-directed mutagenesis for MTB [29, 49, 51], genetic analysis has 
become a powerful tool in the study of magnetosome formation. The capabilities of MTB to 
precisely control the composition and morphology of inorganic of particles have been 
explored only recently, and have contributed to the development of a new and largely 
unexplored area based on the use of MTB in biosynthesis of magnetic nanomaterials. The 
available genetic technology will not only elucidate the pathways of magnetosome formation 
at molecular level, but also holds great promise for the design of biogenic magnetic 
nanoparticles with desired properties by genetic engineering. An in vivo “tailoring” can be 
applied both to organic and inorganic constituents of magnetosomes. The site-directed 
mutagenesis of identified iron-transporting magnetosome proteins might be used to generate 
magnetosome with a modified specificity for the magnetosome-directed uptake of different 
metals, potentially resulting in inorganic magnetic cores with an altered chemical 
composition. Likewise, the biochemical composition of the MM may be altered in vivo by 
genetic engineering. A highly attractive and promising approach will be the design of 
magnetosomes with functionalized surfaces. This can be achieved for instance by the 
generation of chimeric proteins, which are specifically displayed on the surfaces of isolated 
magnetosomes, or by the chemical conjugation of magnetosomes and biomolecules.  
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Summary 
Magnetotactic bacteria (MTB) have the ability to navigate along the Earth’s magnetic 
field. This so-called magnetotaxis is a result of the presence of magnetosomes, organelles 
which comprise nanometer-sized intracellular crystals of magnetite (Fe3O4) enveloped by a 
membrane. Because of their unique characteristics, magnetosomes have a high potential for 
nano- and biotechnological applications, which require a specifically designed particle 
surface. The functionalization of magnetosomes is possible either by chemical modification of 
purified particles or by genetic engineering of magnetosome membrane proteins. The second 
approach is potentially superior to chemical approaches as a large variety of biological 
functions such as protein tags, fluorophores, and enzymes may be directly incorporated in a 
site-specific manner during magnetosome biomineralization. An alternative to the bacterial 
production of magnetosomes are biomimetic approaches, which aim to mimic the bacterial 
biomineralization pathway in vitro.  In MTB a number of magnetosome proteins with putative 
functions in the biomineralization of the nanoparticles have been identified by genetic and 
biochemical approaches. First initial results obtained by several groups indicate that some of 
these proteins have an impact on nanomagnetite properties in vitro. In this article the key 
features of magnetosomes are discussed, an overview of their potential applications are given, 
and different strategies are proposed for the functionalization of magnetosome particles and 
for the biomimetism of their biomineralization pathway. 
 
Summary figure: Transmission electron micrograph of Magnetospirillum gryphiswaldense 
(a). High Resolution image of an isolated magnetosome (b) and high resolution image of an 
abiogenic magnetite crystal (c). Note that purely inorganic crystals are smaller. Isolated 
magnetosomes can be functionalized, for example with fluorophore proteins as shown by this 
model (d). 
 
Keyword: biomimetic; biotechnology; magnetite; magnetosomes; nanoparticles; 
nanotechnology 
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Introduction 
Magnetite nanoparticles (MNPs) are key components to the development of many 
novel bio- and nanotechnological applications. Research in nanosciences and nanotechnology 
has aimed at using magnetic nanoparticles as nanomotors, nanogenerators, nanopumps, and 
other similar nanometer-scale devices.[1] Technical applications include the use of 
nanomagnetite in films,[2] in form of ferrofluids as magnetic inks, in magnetic recording 
media, in liquid sealing, as dampers in motors and shock absorbers, and for heat transfer in 
loudspeakers.[3] MNPs are of biotechnological and biomedical relevance in fields such as 
magnetic separation of biomolecules, magnetic resonance imaging (MRI), tissue repair, drug 
delivery, hyperthermia treatment of tumor cells, or magnetofection.[4-6] In many cases 
particles with a specifically tailored and functionalized surface are required. Especially in 
biotechnological applications, functionalized bacterial magnetosomes represent an attractive 
alternative to chemically synthesized iron oxide particles. Magnetosome particles have been 
employed in numerous applications that range from extraction of DNA and RNA to the highly 
sensitive detection and concentration of toxic substances and the development of 
immunoassays.[7-11] Magnetosomes, which can be isolated now from cells in larger quantities, 
consist of a magnetic mineral crystal, magnetite or greigite,[12] enveloped by a biological 
membrane that contains phospholipids and specific proteins.[13] The magnetosome membrane 
(MM) is not only critical for the control of crystal size and morphology, but also prevents the 
aggregation of extracted magnetosomes and thus stabilizes magnetosome suspensions. In 
addition, the MM provides a matrix for the functionalization of magnetosomes. 
In this article two strategies for the production of MNPs for bio- and 
nanotechnological purposes are discussed. The first strategy is the development of 
functionalized magnetosomes either by chemical modification of isolated particles or genetic 
engineering of magnetosome membrane proteins. The second strategy is based on the 
biomimetic synthesis of magnetic nanoparticles with tailored properties by mimicking the 
bacterial biomineralization pathway in vitro for applications that require larger amounts of 
magnetosome-like MNPs.  
 
Properties of Magnetosomes 
Magnetosomes are formed and aligned intracellularly in well-ordered chains that serve 
as a navigational device for orientation along chemical gradients in aquatic habitats by 
interaction with the Earth’s magnetic field.[14,15] Magnetosome crystals of MTB are typically 
from 30 to about 140 nm in diameter,[16-18] i.e., within the single-magnetic-domain size range, 
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which maximizes the efficiency of the particle as permanent magnetic carrier.[19] Statistical 
analysis of magnetosomes show that their crystal size distributions (CSDs) are narrow, 
asymmetrical, and negatively skewed with sharp cut-offs towards larger size and with shape 
factor (or width-to-length ratio) consistent for a given strain.[16,17,20-22] The magnetosome 
morphology also varies between different species, but is consistent for a given bacterial 
strain[18,23-25] (Figure 1). The cubooctahedral magnetite crystals produced by the 
magnetotactic model organism Magnetospirillum gryphiswaldense have an average size of 
approximately 35 nm. Magnetorelaxometry, DC magnetometry, and atomic force microscopy 
as well as magnetic force microscopy demonstrated that the particles have a high magnetic 
coercivity (2 600 A · m-1) compared to commercially available magnetic nanoparticles, and 
the magnetic moments of single-domain magnetosome particles are predominantly in a 
blocked state.[26,27]  
 
 
Figure 1: TEM images of magnetosomes from different bacterial strain: (a) parallelepipedal projection of a 
possibly pseudo-hexagonal prism, (b) hexagonal projection of a possibly cuboctahedral crystal and (c) tooth-
shaped (anisotropic) magnetosomes (scale bar = 20 nm). Note that the tooth-shaped magnetosomes are usually 
the larger ones and the cuboctahedral the smaller ones. 
 
However, as the crystal size is genetically determined, mutants can be isolated that 
display altered magnetic characteristics. As revealed by small-angle scattering using polarized 
neutrons (SANSPOL), magnetic particles from a mutant not only exhibit a narrower size 
distribution than those from the wild type, but with an average core diameter of 15.6 nm 
mutant particles predominantly fall into the superparamagnetic size range, which might be 
advantageous for certain applications as they are easily dispersible and have a higher surface-
to-volume ratio.[28]  
Another key feature of bacterial magnetosomes is the presence of a biological 
membrane with a defined biochemical composition. This natural ‘coating’ ensures superior 
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dispersibility of the particles and provides an excellent target for modification and 
functionalization of the particles. It was recently confirmed by cryo-electron tomographic 
studies that the magnetosome vesicles originate directly from the cytoplasmic membrane by 
invagination.[29] This explains why the lipid and fatty acid composition of the magnetosome 
membrane and the cytoplasmic membrane are mostly identical.[30,31] However, proteomic 
analysis of the membrane from isolated magnetosome particles revealed a highly specific and 
complex subset of proteins associated with the particles,[30-33] which amount to approximately 
0.1% of the total cellular protein.[31]  
 
Biotechnological Application and Functionalization of Magnetosomes 
Because of their unique characteristics compared to synthetic particles, isolated 
magnetosome crystals are superior for applications that rely on small amounts of highly 
functionalized magnetic material with extraordinary magnetic and biochemical characteristics. 
For instance, magnetosomes have been used in a number of in vitro methods, such as 
procedures for labelling and immobilization of various biomolecules and magnetic separation. 
Bacterial magnetic particles have been employed in numerous purification procedures such as 
the extraction of mRNA and DNA from biological samples such as tissues, blood, and 
bacterial cells[8,11,34] or for the detection of different cyanobacterial DNA with genus specific 
probes.[35] 
The immobilization of proteins, peptides, and enzymes on magnetic particles 
facilitates the selective separation and reuse of immobilized enzymes such as glucose oxidase 
and uricase[36]. Likewise, the immobilization of immunoglobulins has inspired the 
development of diverse applications. Antibody-magnetosome conjugates were employed for 
automated immunoassays to detect environmental pollutants, hormones, and toxic 
substances.[10,37]. In addition, antibody-modified magnetosomes have been used successfully 
for the specific separation of target cells from human blood.[38] Another application is the use 
of streptavidin-modified magnetosomes for the automated discrimination of single nucleotide 
polymorphism. The streptavidin-modified particles were coupled to biotinylated 
oligonucleotides to facilitate magnetic separation of DNA hybrids and used for the detection 
of single nucleotide polymorphisms.[9] Biotin-conjugated magnetosomes were used in 
combination with magnetic force microscopy for the highly sensitive detection and 
quantification of streptavidin immobilized on glass slides.[39]  
The functionalization of biogenic nanoparticles is possible by both chemical and 
biotechnological approaches. A schematic overview over possible modifications is shown in 
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Figure 2. For instance, a rapid method for the immobilization of enzymes and proteins is 
based on glutaraldehyde-induced crosslinking.[35,36]. An alternative is the use of N-
succinimidyl esters, such as the heterobifunctional reagent N-succinimidyl 3-(2-pyridyldithio) 
propionate, which was used for the conjugation of amine-modified oligonucleotides.[8] 
Myosin was immobilized on magnetic particles using sulfosuccinimidyl 6-[3’-(pyridyldithio)-
propionamido]hexanoate and sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-
carboxylate.[40] In addition, the biotinylation of magnetosomes was achieved with different N-
hydroxy-succinimidylesters.[39,41] Biotinylation can be utilized for the modification of 
magnetosomes with various biotinylated biomolecules using streptavidin as a coupling 
reagent.  
 
 
Figure 2: Potential functionalization of magnetosome particles by the introduction of different functional 
moieties resulting in hybrid bacterial magnetic nanoparticles. Magnetosomes could be modified by 
magnetosome-specific expression of enzymes and fluorophore proteins (e. g. GFP) by genetic fusion to MMP. 
The expression of fusion tags such as intein- or strep-tags as anchor groups could be used for the subsequent 
conjugate formation with various biomolecules. The biotinylation of membrane lipids facilitates the subsequent 
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streptavidin-mediated conjugation to various molecules, such as antibodies or nucleic acids which can also be 
used for the formation of conjugates with gold particles or quantum dots.  
 
While chemical approaches allow the incorporation of a variety of functional groups, 
they require additional treatment upon magnetosome isolation from the cell, which can lead to 
denaturation and a loss of activity. Therefore, genetic approaches for the site-specific 
functionalization of MMP are attractive, as they are gentler with respect to the preservation of 
protein activity. This involves the construction of genetic fusions of magnetosome membrane 
anchor polypeptides with functional proteins and enzymes of choice. The chimeric proteins 
are expressed and incorporated into the MM within the bacterium during particle 
biosynthesis. Subsequently, magnetosome particles displaying functional polypeptides and 
enzymatic functions can be directly extracted from the bacterial cell without further chemical 
treatment. Another advantage of this strategy is the possibility to have control of the 
stoichiometry by the modification of either highly or less abundant proteins of the MM. 
Genetic engineering of magnetosome membrane proteins was employed to display the 
reporter enzymes luciferase and acetate kinase, and the antibody binding ‘ZZ’ protein on the 
magnetosome particles.[10,38,42,43] Moreover, it is possible to attach multiple functional 
moieties to the magnetosome surface by utilizing different magnetosome anchors, as 
successfully employed for expression of luciferase and an antibody binding protein on the 
magnetosome surface.[44] In addition, the expression of a human estrogen receptor was used 
for the screening of estrogenic compounds.[7] Ideal candidates for anchor polypeptides are 
integral membrane proteins of the MM, which are tightly attached to the crystals’ surface and 
resist mechanical and chemical stresses. The anchor protein must not interfere with the 
function of the added moiety and vice versa. Moreover, it is required that functional groups 
are highly expressed, resistant to proteolysis, and displayed in similar quantities on the 
surface of all particles. In order to identify appropriate magnetosome anchor proteins we have 
started constructing genetic fusions of different MMPs with the enhanced green fluorescent 
protein (EGFP) as a reporter protein. EGFP was selected because it is a well-characterized 
fluorescent protein, which can be fused to many different proteins without functional 
interference and can be easily expressed in MTB.[29,45,46] By fluorescence microscopy we 
identified several fusion proteins, which are specifically targeted to the MM and exhibit high 
fluorescence on magnetosome chains and purified particles (Figure 3). The fluorescence of 
isolated magnetosome particles can be used to quantify the expression level to characterize 
different magnetosome anchors. Studies are in progress on the stability of the functionalized 
particles with respect to proteolysis and the effects of surfactants and salts. In future, the 
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replacement of the EGFP-function by other relevant polypeptide sequences will be used for 
the introduction of functional moieties as, for instance, biomolecular recognition groups such 
as the biotin-streptavidin system.[47] This will allow the development of multifunctional 
magnetic nanoparticles as innovative biomaterials, which for example, cannot only be used 
for biotechnological purposes but also in nanotechnology for the construction of 
hierarchically ordered supramolecular structures. 
  
 
Figure 3. Fluorescent micrographs of M. gryphiswaldense expressing enhanced green fluorescent protein 
(EGFP) fused to an MMP. The fluorescence signal at midcell originates from the magnetosome chain 
displaying EGFP. Cell membranes were stained with the fluorescent dye FM4-64 (Invitrogen). EGFP 
fluorescence is confined to the intracellular position of magnetosomes at midcell, indicating that the fusion 
proteins are specifically inserted in the MM. This demonstrates that heterologous proteins can be fused to 
functional MMP for a magnetosome-specific display. The length of the scale bar is 2 µm. 
 
Biomimetics 
Inorganic synthesis of magnetite crystals with ‘magnetosome-like’ characteristics is 
attractive for some biomedical and nanotechnological applications. For instance, 
magnetosome crystals are promising candidates for applications such as magnetic resonance 
imaging (MRI),[48,49] targeted in vivo and in vitro gene and drug delivery 
(‘magnetofection’),[50,51] and the hyperthermal treatment of tumours.[26,27] In these cases and 
in nanotechnological applications, which often require the fabrication of hybrid organic-
inorganic nanocomposites, the biomimetic in vitro synthesis of MNPs may be advantageous. 
In biomineralizing systems, organisms exert a high level of control over nucleation 
and growth of inorganic materials such as carbonate, silicate, or iron oxides. For example, 
evidence for biomineral phase control by addition of proteins have been reported for calcium 
carbonate, silica, and hydroxylapatite.[52,53] There are several interconnected approaches 
related to biomimetics. First, biological concepts can be tested in inorganic approaches to 
produce materials with unique properties that are exclusively known from biogenic minerals. 
In the case of MNPs, biomimetic approaches can be purely inorganic. The first step 
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encompasses magnetite precipitation, which can be performed by pyrolysis, gas deposition, 
sol-gel, microemulsion, or bulk solution.[4] Most developed are bulk solution syntheses since 
large quantities of products can be formed. Coprecipitation of ferric and ferrous iron in 
alkaline environments leads to the formation of magnetite crystals[54] (Figure 4). These can 
also be performed under bio-inspired, i.e., controlled conditions, for example, in the presence 
of defined salt and pH conditions that result, for example, in narrower size distributions, 
approximating those found for biogenic particles.[55] For most applications, functionalization 
of particles is required. Thus, the next step is often the coating of surfaces to prevent 
nanoparticles agglomeration. Organic solvent such as oleic acid or alkyl phosphate or 
phosphonate,[56] folic acid or poly(ethylene glycol)[57,58] were shown to be powerful 
surfactants (Figure 4). 
 
 
Figure 4: TEM images of isolated magnetosomes particles (a), purely inorganic nanocrystals (b), and 
inorganic crystals in oleic acid (c). The biogenic magnetites do not agglomerate due to their membrane, 
whereas inorganic particles need further treatment to prevent them from agglomeration. 
 
Another approach of biomimetics depends on biological compounds, which are 
directly added to inorganic assays. For example, preformed magnetite nanoparticles can be 
incorporated into macroscopic threads of Bacillus subtilis by reversible swelling of the 
superstructure in colloidal sols. In this case, the organized bacterial superstructures are used 
as three-dimensional templates for the fabrication of ordered inorganic-organic fibrous 
composites.[59,60] Ultimately, the most promising approach uses isolated biological 
compounds such as specific proteins with defined biological activity related to mineral 
formation. Proteins can be extracted from the biomineralizing organism, or produced by 
recombinant technology and used in an in vitro bio-inorganic assay. This approach has 
already shown great potential, for example, by controlling phase switching between calcite 
and aragonite,[52] or in the case of silicate biomineralization.[53,61] One successful example of 
the bioinorganic formation of magnetite nanoparticles was reported with the use of the iron-
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storage protein ferritin: The demetallated protein shell of apoferritin assembles into a 
multisubunit protein shell to form a hollow cage of about 8 nm in diameter. This natural 
nanometer-sized bioreactor has been used for the biomimetic reconstitution of the 
ferromagnetic iron oxides magnetite and maghemite (γ-Fe2O3).[62,63] Promising examples have 
been reported for in vitro magnetite formation inspired by magnetotactic bacteria.[64,65] In 
these studies, several low-molecular mass proteins bound to bacterial magnetite were 
identified. If the acidic protein Mms6 was added to a reactor concomitantly with the iron ions, 
nanometer-sized magnetic particles somehow reminiscent to those in magnetic bacteria were 
obtained, which is not the case when using another type of protein.[64, 65] This suggested that 
Mms6 is directly involved in biological magnetite crystal formation in MTB. However, 
presented morphological analyses were not fully conclusive, and further studies are required 
to obtain ultimate proof for the suggested activity in vivo. 
Biomimetic approaches will be most promising when our understanding of 
biomineralization pathways are improved down to the molecular level. This would enable the 
exact reproduction of magnetosome-like nanoparticles in a test tube by means of biomimetics. 
So where to start? For biomimetic synthesis of magnetite crystals, the assay has to be at 
micrometer-scale, as the amount of proteins from purification or recombinant production is 
usually limited. A distinctive feature of magnetite biomineralization in magnetosomes at the 
physical level is the limited diffusion of ions. Biological conditions could be mimicked, for 
example, by the use of a gel instead of a liquid phase. Another physical limitation of bulk 
phase synthesis is the lack of spatial control, which in vivo is provided by the magnetosome 
membrane. This could be overcome, for instance, by the use of synthetic membranous 
vesicles, such as liposomes.[66] As formation of crystals occurs through nucleation and 
growth, a given chemical supersaturation needs to be achieved to form magnetite nanocrystals 
by addition of iron ions in basic conditions. The use of artificial vesicles might, therefore, also 
facilitate to locally maintain supersaturating concentrations, which permit magnetite 
nucleation, and also provide spatial constraints to restrict the maximum growth size of the 
particles. Eighteen specific bona fide proteins have so far been identified in the magnetosome 
membrane of M. gryphiswaldense.[67] Their functions with respect to biomineralization 
largely remain unknown, which requires extensive empirical approaches to test their in vitro 
activity. In some cases, putative functions of proteins could be inferred from sequence 
similarities to other proteins. For example MamB and MamM were identified as members of 
the cation diffusion facilitator (CDF) family of metal transporters and preliminary 
experimental evidence has suggested a key function in magnetosome-directed uptake of 
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supersaturating amounts of iron. If reconstituted within vesicles, transport of iron into the 
liposome could be controlled, with slow diffusive rates close to those occurring in vivo. In 
addition, effective buffering is required for the process, as protons are released into the 
solution during the formation of Fe3O4, which have to be removed as magnetite precipitation 
only occurs at basic pH[54,55] Finally, the function of Mms6 and other magnetosome proteins 
that contain related sequence motifs (i.e. MamD, MamG, MamS and others) should be further 
investigated, as initial in vitro results have indicated a potential role in crystals growth. This 
approach, for instance, will also allow identification of the proteins and their interactions 
between proteins required to precipitate magnetite and those responsible for the defined 
morphology. 
Finally, coupling in vivo functional studies, such as the targeted mutagenesis of the 
gene that produces the protein of interest with bio-inorganic in vitro assay using the same 
proteins extracted from magnetotactic bacteria, will be the ‘ultimate’ approach to unravel the 
role played by a given protein, to understand biomineralization at a mechanistic level, and to 
develop biomimetics to obtain innovative material with rationally designed characteristics. 
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Abstract 
Ferrite spinels, especially magnetite (Fe3O4), can be formed either by geological, 
biological or chemical processes leading to chemically similar phases that show different 
physical characteristics. We compare, for the first time, magnetite produced by these three 
different methods using X-ray magnetic circular dichroism (XMCD), a synchrotron radiation 
based technique able to determine the site occupancy of Fe cations in the ferrite spinels. 
Extracellular nanoscale magnetite produced by different Fe(III)-reducing bacteria was shown 
to have different degrees of stoichiometry depending on the bacteria and the method of 
formation, but all were oxygen deficient due to formation under anoxic conditions. 
Intracellular nano-magnetite synthesized in the magnetosomes of magnetotactic bacteria was 
found to have a Fe cation site occupancy ratio most similar to stoichiometric magnetite, 
possibly due to the tight physiological controls exerted by the magnetosome membrane. 
Chemically-synthesised nano-magnetite and bulk magnetite produced as a result of geological 
processes were both found to be cation deficient with a composition between magnetite and 
maghemite (oxidised magnetite). 
 
Keywords: X-ray magnetic circular dichroism, XMCD, nanoparticles, metal reduction, 
Fe(III) reduction, Geobacter, biomineralogy, biogenic magnetite 
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Introduction 
Magnetite is formed by a range of geological, chemical and biological processes 
leading to chemically and structurally similar phases but with very different crystallite sizes, 
stoichiometries and physical properties. Ferrite spinels, especially magnetite (Fe3O4), are of 
special interest as they are among the most important magnetic materials for industrial 
applications. This is the first study to apply the synchrotron radiation based technique of X-
ray magnetic circular dichroism (XMCD) to nano-magnetite samples produced by both 
extracellular and intracellular biogenic processes, in order to compare and discriminate 
between these and non-biogenic geological bulk magnetite and chemically produced nano-
magnetite. XMCD provides unique information on magnetic minerals as it is element specific 
and can quantify the amount and the valence state of Fe on each of the two lattice sites within 
the structure of ferrite spinels such as magnetite (Pattrick et al., 2002; Coker et al., 2006; 
Pearce et al., 2006). XMCD has previously been extensively used to characterise the magnetic 
properties of used technological application such as data storage devices (van der Laan and 
Welbourne, 1996).  
Magnetite is present throughout the Earth’s crust and uppermost mantle and is the 
main contributor to rock magnetism. Formed by magmatic and hydrothermal processes, 
crystal sizes vary from the sub-micron scale to polycrystalline layers several meters thick, 
such as in the ultramafic Bushveld intrusion in South Africa. Nano-magnetite synthesised as a 
chemical precipitate requires a narrow particle size distribution in order to be used in 
technological or medical applications such as magnetic recording media, ferrofluids and 
magnetic resonance imaging (MRI) (Lee et al., 2005).  
Biogenic magnetite nanoparticles are considered to be potential bio-signatures of life 
and further interest has been stimulated by the recognition that they have potential uses in 
nanotechnology, which has led to research into their characterisation (Thomas-Keprta et al., 
2000; Safarik & Safarikova, 2002; Coker et al., 2004; Faivre & Zuddas, 2006). Magnetite can 
be precipitated by a diverse range of bacteria through redox transformations of ferric iron and 
can form as either an extracellular precipitate through Fe(III) reduction (Lovley et al., 1987) 
or Fe(II) oxidation (Chaudhuri et al., 2001), or intracellularly within the magnetosomes of 
magnetotactic bacteria (Schüler, 1999). Magnetite formed by extracellular processes has been 
reported to have a broad size distribution and varied morphology, whereas magnetite formed 
by magnetotactic bacteria is formed within the magnetosomal membrane, and therefore the 
size and shape of the nanoparticles is constrained, leading to a narrow particle size 
distribution (Bazylinski & Moskowitz, 1997).  
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High-resolution electron microscopy (EM) techniques have been the most widely used 
to characterise the morphology and size of biogenic and chemical nanoparticles of magnetite 
(Thomas-Keprta et al., 2000; Glasauer et al., 2003; Taylor & Barry, 2004) and have also been 
used to differentiate between biogenic intracellular magnetite and geological magnetite (Arato 
et al., 2005). Other techniques commonly used are iron and oxygen isotopic studies and 
crystal size distribution analyses (Mandernack et al., 1999; Faivre & Zuddas, 2006). The 
magnetic methods that have been developed to identify biogenic minerals are low-temperature 
SQUID magnetometry (Moskowitz et al., 1993), ferromagnetic resonance (Weiss et al., 2004) 
and coercivity deconvolution (Egli, 2004). 
 
Fe(III)-reducing bacteria 
Dissimilatory Fe(III)-reducing bacteria capable of magnetite production from 
respiration using poorly soluble Fe(III) oxides as a terminal electron acceptor include 
Geobacter sulfurreducens (Gb. sulfurreducens) (Caccavo Jr et al., 1994), Shewanella 
oneidensis (S. oneidensis) (Lovley et al., 1989) and Geothrix fermentans (Gt. fermentans) 
(Coates et al., 1999). This study examines biogenic magnetite produced by these organisms as 
each uses a different mechanism to reduce Fe(III). A full understanding of the mechanisms 
involved in Fe(III)-reduction and magnetite formation is yet to be determined for these and 
other species. Current evidence suggests that Geobacter species require direct contact 
between the cell and the Fe(III)-containing mineral, with electron transfer mediated by outer 
membrane cytochromes (Lovley et al., 2004). Additionally, Gb. sulfurreducens produces pili 
acting as electron transferring ‘nanowires’ when grown on insoluble ferric iron (Reguera et 
al., 2005). S. oneidensis, a facultative anaerobe, (Lovley et al., 1989) is also capable of Fe(III) 
reduction to form the mineral magnetite via outer membrane cytochromes (Myers & Myers, 
1992) and nanowire-like assemblages (Gorby et al., 2006). However, this organism can also 
produce a soluble extracellular electron shuttle to alleviate the need for direct contact between 
the cell surface and Fe(III) mineral substrate (Newman & Banfield, 2002).  The identity of 
this compound has remained elusive, although other naturally occurring electron shuttles have 
been identified that promote microbial Fe(III) reduction, including humics and other 
extracellular quinone containing molecules (Lovley et al., 1996). Finally, Gt. fermentans, 
initially isolated from a hydrocarbon-contaminated aquifer sediments, is also capable of 
producing magnetite through the reduction of Fe(III) (Coates et al., 1999). Evidence suggests 
that this organism is able to produce both an extracellular electron shuttle and chelating agent, 
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the latter to solubilise the highly insoluble Fe(III) oxides, making it more bioavailable for 
respiration..  
 
Magnetotactic Bacteria 
Magnetotactic bacteria use a completely different mechanism to reduce Fe(III) and 
form intracellular magnetite. The first stage in magnetite biomineralization by magnetotactic 
bacteria is the uptake of ferrous or ferric iron (Schüler and Baeuerlein 1996).  Subsequently, 
the formation of magnetite probably proceeds via a ferrihydrite-like mineral (Ofer et al., 
1984). Individual magnetite crystals form chains within the bacterial cell enveloped by a 
trilaminate structure, called the magnetosome membrane (Balkwill et al., 1980). Magnetite 
formation requires the presence of mixed-valence iron complexes in solution. Therefore, 
biomineralization of this material depends on precise regulation of iron supersaturation and 
both redox potential and pH (Schüler, 2004). 
 
Magnetite  
The mineral magnetite has an inverse spinel structure with one quarter of the 
tetrahedral (Td) and one half of the octahedral [Oh] sites filled by iron. The formula for 
magnetite is -24
323 O]FeFe)[Fe( +++ , where the parentheses and square brackets indicate Td and 
Oh sites, respectively. While the Fe(III) is equally split between Td and Oh sites, the Fe(II) 
occupies only Oh sites. Hence in stoichiometric magnetite the Fe occupancy of the d6 Oh : d5 
Td : d5 Oh sites is 1:1:1. The Oh and Td sublattices contain cations with anti-parallel aligned 
magnetic moments, which results in a net magnetisation in the Oh sub-lattice that does not 
cancel out, giving rise to ferrimagnetism. Non-stoichiometry of magnetite is manifest by the 
presence of vacant cation sites in the structure. These are caused by oxidation of Fe(II) in the 
Oh sites to Fe(III), leading to a charge imbalance so that additional Fe(II) is removed from the 
structure giving a formula -24
3
21
2
3-1
3 O]FeFe)[Fe( δδδ Δ++++  = Fe3-δO4, where δ quantifies the 
deviation from stoichiometry due to cation vacancies Δ (Pearce et al., 2006).  
 
Materials and Methods 
Fe(III) reduction 
Gb. sulfurreducens and Gt. fermentans were obtained from our laboratory culture 
collection and grown under strictly anaerobic conditions at 30 oC in modified fresh water 
medium as described previously (Lloyd et al., 2003). Sodium acetate (20 mM) and fumarate 
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(40 mM) were provided as the electron donor and acceptor, respectively. All manipulations 
were done under an atmosphere of N2–CO2 (80:20). S. oneidensis was obtained from 
laboratory cultures and grown under aerobic conditions from frozen stock at 30 oC in tryptone 
soy broth (TSB) media. After 24 hours a 10% inoculum of late log-phase aerobic cultures was 
used to inoculate anaerobic ferric citrate media (Lovley & Phillips, 1988). Sodium lactate (20 
mM) and ferric citrate (56 mM) were provided as the electron donor and acceptor, 
respectively.  
Late log-phase cultures of Gb. sulfurreducens, Gt. fermentans and S. oneidensis were 
harvested by centrifugation at 4920 g for 20 minutes and washed twice in carbonate buffer 
(NaHCO3; 30 mM, pH 7.1) under N2–CO2 (80:20) gas prior to use. Aliquots of the washed 
cell suspension (1.5 ml) were added to sealed anaerobic bottles containing 28.5 ml 
bicarbonate buffer. The final concentration of bacteria corresponded to 0.2 mg protein per 
mL. The following additions were made from anaerobic stocks as required; poorly crystalline 
Fe(III) oxide (10 mM), sodium acetate (10 mM), sodium lactate (10 mM) and the humic 
analogue/electron shuttle anthraquinone-2,6-disulphonate (10 µM). Bottles were incubated in 
the dark at 20 °C. 100 µl of slurry was removed from each serum bottle periodically, after 
gentle shaking, using aseptic and anaerobic technique and analyzed for 0.5 M HCl-extractable 
Fe(II) using the ferrozine method (Lovley & Phillips, 1986). All experiments, including 
abiotic controls, were done in triplicate and representative data shown throughout. Standard 
errors were within ± 10% of the mean.  
 
Production of Magnetosomes 
The magnetotactic bacterium Magnetospirillum gryphiswaldense MSR1 (Schleifer, et 
al. 1991) was grown under microaerobic conditions in a 20L oxystat fermenter as described 
previously (Heyen and Schüler 2003). Cells were grown to stationary phase and harvested by 
centrifugation. Magnetosomes were purified as described by Grünberg et al. (2004). Upon 
isolation magnetosomes were resuspended in storage buffer (10 mM HEPES pH 7.4, 1 mM 
EDTA pH 8.0, 0.1 mM PMSF, 0.04% NaN3) and stored in a nitrogen atmosphere to prevent 
oxidation. 
 
Chemical magnetite 
The chemical magnetite analyzed in this study as a comparison to biogenic and 
geogenic magnetite was Fe3O4 20–30 nm APS Powder, with a surface area > 60 m2/g (Alfa 
Aesar Cas. no. 1317-61-9). 
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Transmission electron microscopy 
Imaging of the samples produced by the various bacteria was performed on a Philips 
CM200 microscope operating at 120 kV. Samples were washed using degassed distilled water 
several times before being re-suspended in ethanol and dropped onto a carbon-coated copper 
grid and left to dry just prior to insertion into the TEM. 
 
 X-ray Magnetic Circular Dichroism 
X-ray absorption spectra were collected on stations 1.1 and 5U.1 using the Flipper 
electromagnet endstation (Dudzik et al., 2000) at the Synchrotron Radiation Source (SRS), 
Daresbury Laboratory, UK and station 4.0.2 using the octopole magnet endstation (Arenholz 
& Prestemon, 2005) at the Advanced Light Source (ALS), Berkeley, CA. Samples Gb. 
sulfurreducens, Gb. sulfurreducens + AQDS, S. oneidensis, S. oneidensis + AQDS and 
chemical magnetite were measured on ALS station 4.0.2, Gt. fermentans, Gt. fermentans + 
AQDS, both oxidised Gt. sulfurreducens samples and the natural magnetite sample on SRS 
station 1.1 and the magnetosomes were measured on SRS station 5U.1. Samples were 
prepared by washing aliquots of the suspension in deionised water before drying under 
anaerobic conditions. Approximately 0.01 g of each powder was then mounted in an 
anaerobic cabinet on carbon tape attached to the sample manipulator. Samples were kept 
anaerobic during sampling loading by saturating the manipulator in a stream of N2 gas during 
insertion into the vacuum chamber. The specimen was positioned central to the magnetic pole 
pieces, with the X-ray beam entering through a small centred hole in one of the pole pieces, 
parallel to the magnetic field and perpendicular to the sample surface. The XAS were 
monitored in total-electron yield mode, which gives an effective probing depth of ~4.5 nm. At 
each energy point the XAS were measured for the two opposite magnetisation directions by 
reversing the applied field of 0.6 Tesla. The XAS spectra of the two magnetisation directions 
were normalised to the incident beam intensity and subtracted from each other to give the 
XMCD spectrum (Pattrick et al., 2002). 
The measured Fe L2,3 XMCD was used to obtain the site occupancies of the Fe cations 
in the spinel structure of the magnetite. At the Fe L2,3-edge, 2p core electrons are excited by 
electric-dipole transitions into (partially) localised unoccupied 3d states, so that XMCD 
provides information about the local electronic and magnetic structure of the absorbing atom 
(van der Laan & Thole, 1991). The spectrum is split by the 2p spin-orbit interaction into two 
main structures: the L3- and L2-edge. For magnetite, the intensities of the three main peaks in 
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the L3-edge XMCD with negative, positive, negative intensity are related to the amounts of Fe 
d6 Oh, d5 Td and d5 Oh, respectively, present in the sample (Pattrick et al., 2002). 
To obtain the relative amounts of the three Fe sites, the experimental spectra were 
fitted by means of a non-linear least-squares analysis, using calculated spectra for each of the 
Fe sites (Figure 1). In the calculations, as described in (van der Laan & Thole, 1991), the 
Hartree-Fock Slater integrals for the 3d-3d and 2p-3d Coulomb and exchange interactions 
were scaled to 70% and 80%, respectively, and the crystal fields for the Oh and Td sites were 
taken as 10Dq = 1.2 eV and 0.6 eV, respectively. The calculated spectra were convoluted by a 
Lorentzian of Γ = 0.3(0.5) eV for the L3- (L2-) edge to account for the intrinsic core-hole 
lifetime broadening and by a Gaussian of σ = 0.35 for the SRS 1.1 data, σ = 0.5 eV for the 
SRS 5U.1 data and σ = 0.2 eV for the ALS 4.0.2 data to account for instrumental broadening. 
The experimental spectra were fitted over the L3 main peaks only, which has previously been 
shown to give meaningful results, although fitting over the L2 peak does give good qualitative 
agreement (Pattrick et al., 2002; Pearce et al., 2006).  
To calculate the errors in the fitting of the XMCD spectra the same sample of bio-
magnetite was measured on three different beamlines and then the spectra were fitted using 
the methods above. By taking the standard deviation of the site occupancies according to the 
three different spectra the error in each of the individual sites was found to be 1.10 ± 0.02, 
0.99 ± 0.01, 0.98 ± 0.02 for the d6 Oh, d5 Td, and d5 Oh, respectively. The error in the 
vacancies, which indicate the degree of departure from stoichiometric magnetite, was found to 
be ± 0.01. 
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Figure 1: The calculated Fe L2,3 XMCD spectra for the three different Fe sites in magnetite together with 
the total spectrum. 
 
Results 
Fe(III) reduction 
During anaerobic incubation and transformation to magnetite, cultures containing 
Fe(III)-reducing bacteria were analyzed for Fe(II) concentration using the Ferrozine technique 
(Lovley & Phillips, 1986). Analyses of HCl extractable Fe(II) showed an increase in ferrous 
iron with time and cultures supplemented with the electron shuttle AQDS had a higher rate of 
Fe(III) reduction than those without AQDS (Figure 2). The final amount of Fe(II) in the 
AQDS-supplemented cultures was between 2.5 and 3.0 mM, whereas cultures without the 
electron shuttle showed that only between 1.0 and 1.5 mM of Fe(II) was detectable. However, 
all cultures formed a magnetic precipitate, which was confirmed by holding a bar magnet next 
to the microcosm. The solid also changed colour from orange-brown to black during the 
course of the transformation. 
The size of the biogenic nano-particles was found to range depending on the 
method of formation. M. gryphiswaldense produced cubo-octahedral particles between 42–
45 nm in size (see Figure 3 and (Schüler, 1999)), these are single-domain nanoparticles 
(Dunin-Borkowski et al., 1998). Extracellular biogenic magnetite produced by the 
dissimilatory Fe(III)-reducers all had a less well-defined shape and the particle size range 
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was more varied between 20–30 nm, consistent with previous work by (Fredrickson et al., 
1998; Sparks et al., 1990) 
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Figure 2: Fe(II) concentration variation with time for reduction of ferrihydrite to form magnetite by the Fe(III)-
reducing bacteria, Gb. sulfurreducens (diamonds), S. oneidensis (squares) and Gt. fermentans (triangles), with 
(dotted lines) and without (solid lines) supplementation of the cultures with the electron shuttle AQDS. 
 
 
 
Figure 3. Transmission electron microscope (TEM) images of biogenic magnetite samples, A, 
Magnetospirillum gryphiswaldense, B ,  Geobacter sulfurreducens, C , Shewanella oneidensis,  D ,  Geothrix 
fermentans. 
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XMCD data 
The Fe L2,3 edge XAS spectra for each biogenic magnetite sample were collected in 
opposite magnetic fields, and subtracted from each other to give the XMCD spectrum; an 
example using spectra obtained by analysing the magnetosome magnetite is shown in Figure 
4. These spectra show similar characteristics to those previously recorded for magnetic ferrite-
spinel structure minerals (Pattrick et al., 2002; Pearce et al., 2006). Figure 5 shows the 
XMCD spectra and fits derived from the calculated spectra for each reduced magnetite sample 
(all biogenic) and Figure 6 shows the spectra and fits for each oxidised magnetite sample 
(biogenic, chemical and geological). The curve fitting of each spectrum provides the Fe ion 
oxidation state and site occupancies presented in Table 1. These data were used to determine 
the stoichiometry of the magnetite samples and to calculate the number of vacancies in the 
spinel structure using the method described in (Pearce et al., 2006). The data are compared to 
the theoretical stoichiometric magnetite spectra (see XMCD methods section, Figure 1 & 
Table 1).  
XAS at the L-edge has a probing depth of 4.5 nm. Hence it does not fully reach to the 
core of our nanoparticles, but the fact that smaller particles have an increased surface area 
compared to the core volume works strongly in favour of a representative probing of the 
particles. For the smallest and largest sizes of nanoparticles probed in this study, 20 and 45 
nm in diameter, respectively, the probing depth of XMCD results in information being 
gathered from 83% and 49% of the particle’s material, respectively. In this calculation we 
assumed for simplicity that the particles are spherical. If they are not spherical then the 
surface contribution is even larger, so that the above given percentages can be regarded as 
lower values. Thus the results indicate that a large proportion of the particle is probed by 
XMCD, even for the largest diameter nanoparticles, and therefore it can be considered to be a 
bulk technique in the case of our samples. Furthermore, the results are expected be unaffected 
by the influence of surface effects, such as surface relaxation, which would only affect a depth 
up to ~ 0.35 nm (Kachkachi et al., 2000). 
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Figure 4: The Fe L2,3 absorption spectra of magnetosomes produced by M. gryphiswaldense. The L2,3 edge 
spectra were measured in a reversible 0.6 Tesla magnetic field (dashed and solid lines) and the resulting 
difference spectrum, the XMCD, is shown below (intensity multiplied by three). 
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Figure 5 The Fe L2,3 XMCD experimental (solid line) spectrum and best fit (dashed line) calculated spectrum 
based on the three theoretical site components listed in Table 1 for each reduced magnetite sample (biogenic). 
The difference in energy resolution between the spectra is mainly due to the difference in instrumental resolution 
of the beamlines. 
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Figure 6: The Fe L2,3 XMCD experimental (solid line) spectrum and best fit (dashed line) calculated spectrum 
based on the three theoretical site components listed in Table 1 for each reduced magnetite sample (chemical, 
biogenic and geological). The difference in energy resolution between the spectra is mainly due to the difference 
in instrumental resolution of the beamlines. 
 
Reduced magnetite 
From Table 1 it can be seen that magnetite produced by the three dissimilatory Fe(III)-
reducing bacteria and measured under anaerobic conditions to preserve the characteristics of 
the magnetite at the time of formation, give a different value for the distribution of Fe(II) and 
Fe(III) across the tetrahedral and octahedral sites. These data give a different number of 
vacancies, δ within the spinel structure for each set of samples depending on the bacterium, 
varying from δ = 0 for Gt. fermentans to δ = - 0.03 for Gb. sulfurreducens. For each Fe(III)-
reducing bacterium the samples produced with the electron shuttling compound, AQDS, had a 
value within the error bar of the samples produced without AQDS. Each magnetite sample 
made by Gb. sulfurreducens and S. oneidensis had an Fe(II)/Fe(III) ratio higher, but a Td/Oh 
ratio lower, than that of stoichiometric magnetite. Gt. fermentans had an Fe(II)/Fe(III) ratio 
within error of that of stoichiometric magnetite but a Td/Oh ratio similar to the other bacterial 
samples. Magnetosomal magnetite had a similar distribution of Fe cations to the magnetite 
made by S. oneidensis and Gb. sulfurreducens as the data showed an Fe(II)/Fe(III) ratio of 
0.52, revealing an excess of Fe d6 Oh compared to stoichiometric magnetite. Magnetosomal 
magnetite also had a Td/Oh ratio lower than that of stoichiometric magnetite, similar to the 
extracellular magnetite where there is a slight deficit of d5 cations on the Td sites. 
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Table 1. Fe site occupancies and cation vacancies for magnetites, calculated from XMCD. The spectra were 
fitted to the three main spectral features in the Fe L3 peaks only and the ratios were calculated to the number of 
Fe atoms per unit spinel formula on a 4 oxygen basis. *From Pearce et al. (2006). 
Sample d6 Oh d5 Td d5 Oh 
Cation 
total 
Vacancy Td/Oh Fe2+/Fe3+ 
        
Calculated 1.00 1.00 1.00 3.00 0.00 0.50 0.50 
        
Reduced samples (biogenic) 
        
Gb. sulfurreducens 1.08 0.98 0.97 3.03 -0.03 0.48 0.55 
Gb. sulfurreducens + AQDS 1.04 0.99 0.98 3.01 -0.01 0.49 0.53 
        
S. oneidensis 1.04 0.99 0.98 3.01 -0.01 0.49 0.53 
S. oneidensis + AQDS 1.05 0.99 0.97 3.01 -0.01 0.49 0.54 
        
Gt. fermentans 0.99 0.93 1.08 3.00 0.00 0.45 0.49 
Gt. fermentans + AQDS 0.99 0.94 1.07 3.00 0.00 0.46 0.49 
        
M. gryphiswaldense 1.03 0.97 1.00 3.00 0.00 0.48 0.52 
        
Oxidised samples (biogenic, natural and synthetic) 
        
Gb. sulfurreducens     
(exposed to air for 24 hrs) 
0.76 0.94 1.22 2.92 0.08 0.47 0.35 
        
Gb. sulfurreducens    
(exposed to air for 7 days) 
0.69 1.10 1.11 2.90 0.10 0.61 0.31 
        
Natural magnetite* 0.88 1.00 1.08 2.96 0.04 0.51 0.42 
        
Chemical magnetite 0.70 1.03 1.17 2.90 0.10 0.55 0.32 
 
Oxidised magnetite  
When any single sample of biogenic magnetite data was compared to a sample of 
natural magnetite analyzed using XMCD (Pearce et al., 2006) the contrast was striking. The 
natural ‘geogenic’ magnetite, containing negligible trace elements, had a cation total of 2.96 
and included 0.04 vacancies per formula unit (Table 1). The Fe d6 Oh of geogenic magnetite is 
seen to be lower than for biogenic samples measured anoxically resulting in the Fe(II)/Fe(III) 
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ratio also being lower and the amount of d5 Oh being higher (1.08) to compensate. Chemical 
nano-magnetite (Alfa-Aesar CAS no. 1317-61-9) also showed a site occupancy pattern 
different to the biogenic samples. The same changes were observed as for the sample of 
natural magnetite, but with a greater number of vacancies in the structure; δ = 0.10, as Fe d6 
Oh was only 0.70 (Table 1). 
Samples of biogenic magnetite exposed to air prior to the XMCD measurements were 
also measured and showed similar trends in site occupancy and vacant sites as the natural and 
chemically formed samples above (Table 1 and Figure 6). The amount of Fe d6 Oh in a sample 
of magnetite produced by Gb. sulfurreducens decreased with 12 hours exposure to air with a 
corresponding increase in Fe d5 Oh from 0.97 to 1.22. After further exposure to air for 7 days 
the sample showed a further decrease in Fe d6 Oh from 0.76 to 0.69 with a subsequent increase 
in d5 Td from 0.94 to 1.10 and slight decrease of d5 Oh. The Td/Oh ratio did not change with 
initial exposure to an oxidising atmosphere but after 7 days had increased significantly from 
0.47 to 0.61. The Fe(II)/Fe(III) ratio gradually decreased from 0.55 for reduced bio-magnetite 
to 0.31 for the sample exposed to air for 7 days reflecting the changing site occupancies. 
 
Discussion 
The slower ferrihydrite reduction rates in cultures without AQDS (Figure 2), which 
led to a slower rate of magnetite formation due to a lower concentration of Fe(II) in the 
system, which is thought to catalyse the formation of magnetite from ferrihydrite by Fe(III)-
reducing bacteria (Hansel et al., 2005; Coker et al., submitted), had no effect on the XMCD 
spectra of the magnetite formed. However, the differences in the magnetite produced by 
different bacteria indicates that the mode of iron metabolism does affect the 
structure/chemistry of the magnetite produced. 
 
Reduced biogenic magnetites.  
Both Gb. sulfurreducens and S. oneidensis magnetite samples had Fe(II)/Fe(III) ratios 
larger than 0.50 indicating a more reduced form of magnetite than calculated stoichiometric 
magnetite (Table 1). The increase in Fe d6 Oh compared to stoichiometric magnetite explains 
the excess of total Fe reflected in the ‘negative’ vacancies for these samples. Previous studies 
suggest that factors leading to cation-excess magnetite include environmental parameters such 
as temperature and H2-gas flow rate (Togawa et al., 1996). However, since biogenic 
magnetite is made within a closed system at room temperature, a different mechanism must 
be involved. It has previously been speculated that the anoxic environment that the bacteria 
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require for growth results in an oxygen-deficient spinel (Coker et al., 2006). Magnetite made 
by Gt. fermentans has three Fe cations per formula unit; the same as stoichiometric magnetite. 
However, the XMCD results in Table 1 show that the d5 cations are actually unevenly 
distributed between the Td and Oh sites giving a Td/Oh ratio of 0.45 and 0.46 for samples with 
and without AQDS, respectively. This is lower than the ratio of 0.50 for stoichiometric 
magnetite, showing a statistical preference for the octahedral site by the Fe cations. 
If the subtle differences in the magnetites produced by the bacteria reflect different 
formational mechanisms, the different pathways to produce reduced Fe(II) may provide an 
explanation. In addition to a potentially distinct complement of enzymes in each organism 
that are involved in Fe(III) reduction (reviewed in Lloyd, (2003)), other factors could also be 
important. Gt. fermentans is thought to produce both a chelating agent and an electron 
shuttling compound in order to promote access to reducible Fe(III) (see above). Thus, at least 
some of the ferrihydrite could first be solubilised to form chelated Fe(III) prior to being 
reduced to Fe(II) in the aqueous phase, by the electron shuttle or directly by a terminal 
reductase on  the cell, leading to magnetite production. In this situation the supply of chelated 
Fe(III) could play an important role in controlling the rate of Fe(III) availability as reduction 
proceeds to magnetite in an ordered manner. Under these conditions, the predominance of 
octahedral sites in chelated Fe species may explain the inheritance of a high Oh/Td ratio in the 
magnetite. In contrast, chelating agents have not been detected in cultures of Gb. 
sulfurreducens and S. oneidensis and, interestingly, during reduction of ferrihydrite and 
formation of magnetite an intermediate phase of a more crystalline Fe(III)-mineral, goethite 
(FeO.OH), is formed (Hansel et al., 2003; Coker et al., 2007). The presence of such a phase in 
Geothrix cultures has yet to be assessed, but it is feasible that the diverse mechanisms at work 
may result in Gt. fermentans forming magnetite with a slightly different spinel structure to 
Gb. sulfurreducens and S. oneidensis. This requires further investigation, as there is an 
obvious need for a more detailed picture of the quantitative impact of each distinct 
mechanism on the rate and end point of Fe(III) reduction in the three model organisms. 
Nevertheless, the mineralogical form of Fe(II) and Fe(III), and therefore indirectly the 
mechanism of Fe(III) reduction by different bacterial species, are clearly important factors 
defining the stoichiometry of the mineral that forms from these processes. The rate of 
reduction, affected by the presence of an electron shuttle, is probably not such an important 
factor controlling end product formation due to the lack of difference between those cultures 
supplemented by AQDS compared to those that were not but contained the same bacteria. 
Magnetosomal magnetite has a site occupancy ratio constistent with stoichiometric 
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magnetite. Magnetite produced by magnetotactic bacteria is well ordered as the 
magnetosomal membrane constrains the formation of the magnetite particles resulting in the 
formation of near-stoichiometric nanoparticles (Balkwill et al., 1980; Vali & Kirschvink, 
1990; Taylor & Barry, 2004) 
 
Oxidised magnetites 
Samples of magnetite produced by Gb. sulfurreducens exposed to air for 12 hours, and 
subsequently for a further 7 days, show how sensitive samples of nano-magnetite are to 
oxidation. The end-member of oxidised magnetite is maghemite, Fe3-δO4 where δ= 0.33 for 
the number of vacancies. Vacancies are found on the octahedral site as represented by the 
formula ( )[ ] 43 212 3-13 OFeFeFe δδδ Δ++++ . However, this formula does not give a good description of 
the vacancy distribution in either of the oxidised biogenic magnetite samples since it does not 
account for a change in tetrahedral site occupancy. Schedin et al. (2004) devised a slightly 
different formula however, that takes into account the change in Td site occupancy; 
( )[ ] 43 212 3-13-1 OFeFeFe xyxxy Δ+ ++++ where x is the number of vacant sites Δ, and y is the net transfer of 
Fe(III) from Td to Oh coordination. This formula describes the partially oxidised magnetite 
exposed to air for only 12 h, giving values of x = 0.08 and y = 0.06, respectively. The same 
sample exposed for 7 days gives x = 0.10 and y = 0.10, showing a net transfer of Fe(III) ions 
from Oh to Td coordination, the opposite to that reported in Schedin et al. (2004), as well as a 
continued decrease of the amount of Fe(II) in the structure, expected during an oxidation 
process. These two results show that the oxidation of nano-magnetite occurs in two stages. 
Firstly, Fe(II) Oh is oxidised to Fe(III) but remains on the octahedral sites, with an additional 
transfer of Fe(III) from the tetrahedral sites to maintain charge neutrality. After further 
oxidation, shown by a decrease in the Fe(II)/Fe(III) ratio from 0.35 to 0.31, there is a net gain 
of Fe(III) on the Td sites shown by the Td/Oh ratio increasing from 0.47 to 0.61 and the 
amount of vacancies increasing, again due to a requirement to keep the charge of the Fe 
cations balanced within the mineral. This rapid oxidation of the nano-magnetite surface is a 
result of a large surface to bulk ratio.  
Since XMCD is a surface sensitive technique, the measurements are indicative of 
surface oxidation due to exposure to air. The strongly defective surface of the particle could 
be considered a superstructure, or a second magnetic phase, as it results in nano-particles with 
different magnetic properties (Nekov et al., 2006), which will affect the use of these particles 
in technological applications. If samples of biogenic magnetite are not oxidised then XMCD 
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can differentiate between geogenic (for instance detrital) and biogenic magnetite in sediments 
and soils. However, exposure to air for short periods removes this difference. 
Nanoparticulate chemical magnetite and natural magnetite were also both found to be 
oxidised and contained vacancies due to an iron cation deficiency on the octahedral sites 
(Table 1). Neither show a significant increase or decrease in Td iron, unlike the biogenic 
samples, but instead the Fe cation site occupancy is described well by the simple formula for 
oxidised magnetite of ( )[ ] 43 212 3-13 OFeFeFe δδδ Δ++++ (Schedin et al., 2004), in line with maghemite. 
This differs from the samples of biogenic magnetite that have become oxidised with time 
rather than formed as oxidised precipitates. 
Different Fe(III)-reducing bacteria produce magnetite with subtly different 
characteristics and differences to geogenic and chemically precipitated magnetites. XMCD is 
a very sensitive technique that reveals these differences. Magnetotactic bacteria produce 
magnetite similar to geogenic and chemical magnetite. Small differences in stoichiometry and 
structure can produce major differences in the magnetic and electrical properties that define 
the performance of ferrite spinels in technological devices. Thus these small differences 
reveal the potential of biogenic magnetites to produce materials with unique properties. By 
screening more extracellular magnetite producers, more variations will be revealed. By 
understanding the processes that control the nature of the magnetite produced (including 
genomic investigations) the potential to customise biogenic magnetite for technological uses 
can be exposed.  For instance non-oxidised extracellular magnetite can be used as a catalyst 
for the reduction of azo dyes and other hazard waste compounds and has been found to be 
more efficient than chemical nano-magnetite (Pearce et al., unpublished data). The oxidation 
of biogenic magnetite changes its stoichiometry and its properties, thus it has the potential 
uses in magnetic recording media and drug delivery systems which currently use oxidised 
magnetite (Borrelli et al., 1972; Norio et al., 2005).   
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